 AGREEMENT AND PLAN OF MERGER     

Exhibit 2.1

  

  

  

 


 

  

 


   

  


 

  


 

 

  


 

  

AGREEMENT AND PLAN OF MERGER

  


 

  

among

  


 

  

PHARMEDIUM HEALTHCARE HOLDINGS, INC.,

  


 

  

AMERISOURCEBERGEN CORPORATION,

  


 

  

PARIS ACQUISITION CORP.

  


 

  

and

  


 

  

CLAYTON, DUBILIER and RICE, LLC, as Representative

  


 

  


 

  


 

  

Dated as of October 5, 2015

  


 

  


 

  


    

  

    

  

  

  

TABLE OF CONTENTS

  

  

     

ARTICLE I DEFINITIONS

  

  |  

1

  

   
---|--- 
    

1.1

  

  |  |  

Definitions

  

  |  

1

  

   
    

ARTICLE II MERGER OF MERGER SUB INTO THE COMPANY

  

  |  

16

  

   
    

2.1

  

  |  |  

Merger

  

  |  

16

  

   
    

2.2

  

  |  |  

Closing

  

  |  

16

  

   
    

2.3

  

  |  |  

Effective Time

  

  |  

17

  

   
    

2.4

  

  |  |  

Effects of the Merger

  

  |  

17

  

   
    

2.5

  

  |  |  

Certificate of Incorporation and By-Laws

  

  |  

17

  

   
    

2.6

  

  |  |  

Directors and Officers

  

  |  

17

  

   
    

2.7

  

  |  |  

Conversion of Shares

  

  |  

17

  

   
    

2.8

  

  |  |  

Dissenting Shares

  

  |  

18

  

   
    

2.9

  

  |  |  

Options

  

  |  

19

  

   
    

2.10

  

  |  |  

Payment of Merger Consideration

  

  |  

19

  

   
    

2.11

  

  |  |  

Merger Consideration Adjustment

  

  |  

22

  

   
    

ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  

  |  

27

  

   
    

3.1

  

  |  |  

Due Incorporation; Capitalization

  

  |  

27

  

   
    

3.2

  

  |  |  

Due Authorization

  

  |  

30

  

   
    

3.3

  

  |  |  

Consents and Approvals; No Violations

  

  |  

30

  

   
    

3.4

  

  |  |  

Financial Statements; No Undisclosed Liabilities; Registration Statement

  

  |  

31

  

   
    

3.5

  

  |  |  

Title to Assets, etc

  

  |  

31

  

   
    

3.6

  

  |  |  

Intellectual Property

  

  |  

32

  

   
    

3.7

  

  |  |  

Contracts

  

  |  

34

  

   
    

3.8

  

  |  |  

Insurance

  

  |  

36

  

   
   


 

  


 

  

 

-ii-  

  

TABLE OF CONTENTS

  

(continued)

  

     

3.9

  

  |  |  

Employee Benefit Plans

  

  |  

37

  

   
---|---|---|--- 
    

3.10

  

  |  |  

Taxes

  

  |  

40

  

   
    

3.11

  

  |  |  

Litigation

  

  |  

41

  

   
    

3.12

  

  |  |  

Compliance with Laws; Permits.

  

  |  

42

  

   
    

3.13

  

  |  |  

Environmental Matters

  

  |  

43

  

   
    

3.14

  

  |  |  

Absence of Changes

  

  |  

45

  

   
    

3.15

  

  |  |  

Labor Relations; Compliance

  

  |  

45

  

   
    

3.16

  

  |  |  

Real Property

  

  |  

46

  

   
    

3.17

  

  |  |  

Brokers and Finders

  

  |  

46

  

   
    

3.18

  

  |  |  

Affiliate Agreements

  

  |  

46

  

   
    

3.19

  

  |  |  

Significant Customers and Suppliers

  

  |  

47

  

   
    

3.20

  

  |  |  

Sourcing Arrangements

  

  |  

48

  

   
    

3.21

  

  |  |  

Certain Business Practices

  

  |  

48

  

   
    

3.22

  

  |  |  

NO OTHER REPRESENTATIONS OR WARRANTIES

  

  |  

48

  

   
    

ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  

  |  

48

  

   
    

4.1

  

  |  |  

Due Incorporation

  

  |  

48

  

   
    

4.2

  

  |  |  

Due Authorization

  

  |  

49

  

   
    

4.3

  

  |  |  

Consents and Approvals; No Violations

  

  |  

49

  

   
    

4.4

  

  |  |  

Investigation; Limitation on Warranties

  

  |  

49

  

   
    

4.5

  

  |  |  

No Fraudulent Intent

  

  |  

50

  

   
    

4.6

  

  |  |  

Acquisition for Investment

  

  |  

50

  

   
    

4.7

  

  |  |  

Plant Closings and Mass Layoffs

  

  |  

50

  

   
    

4.8

  

  |  |  

Brokers and Finders

  

  |  

50

  

   
    

4.9

  

  |  |  

Sufficient Funds

  

  |  

50

  

   
   


 

  


 

  

   

  


 

TABLE OF CONTENTS

  

(continued)

  

 

     

4.10

  

  |  |  

Litigation

  

  |  

50

  

   
---|---|---|--- 
    

4.11

  

  |  |  

Operations of Merger Sub

  

  |  

50

  

   
    

ARTICLE V COVENANTS

  

  |  

51

  

   
    

5.1

  

  |  |  

Access to Information and Facilities

  

  |  

51

  

   
    

5.2

  

  |  |  

Preservation of Business

  

  |  

52

  

   
    

5.3

  

  |  |  

Exclusivity

  

  |  

55

  

   
    

5.4

  

  |  |  

Efforts

  

  |  

55

  

   
    

5.5

  

  |  |  

Maintenance of Insurance

  

  |  

57

  

   
    

5.6

  

  |  |  

Supplemental Information

  

  |  

57

  

   
    

5.7

  

  |  |  

Preservation of Records; Post-Closing Access and Cooperation; Litigation
Support

  

  |  

57

  

   
    

5.8

  

  |  |  

Employees and Benefits

  

  |  

58

  

   
    

5.9

  

  |  |  

Public Announcements

  

  |  

59

  

   
    

5.10

  

  |  |  

Indemnification of Directors and Officers

  

  |  

59

  

   
    

5.11

  

  |  |  

Tax Cooperation

  

  |  

60

  

   
    

5.12

  

  |  |  

Transfer Taxes

  

  |  

61

  

   
    

5.13

  

  |  |  

Section 280G Stockholder Approval

  

  |  

61

  

   
    

5.14

  

  |  |  

Section 338 Election

  

  |  

61

  

   
    

5.15

  

  |  |  

Termination of Affiliate Agreements

  

  |  

61

  

   
    

5.16

  

  |  |  

Appraisal Notice

  

  |  

61

  

   
    

5.17

  

  |  |  

Financing

  

  |  

61

  

   
    

5.18

  

  |  |  

Regulatory Matters

  

  |  

62

  

   
    

ARTICLE VI CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB

  

  |  

63

  

   
    

6.1

  

  |  |  

Accuracy of Warranties

  

  |  

63

  

   
   


 

  


 

  


 

  

   

  

TABLE OF CONTENTS

  

(continued) 
 

  


 

     

6.2

  

  |  |  

Compliance with Agreements and Covenants

  

  |  

63

  

   
---|---|---|--- 
    

6.3

  

  |  |  

HSR Clearance

  

  |  

64

  

   
    

6.4

  

  |  |  

No Prohibition

  

  |  

64

  

   
    

6.5

  

  |  |  

No Material Adverse Effect

  

  |  

64

  

   
    

ARTICLE VII CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY

  

  |  

64

  

   
    

7.1

  

  |  |  

Accuracy of Warranties

  

  |  

64

  

   
    

7.2

  

  |  |  

Compliance with Agreements and Covenants

  

  |  

64

  

   
    

7.3

  

  |  |  

HSR Clearance

  

  |  

64

  

   
    

7.4

  

  |  |  

No Prohibition

  

  |  

64

  

   
    

ARTICLE VIII TERMINATION

  

  |  

65

  

   
    

8.1

  

  |  |  

Termination

  

  |  

65

  

   
    

8.2

  

  |  |  

Expenses

  

  |  

66

  

   
    

8.3

  

  |  |  

Effect of Termination

  

  |  

66

  

   
    

8.4

  

  |  |  

Specific Performance

  

  |  

66

  

   
    

ARTICLE IX SURVIVAL; INDEMNIFICATION

  

  |  

66

  

   
    

9.1

  

  |  |  

Survival

  

  |  

66

  

   
    

9.2

  

  |  |  

Parent Parties Indemnification

  

  |  

67

  

   
    

9.3

  

  |  |  

Seller Indemnification

  

  |  

68

  

   
    

9.4

  

  |  |  

Claims

  

  |  

68

  

   
    

9.5

  

  |  |  

Limitations on Indemnification Obligations

  

  |  

70

  

   
    

9.6

  

  |  |  

Indemnification Payments and Indemnification Escrow

  

  |  

72

  

   
    

9.7

  

  |  |  

Exclusive Remedy

  

  |  

73

  

   
    

9.8

  

  |  |  

Tax Treatment of Indemnity Payments

  

  |  

73

  

   
   

     


 

TABLE OF CONTENTS

  

(continued) 
 

 

     

ARTICLE X MISCELLANEOUS

  

  |  

73

  

   
---|--- 
    

10.1

  

  |  |  

Amendment

  

  |  

73

  

   
    

10.2

  

  |  |  

Notices

  

  |  

74

  

   
    

10.3

  

  |  |  

Waivers

  

  |  

75

  

   
    

10.4

  

  |  |  

Counterparts

  

  |  

76

  

   
    

10.5

  

  |  |  

Interpretation

  

  |  

76

  

   
    

10.6

  

  |  |  

APPLICABLE LAW

  

  |  

76

  

   
    

10.7

  

  |  |  

Binding Agreement

  

  |  

76

  

   
    

10.8

  

  |  |  

Assignment

  

  |  

76

  

   
    

10.9

  

  |  |  

Third Party Beneficiaries

  

  |  

77

  

   
    

10.10

  

  |  |  

Further Assurances

  

  |  

77

  

   
    

10.11

  

  |  |  

Entire Understanding

  

  |  

77

  

   
    

10.12

  

  |  |  

JURISDICTION OF DISPUTES

  

  |  

77

  

   
    

10.13

  

  |  |  

WAIVER OF JURY TRIAL

  

  |  

78

  

   
    

10.14

  

  |  |  

Disclosure Letter

  

  |  

78

  

   
    

10.15

  

  |  |  

Severability

  

  |  

79

  

   
    

10.16

  

  |  |  

Construction

  

  |  

79

  

   
    

10.17

  

  |  |  

Provision Respecting Representation of Company

  

  |  

79

  

   
    

10.18

  

  |  |  

Representative

  

  |  

80

  

   
    

10.19

  

  |  |  

Release

  

  |  

81

  

   
   

  


    


 

  

EXHIBITS

  


 

     

Exhibit A

  |  

-

  |  

Accounting Principles and Illustrative Calculation of Working Capital

   
---|---|--- 
     |  |   
    

Exhibit B

  |  

-

  |  

Form of Letter of Transmittal

   
   


 

  


 

  


 

  

   

  


 

  


 

  


 

  

 _AGREEMENT AND PLAN OF MERGER_

  


 

  

THIS AGREEMENT AND PLAN OF MERGER is made as of October 5, 2015, by and among
PharMEDium Healthcare Holdings, Inc., a Delaware corporation (" _Company_ "),
AmerisourceBergen Corporation, a Delaware corporation (" _Parent_ "), Paris
Acquisition Corp., a Delaware corporation (" _Merger Sub_ ") and Clayton,
Dubilier and Rice, LLC, a Delaware limited liability company, solely in its
capacity as the representative for the Common Stockholders and Optionholders
as further provided herein (the " _Representative_ "). Certain capitalized
terms used herein are defined in _Article I_.

  


 

  

 _W I T N E S S E T H_ :

  


 

  

WHEREAS, the boards of directors of Parent (on its own behalf and as the sole
stockholder of Merger Sub) and Merger Sub have approved the acquisition of the
Company by Parent, by means of a merger of Merger Sub with and into the
Company (the " _Merger_ "), with the Company continuing as the surviving
corporation and a wholly-owned subsidiary of Parent (as such, the " _Surviving
Corporation_ "), on the terms and subject to the conditions set forth in this
Agreement;

  


 

  

WHEREAS, the board of directors of the Company ( _i_ ) has determined that the
Merger is advisable and fair to, and in the best interests of, the Company and
its stockholders, ( _ii_ ) has approved this Agreement and the transactions
contemplated hereby and ( _iii_ ) is recommending the adoption of this
Agreement by the stockholders of the Company; and

  


 

  

WHEREAS, the Company expects that within twenty-four (24) hours of the
execution of this Agreement, stockholders of the Company who hold at least
eighty-five percent (85%) of the outstanding Common Stock (the " _Consenting
Stockholders_ ") will adopt and approve this Agreement by execution of a
written consent (the " _Stockholder Consent_ ").

  


 

  

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants,
agreements and warranties herein contained, the parties agree as follows:

  


 

  

ARTICLE I

  


 

  

DEFINITIONS

  


 

  

1.1 _Definitions_. The following terms shall have the following meanings for
the purposes of this Agreement:

  


 

  

" _Additional Merger Consideration_ " shall have the meaning set forth in
_Section 2.11(h)_.

  


 

  

" _Affiliate_ " shall mean, with respect to any specified Person, any other
Person which, directly or indirectly, controls, is under common control with,
or is controlled by, such specified Person.

  


 

  

" _Affiliate Agreements_ " shall have the meaning set forth in _Section 3.18_.

  


 

  


 

    

  


 

  


 

  

" _After-Tax Basis_ " shall mean that, in determining the amount of the
payment necessary to indemnify any Indemnified Party against, or reimburse any
Indemnified Party for, Losses, the amount of such Losses shall be reduced by
any Tax benefit actually realized in the year in which such Losses are
sustained, or the following year, in each case, determined on a "with and
without" basis. For the avoidance of doubt, in the event such Tax benefit is
actually realized in the year following the year in which such Loss is
sustained, the reduction of the Loss will take the form of a repayment to the
applicable Responsible Party when such Tax benefit is actually realized in
such following year.

  


 

  

" _Agreement_ " shall mean this Agreement, including the Disclosure Letter and
the exhibits hereto, as it and they may be amended from time to time.

  


 

  

" _Anti-Corruption Laws_ " shall have the meaning set forth in _Section
3.21(a)_.

  


 

  

" _Applicable Accounting Principles_ " shall mean the accounting principles,
practices and methodologies set forth in _Exhibit A_.

  


 

  

" _Assets_ " shall have the meaning set forth in _Section 3.5_.

  


 

  

" _Balance Sheet Date_ " shall mean June 30, 2015.

  


 

  

" _Benefit Plans_ " shall have the meaning set forth in _Section 3.9(a)_.

  


 

  

" _Burdensome Effect_ " shall have the meaning set forth in _Section_ 5.4(e).

  


 

  

" _Business Day_ " shall mean any day other than a Saturday, Sunday or other
day on which banking institutions in the State of New York are authorized or
required by law or other action of a Governmental Authority to close.

  


 

  

" _Cash_ " shall mean all cash and cash equivalents of the Company and the
Subsidiaries on a consolidated basis determined in accordance with GAAP,
including deposits in transit but net of any outstanding checks (whether
physical checks or wires).

  


 

  

" _CD andR Consulting Agreement_" shall mean that Consulting Agreement, dated as
of January 28, 2014, by and among the Company, CDRF Parent, Inc., PHC and
Clayton, Dubilier and Rice, LLC, as it may be amended from time to time.

  


 

  

" _CD andR Investor_" shall mean CDandR Forest Holdings, L.P.

  


 

  

" _CD andR Pay-off Letter_" shall have the meaning set forth in _Section
2.10(b)(v)_.

  


 

  

" _Certificate_ " shall mean a stock certificate which, immediately prior to
the Effective Time, represents shares of Common Stock.

  


 

  

" _Certificate of Incorporation_ " shall mean the Certificate of Incorporation
of the Company, as amended from time to time, and as filed as of the date
hereof with the Secretary of State of the State of Delaware.

  


 

  


 

  

 

2  

  


 

  


 

  

" _Certificate of Merger_ " shall have the meaning set forth in _Section 2.3_.

  


 

  

" _Claims_ " shall have the meaning set forth in _Section 9.20_.

  


 

  

" _Claim Notice_ " shall have the meaning set forth in _Section 9.4(a)_.

  


 

  

" _Closing_ " shall mean the consummation of the transactions contemplated
herein.

  


 

  

" _Closing Cash Amount_ " shall mean the aggregate amount of Cash as of 11:59
p.m., New York City time, on the day immediately preceding the Closing Date
(but giving effect to and net of any subsequent cash dividends or
distributions by the Company to its stockholders).

  


 

  

" _Closing Date_ " shall have the meaning set forth in _Section 2.2(a)_.

  


 

  

" _Closing Indebtedness_ " shall mean the aggregate amount of Indebtedness
(excluding (x) clause (iv) of the definition of Indebtedness and (y) clause
(vii) of the definition of Indebtedness to the extent not in respect of other
forms of Indebtedness described in clauses (i) - (vi) or (viii) of the
definition thereof) of the Company and the Subsidiaries outstanding
immediately prior to the Closing, together with any prepayment premiums,
penalties, breakage costs, "make whole amounts," costs, expenses and other
payment obligations with respect to such Indebtedness and the repayment,
discharge, unwind or settlement thereof at the Closing.

  


 

  

" _Closing Statement_ " shall have the meaning set forth in _Section 2.11(b)_.

  


 

  

" _Closing Working Capital_ " shall mean Working Capital as of 11:59 p.m., New
York City time, on the day immediately preceding the Closing Date.

  


 

  

" _Code_ " shall mean the Internal Revenue Code of 1986, as amended from time
to time.

  


 

  

" _Common Stock_ " shall have the meaning set forth in _Section 3.1(b)_.

  


 

  

" _Common Stockholder_ " shall mean a holder of Common Stock.

  


 

  

" _Company_ " shall have the meaning set forth in the Preamble.

  


 

  

" _Company Real Property_ " shall have the meaning set forth in _Section
3.16(b)_.

  


 

  

" _Company Representatives_ " shall have the meaning set forth in _Section
5.17(a)_.

  


 

  

" _Company Securities_ " shall have the meaning set forth in _Section 3.1(b)_.

  


 

  

" _Competing Transaction_ " shall have the meaning set forth in _Section 5.3_.

  


 

  

" _Competition Laws_ " shall mean all Laws that are designed or intended to
prohibit, restrict or regulate actions having the purpose or effect of
monopolization or lessening of competition through merger or acquisition or
restraint of trade.

  


 

  

" _Conclusive Date_ " shall have the meaning set forth in _Section
2.11(i)(i)_.

  


 

  


 

  

 

3  

  


 

  


 

  

" _Conclusive Merger Consideration_ " shall have the meaning set forth in
_Section 2.11(g)_.

  


 

  

" _Confidentiality Agreement_ " shall mean that certain letter agreement,
executed as of September 14, 2015, between the Company and Parent relating to
the transactions contemplated hereby.

  


 

  

" _Consenting Stockholders_ " shall have the meaning set forth in the
Recitals.

  


 

  

" _Contamination_ " or " _Contaminated_ " shall mean the presence of Hazardous
Substances in, on or under the soil, groundwater, surface water, groundwater,
air or other environmental media to an extent that any Response Action is
legally required by any Governmental Authority or under any Environmental Law
with respect to such presence of Hazardous Substances.

  


 

  

" _D andO Insurance_" shall have the meaning set forth in _Section 5.10(b)_.

  


 

  

" _DEA_ " shall mean the United States Drug Enforcement Administration.

  


 

  

" _Debt Financing_ " shall have the meaning set forth in _Section 5.17(a)_.

  


 

  

" _Deductible_ " shall have the meaning set forth in _Section 9.5(e)_.

  


 

  

" _DGCL_ " shall mean the General Corporation Law of the State of Delaware, as
amended from time to time.

  


 

  

" _Disclosure Letter_ " shall mean the Disclosure Letter delivered by the
Company to Parent and Merger Sub on the date of this Agreement.

  


 

  

" _Dispute Notice_ " shall have the meaning set forth in _Section 2.11(c)_.

  


 

  

" _Disputed Item_ " shall have the meaning set forth in _Section 2.11(c)_.

  


 

  

" _Dissenting Shares_ " shall have the meaning set forth in _Section 2.8_.

  


 

  

" _DOJ_ " shall have the meaning set forth in _Section 5.4(c)_.

  


 

  

" _Effective Time_ " shall have the meaning set forth in _Section 2.3_.

  


 

  

" _Eligible Insurance Proceeds_ " shall have the meaning set forth in Section
9.5(g).

  


 

  

" _Employee Stock Subscription Agreement_ " shall mean an agreement between
the Company and an employee or director of the Company or any of the
Subsidiaries governing the purchase of Common Stock under the Stock Incentive
Plan.

  


 

  

" _Employees_ " shall have the meaning set forth in _Section 5.7(a)_.

  


 

  

" _Environmental Law_ " shall mean any Law or Permit pertaining to the
protection of the environment (including ISRA) or, as it relates to exposure
to hazardous or toxic materials present in the indoor or outdoor environment,
health and safety.

  


 

  


 

  

 

4  

  


 

  


 

  

" _Environmental Permits_ " shall have the meaning set forth in Section
3.13(b).

  


 

  

" _ERISA_ " shall mean the Employee Retirement Income Security Act of 1974, as
amended.

  


 

  

" _ERISA Affiliate_ " shall mean, with respect to any Person, any trade or
business, whether or not incorporated, which, together with such Person, is
treated as a single employer under Section 414 of the Code.

  


 

  

" _Escrow Agent_ " shall mean JPMorgan Chase Bank, N.A. or another financial
institution jointly designated by the Representative and Parent.

  


 

  

" _Estimated Closing Cash Amount_ " shall have the meaning set forth in
_Section 2.11(a)_.

  


 

  

" _Estimated Closing Indebtedness_ " shall have the meaning set forth in
_Section 2.11(a)_.

  


 

  

" _Estimated Merger Consideration_ " shall have the meaning set forth in
_Section 2.10(a)_.

  


 

  

" _Estimated Seller Transaction Expenses_ " shall have the meaning set forth
in _Section 2.11(a)_.

  


 

  

" _Estimated Transaction Tax Benefit Amount_ " shall have the meaning set
forth in _Section 2.11(a)_.

  


 

  

" _Estimated Working Capital_ " shall have the meaning set forth in _Section
2.11(a)_.

  


 

  

" _Estimated Working Capital Adjustment_ " shall have the meaning set forth in
_Section 2.10(a)(iii)_.

  


 

  

" _Excess Amount_ " shall have the meaning set forth in _Section 2.11(h)_.

  


 

  

" _Existing Credit Agreements_ " shall mean ( _i_ ) the First Lien Credit
Agreement, dated January 28, 2014, by and among PHC, the lenders from time to
time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and
collateral agent and the other agents party thereto, and ( _ii_ ) the Second
Lien Credit Agreement, dated January 28, 2014, by and among PHC, the lenders
from time to time party thereto, Credit Suisse AG, as administrative agent and
collateral agent and the other agents party thereto.

  


 

  

" _Existing Lenders_ " shall mean the lending institutions party to the Credit
Agreements.

  


 

  

" _Existing Lenders Pay-off Letters_ " shall have the meaning set forth in
_Section 2.10(b)(i)_.

  


 

  

" _FDA_ " shall mean the United States Food and Drug Administration.

  


 

  

" _Final Adjustment Amount_ " shall have the meaning set forth in _Section
2.11(h)_.

  


 

  

" _Final Working Capital_ " shall have the meaning set forth in _Section
2.11(b)_.

  


 

  

" _Financial Advisor Fees_ " shall have the meaning set forth in _Section
2.10(b)(v)_.

  


 

  


 

  

 

5  

  


 

  


 

  

" _Financial Statements_ " shall mean the following:

  


 

  

(a) the audited consolidated financial statements of the Company and the
Subsidiaries as of December 31, 2014 and 2013 (including all notes thereto),
as included in Section 1.1(a) of the Disclosure Letter, consisting of the
consolidated balance sheet at such date and the related consolidated
statements of operations, shareholders' equity and cash flows for each of the
fiscal years then ended; and

  


 

  

(b) the unaudited consolidated financial statements of the Company and the
Subsidiaries as of June 30, 2015, as included in Section 1.1(a) of the
Disclosure Letter, consisting of the consolidated balance sheet at such date
and the related consolidated statements of operations and cash flows for the
six-month period then ended (the " _Interim Financial Statements_ ").

  


 

  

" _FTC_ " shall have the meaning set forth in _Section 5.4(c)_.

  


 

  

" _Fully-Diluted Outstanding Stock_ " shall mean, as of any date, the total
number of shares of Common Stock outstanding as of such date (determined on a
fully-diluted, as-if-exercised basis and assuming the exercise and settlement
of all Options, whether or not exercised, exercisable, settled, eligible for
settlement or vested).

  


 

  

" _Fully-Diluted Stockholder_ " shall mean each holder of the Fully-Diluted
Outstanding Stock (including the Options), all of whom, as of the date hereof,
are set forth in Section 1.1(b) of the Disclosure Letter.

  


 

  

" _Fully-Diluted Stockholder Proceeds_ " shall have the meaning set forth in
_Section 2.10(b)_.

  


 

  

" _Fundamental Representations_ " shall have the meaning set forth in _Section
6.1_.

  


 

  

" _Funds Flow Memo_ " shall have the meaning set forth in _Section 2.10(b)_.

  


 

  

" _GAAP_ " shall mean U.S. generally accepted accounting principles,
consistently applied.

  


 

  

" _Governmental Authority_ " shall mean any U.S., state, local or foreign
government, any governmental, regulatory or administrative body, agency or
authority, any court or judicial authority or arbitration tribunal, whether
national, federal, state or local or otherwise.

  


 

  

" _GPO_ " shall have the meaning set forth in _Section 3.7(a)(xxi)_.

  


 

  

" _Hazardous Substance_ " shall mean any substance, material or waste that is
or contains asbestos, urea formaldehyde insulation, polychlorinated biphenyls,
petroleum or any petroleum-based products or constituents, radon gas,
microbiological contamination or related materials or any other substance,
material, pollutant, contaminant or waste, that is defined, classified, listed
or regulated under, or require a Response Action pursuant to, any
Environmental Law.

  


 

  

" _Health Care Provider_ " shall mean any Person involved in the provision of
health care services and or items to patients, which Person is in a position
to purchase, lease, recommend, use, arrange for the purchase or lease of, or
prescribe any products sold by the Company or any of the Subsidiaries.

  


 

  


 

  

 

6  

  


 

  


 

  

" _HSR Act_ " shall mean the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended, and the regulations promulgated thereunder.

  


 

  

" _Indebtedness_ " shall mean, with respect to any Person, without
duplication, (i) all obligations of such Person for borrowed money, including
accrued and unpaid interest thereon (but excluding, for the avoidance of
doubt, any trade payables and accrued expenses arising in the ordinary course
of business consistent with past practice), (ii) all obligations of such
Person evidenced by bonds (other than the surety bonds set forth in Section
1.1(c) of the Disclosure Letter), debentures, notes or similar instruments,
(iii) all obligations of such Person to pay the deferred purchase price of
property or services (including any potential future earn-out, purchase price
adjustment, release of "holdback" or similar payment, but excluding any
obligations for raw materials, inventory, services and supplies incurred in
the ordinary course of business consistent with past practice), (iv) all lease
obligations of such Person required under GAAP to be capitalized on the books
and records of such Person, but only to the extent that such lease either is
not set forth in Section 1.1(c) or 3.16(a) of the Disclosure Letter or is
entered into after the date hereof, (v) all obligations of such Person under
interest rate, currency or commodity derivatives or hedging transactions or
similar arrangement, (vi) all obligations under drawn letters of credit or
performance bonds issued for the account of such Person (other than the surety
bonds set forth in Section 1.1(c) of the Disclosure Letter and excluding
letters of credit issued for the benefit of suppliers to support accounts
payable to suppliers incurred in the ordinary course of business consistent
with past practice), (vii) all guarantees and keepwell arrangements of such
Person of any Indebtedness of any other Person other than a subsidiary of such
Person and (viii) all obligations in respect of prepayment premiums,
penalties, breakage costs, "make whole amounts," costs, expenses and other
payment obligations that would arise if all Indebtedness referred to in
clauses (i) through (vii) above were prepaid (or, in the case of any swap,
option, derivative, hedging or similar arrangement, unwound and fully
settled).

  


 

  

" _Indemnification Dispute Notice_ " shall have the meaning set forth in
_Section 9.4(b)_.

  


 

  

" _Indemnification Escrow Account_ " shall have the meaning set forth in
_Section 2.10(b)(ii)_.

  


 

  

" _Indemnification Escrow Agreement_ " shall mean an Indemnification Escrow
Agreement, dated as of the Closing Date, among the Representative, on behalf
of the Fully-Diluted Stockholders, the Escrow Agent, and Parent, in a form to
be reasonably agreed upon by the parties thereto, as such agreement may be
amended from time to time.

  


 

  

" _Indemnification Escrow Amount_ " shall have the meaning set forth in
_Section 2.10(b)(ii)_.

  


 

  

" _Indemnification Escrow Remainder_ " shall have the meaning set forth in
_Section 9.6(b)_.

  


 

  

" _Indemnified Party_ " shall have the meaning set forth in _Section 9.4(a)_.

  


 

  

" _Indemnitees_ " shall have the meaning set forth in _Section 5.10(a)_.

  


 

  


 

  

 

7  

  


 

  


 

  

" _Independent Accountant_ " shall mean a partner in the New York office of a
nationally recognized independent registered public accounting firm appointed
by mutual agreement of Parent and the Representative.

  


 

  

" _Intellectual Property_ " shall mean all intellectual property and other
similar proprietary rights in any jurisdiction, including: (a) all United
States and foreign patents and applications therefor (including utility and
design patents), statutory invention registrations and all reissues,
divisions, renewals, extensions, provisionals, continuations and
continuations-in-part thereof, (b) all inventions (whether patentable or not),
invention disclosures, improvements, trade secrets, manufacturing processes,
test and qualification processes, designs, schematics, proprietary
information, know-how, technology, technical data, regulatory requirements and
information, clinical data and protocols, research and development information
(including all research and development data, experimental and project plans
and pipeline product information), and all documentation (in whatever form or
medium) to the extent embodying any of the foregoing, (c) all works of
authorship (whether copyrightable or not), copyrights, copyright registrations
and applications therefor, including in Software, documentation, databases and
internet website content, (d) all internet uniform resource locators and
domain names, and (e) all trade names, logos, slogans, designs, trade dress,
common law trademarks and service marks, trademark and service mark and trade
dress registrations and applications therefor.

  


 

  

" _Internal IT Systems_ " shall mean the hardware, Software, network and
telecommunications equipment and Internet-related information technology
infrastructure owned or leased by the Company or any of the Subsidiaries and
used in their businesses.

  


 

  

" _ISRA_ " shall mean the New Jersey Industrial Site Recovery Act, NJSA
13:1K-6 et seq, as amended and including all regulations thereunder.

  


 

  

" _Knowledge of Parent_ " shall mean the actual knowledge, after reasonable
inquiry, of the individuals set forth in Section 1.1(d) of the Disclosure
Letter.

  


 

  

" _Knowledge of the Company_ " shall mean the actual knowledge, after
reasonable inquiry, of the individuals set forth in Section 1.1(e) of the
Disclosure Letter.

  


 

  

" _Laws_ " shall have the meaning set forth in _Section 3.12(a)_.

  


 

  

" _Leased Real Property_ " shall have the meaning set forth in _Section
3.16(a)_.

  


 

  

" _Leases_ " shall have the meaning set forth in _Section 3.16(a)_.

  


 

  

" _Letter of Transmittal_ " shall have the meaning set forth in _Section
2.10(c)(i)_.

  


 

  

" _Liabilities_ " shall have the meaning set forth in _Section 3.4(b)_.

  


 

  

" _License_ " shall have the meaning set forth in _Section 3.6(d)_.

  


 

  

" _Liens_ " shall mean liens, encumbrances, mortgages, charges, claims,
restrictions, pledges, security interests, title defects, easements, rights-
of-way, covenants, encroachments or other similar adverse claims of any kind
with respect to a property or asset.

  


 

  


 

  

 

8  

  


 

  


 

  

" _Litigation_ " shall have the meaning set forth in _Section 3.11_.

  


 

  

" _Losses_ " shall mean any and all damages, judgments, awards, Liabilities,
Taxes, losses, obligations, fines and costs and expenses (including reasonable
fees and expenses of attorneys, auditors, consultants and other agents).

  


 

  

" _Material Adverse Effect_ " shall mean any change, event, fact, effect or
occurrence that has, or would reasonably be expected to have, a material
adverse effect on the financial condition, business, properties, assets or
results of operations of the Company and the Subsidiaries, taken as a whole;
_provided_ , _however_ , that in determining whether there has been a Material
Adverse Effect or whether a Material Adverse Effect could or would occur, any
change, event, fact, effect or occurrence attributable to, arising out of, or
resulting from any of the following shall be disregarded: (i) general
political, economic, business, industry, credit, financial or capital market
conditions in the United States or internationally, including conditions
affecting generally the principal industries in which the Company and the
Subsidiaries operate; (ii) the taking of any action required by, or the
omission of any action prohibited by, this Agreement; (iii) other than for
purposes of the representations and warranties made in _Section 3.3_ , the
negotiation, execution or announcement of this Agreement or pendency of the
Merger; (iv) the taking or omission of any action expressly with the written
approval of Parent; (v) pandemics, earthquakes, tornados, hurricanes, floods
and acts of God; (vi) acts of war (whether declared or not declared),
sabotage, terrorism, military actions or the escalation thereof; and (vii) any
changes or proposed changes after the date hereof in applicable Laws,
regulations or accounting rules, including GAAP or interpretations thereof or
any changes or proposed changes after the date hereof in the interpretation or
enforcement of any of the foregoing; _provided_ , _further_ , that changes,
events, facts, effects or occurrences set forth in clauses (i), (v) or (vi)
may be taken into account in determining whether there has been, could or
would be a Material Adverse Effect to the extent such changes, events, facts,
effects or occurrences have a disproportionate adverse effect on the Company
and the Subsidiaries, taken as whole, in relation to other Persons in the
principal industries of the Company and the Subsidiaries.

  


 

  

" _Material Contracts_ " shall have the meaning set forth in _Section 3.7(a)_.

  


 

  

" _Merger_ " shall have the meaning set forth in the Recitals.

  


 

  

" _Merger Consideration_ " shall have the meaning set forth in _Section
2.11(a)_.

  


 

  

" _Merger Sub_ " shall have the meaning set forth in the Preamble.

  


 

  

" _Multiemployer Plan_ " shall have the meaning set forth in Section 3(37) of
ERISA.

  


 

  

" _Multiple Employer Plan_ " shall mean a plan that has two or more
contributing sponsors at least two of whom are not under common control,
within the meaning of Section 4063 of ERISA.

  


 

  

" _Notice of Disagreement_ " shall have the meaning set forth in _Section
2.11(c)_.

  


 

  

" _Notice of Insurance_ " shall have the meaning set forth in Section 9.5(g).

  


 

  


 

  

 

9  

  


 

  


 

  

" _Open Source Code_ " shall mean any software code, or data library that is
licensed as freeware, shareware, open source software or similar licensing
models and that (i) requires the licensing or distribution of source code to
licensees, at no additional charge, (ii) prohibits or limit the receipt of
consideration in connection with sublicensing or distributing any software, or
(iii) requires (or could or does condition the use or distribution of such
software on) the granting of a license under the patent rights of the Company
or the Subsidiaries. For the avoidance of doubt, Open Source Code includes
software licensed or distributed under any of the following licenses or
distribution models terms: (i) GNU's General Public License (GPL) or
Lesser/Library GPL (LGPL); (ii) the Artistic License (e.g., PERL); (iii) the
Mozilla Public License; (iv) the BSD License; and (v) the Apache License.

  


 

  

" _Option Proceeds_ " shall mean the aggregate exercise price payable to the
Company upon exercise of all Options that are outstanding immediately prior to
the Effective Time.

  


 

  

" _Optionholder_ " shall mean a holder of Options.

  


 

  

" _Options_ " shall mean the outstanding options to purchase shares of Common
Stock under the Stock Incentive Plan.

  


 

  

" _Order_ " shall mean any award, judgment, injunction, determination,
consent, ruling, decree or order (whether temporary, preliminary or permanent)
issued, adopted, granted, awarded or entered by any Governmental Authority or
private arbitrator of competent jurisdiction.

  


 

  

" _Organizational Documents_ " shall mean the articles of incorporation,
certificate of incorporation, charter, by-laws, articles of formation,
certificate of formation, regulations, operating agreement, certificate of
limited partnership, partnership agreement and all other similar documents,
instruments or certificates executed, adopted or filed in connection with the
creation, formation or organization of a Person, including any amendments
thereto.

  


 

  

" _Owned Intellectual Property_ " shall have the meaning set forth in _Section
3.6(a)_.

  


 

  

" _Owned Real Property_ " shall have the meaning set forth in _Section
3.16(b)_.

  


 

  

" _Ownership Percentage_ " shall mean the percentage set forth opposite each
Fully-Diluted Stockholder's name in Section 1.1(b) of the Disclosure Letter.

  


 

  

" _Parent_ " shall have the meaning set forth in the Preamble.

  


 

  

" _Parent Indemnified Parties_ " shall have the meaning set forth in _Section
9.2_.

  


 

  

" _Parent Releasor_ " shall have the meaning set forth in _Section 9.20_.

  


 

  

" _Per Option Merger Consideration_ " shall mean, with respect to any Option,
an amount equal to (A) the number of shares of Common Stock underlying such
Option multiplied by (B) (i) the Per Share Common Stock Merger Consideration,
minus (ii) the per share exercise price of such Option.

  


 

  


 

  

 

10  

  


 

  


 

  

" _Per Share Common Stock Merger Consideration_ " shall mean, with respect to
each share of Common Stock, the per share cash amount determined by _dividing_
( _A_ ) the sum of: ( _i_ ) the Fully-Diluted Stockholder Proceeds and ( _ii_
) the Option Proceeds, _by_ ( _B_ ) the Fully-Diluted Outstanding Stock
immediately prior to the Effective Time.

  


 

  

" _Permits_ " shall have the meaning set forth in _Section 3.12(b)_.

  


 

  

" _Permitted Liens_ " shall mean (a) Liens for Taxes, assessments and
governmental charges or levies not yet delinquent or being contested in good
faith through appropriate proceedings and for which adequate reserves are
maintained on the Interim Financial Statements in accordance with GAAP; (b)
materialmen's, mechanics', carriers', workmen's and repairmen's liens and
other similar liens imposed by Law arising in the ordinary course of business
securing obligations that are not overdue for a period of more than sixty (60)
calendar days or which are being contested in good faith by appropriate
proceedings and, to the extent required under GAAP, for which adequate
reserves are maintained on the Interim Financial Statements; (c) pledges or
deposits to secure obligations under workers' compensation laws or similar
legislation or to secure public or statutory obligations; (d) deposits to
secure the performance of bids, trade contracts, leases, statutory
obligations, surety and appeal bonds, performance bonds and other obligations
of a like nature incurred in the ordinary course of business consistent with
past practice; (e) all matters set forth in the title insurance policies for
Owned Real Property provided to Parent, none of which materially detracts from
the value of, or materially and adversely interfere with the present use of,
such real property; (f) all applicable zoning, entitlement, conservation
restrictions and other land use regulations; (g) all exceptions, restrictions,
easements, charges, rights-of-way and other Liens set forth in any permits,
any deed restrictions, groundwater or land use limitations or other
institutional controls, in each case to the extent utilized in connection with
any required Response Action, or other state, local or municipal Permit
applicable to the Company or the Subsidiaries or any of their respective
properties; (h) Liens, including those securing the obligations of the Company
or the Subsidiaries under or in respect of Indebtedness under the Existing
Credit Agreements, which shall be removed prior to or at the Closing; and (i)
Liens listed in Section 1.1(f) of the Disclosure Letter.

  


 

  

" _Person_ " shall mean an individual, corporation, partnership, joint
venture, trust, association, estate, joint stock company, limited liability
company, Governmental Authority or any other organization or entity of any
kind (other than the Company or the Subsidiaries).

  


 

  

" _Personal Information_ " shall mean (a) any information which can be
reasonably used to identify an individual, including individual demographic
information, (b) social security number or (c) any individual information that
is covered by the Payment Card Industry Data Security Standard or HIPAA.

  


 

  

" _PHC_ " shall mean PharMEDium Healthcare Corporation, a Delaware
corporation.

  


 

  

" _Post-Closing Payments_ " shall mean the amounts, if any, paid per share of
Common Stock or Option pursuant to _Section 2.11(i)_, _Section 9.6(b)_ and
_Section 9.6(c)_.

  


 

  

" _Potential Contributors_ " shall have the meaning set forth in Section
9.5(i).

  


 

  

" _Pre-Closing Statement_ " shall have the meaning set forth in _Section
2.11(a)_.

  


 

  


 

  

 

11  

  


 

  


 

  

" _Purchase Price Adjustment Escrow Account_ " shall have the meaning set
forth in _Section 2.10(b)(iii)_.

  


 

  

" _Qualifying Loss_ " shall have the meaning set forth in _Section_ 9.5(b).

  


 

  

" _Purchase Price Adjustment Escrow Agreement_ " shall mean a Purchase Price
Adjustment Escrow Agreement, dated as of the Closing Date, among the
Representative, on behalf of the Fully-Diluted Stockholders, the Escrow Agent,
and Parent, in a form to be reasonably agreed upon by the parties thereto, as
such agreement may be amended from time to time.

  


 

  

" _Purchase Price Adjustment Escrow Amount_ " shall have the meaning set forth
in _Section 2.10(b)(iv)_.

  


 

  

" _Related Parties_ " shall mean, collectively, ( _x_ ) Parent and Merger Sub,
( _y_ ) the former, current and future holders of any equity, partnership or
limited liability company interest, controlling persons, directors, officers,
employees, agents, attorneys, Affiliates, members, managers, general or
limited partners, stockholders, or assignees of Parent or Merger Sub and ( _z_
) any future holders of any equity, partnership or limited liability company
interest, controlling persons, directors, officers, employees, agents,
attorneys, Affiliates, members, managers, general or limited partners,
stockholders, or assignees of any of the foregoing.

  


 

  

" _Release_ " shall mean any releasing, disposing, discharging, injecting,
spilling, leaking, leaching, pumping, dumping, emitting, escaping, emptying,
seeping, dispersal, migration, transporting, placing and the like, including
the moving of any materials through, into or upon, any land, soil, surface
water, groundwater or air, or otherwise entering into the indoor or outdoor
environment.

  


 

  

" _Representative_ " shall have the meaning set forth in the Preamble.

  


 

  

" _Representative Escrow Amount_ " shall have the meaning set forth in
_Section 2.10(b)(iii)_.

  


 

  

" _Resolution Period_ " shall have the meaning set forth in _Section 2.11(d)_.

  


 

  

" _Response Action_ " shall mean any action taken to investigate, abate,
monitor, remediate, remove, mitigate or otherwise address any violation of
Environmental Law, any Contamination of any property owned, leased or occupied
by the Company or the Subsidiaries or any Release or threatened Release of
Hazardous Substances, including any action that would be a "response" as
defined by the Comprehensive Environmental Response, Compensation and
Liability Act, as amended at the Closing Date, 42 U.S.C. ยง9601 (25).

  


 

  

" _SEC_ " shall mean the Securities and Exchange Commission.

  


 

  

" _Securities Act_ " shall mean the Securities Act of 1933, as amended from
time to time.

  


 

  

" _Seller Group_ " shall have the meaning set forth in _Section 10.17_.

  


 

  

" _Seller Releasee_ " shall have the meaning set forth in _Section 1019_.

  


 

  


 

  

 

12  

  


 

  


 

  

" _Seller Transaction Expenses_ " shall mean all fees, costs and expenses
incurred or payable by or on behalf of the Company or any Subsidiary
(including, for purposes of clarity, any such fees, costs or expenses incurred
by any Affiliate of the Company but payable by the Company or any Subsidiary)
in connection with or arising out of the contemplated initial public offering
of equity securities of the Company or this Agreement or the planning,
structuring, negotiation or consummation of the transactions contemplated
hereby, including (a) those of all attorneys, accountants, actuaries,
consultants, experts or other professionals, if any, engaged by or on behalf
of the Company or any Subsidiary in connection with the contemplated initial
public offering of equity securities of the Company or this Agreement and the
transactions contemplated hereby and (b) the amount of any retention, sale,
management or other amount paid or payable to any director, officer, employee
or independent contractor in the nature of a related transaction or retention
bonus, together with 50% of the uncapped employer portion of any employment
Taxes imposed at a rate of 1.45% on the payment of any such amounts;
_provided_ , that Seller Transaction Expenses shall not include any fees,
costs or expenses incurred by the Company after the Effective Time in relation
to or arising out of any interpretation, dispute or Litigation relating to
this Agreement or the transactions contemplated hereby (it being agreed that
any fees, costs or expenses incurred after the Effective Time by the
Representative, including when acting on behalf of the Fully-Diluted
Stockholders, shall be the responsibility of the Representative and shall not
be the responsibility of the Company, Parent or any of their respective
Subsidiaries).

  


 

  

" _Significant Customers_ " shall have the meaning set forth in _Section
3.19(a)_.

  


 

  

" _Significant Suppliers_ " shall have the meaning set forth in _Section
3.19(b)_.

  


 

  

" _Software_ " shall mean all computer software and programs, including, but
not limited to, application software, system software and firmware, including
all source code and object code versions thereof, in any and all forms and
media, and all related documentation.

  


 

  

" _Specified Permit Assurance_ _s_ " shall have the meaning set forth in
_Section 2.2_ of the Disclosure Letter.

  


 

  

" _Stock Incentive Plan_ " shall mean the CDRF Topco, Inc. Stock Incentive
Plan, as amended from time to time.

  


 

  

" _Stockholder Consent_ " shall have the meaning set forth in the Recitals.

  


 

  

" _Subsidiaries_ " shall mean each of the Company's direct and indirect
subsidiaries.

  


 

  

" _Subsidiary Securities_ " shall have the meaning set forth in _Section
3.1(c)_.

  


 

  

" _Survival Termination Date_ " shall have the meaning set forth in _Section
9.1_.

  


 

  

" _Surviving Corporation_ " shall have the meaning set forth in the Recitals.

  


 

  

" _Takeover Law_ " shall mean any "moratorium," "control share acquisition,"
"business combination," "fair price" or other form of anti-takeover Laws of
any jurisdiction or other applicable Laws that purport to limit or restrict
business combinations or the ability to limit or restrict business
combinations or the ability to acquire or to vote shares.

  


 

  


 

  

 

13  

  


 

  


 

  

" _Target Working Capital_ " shall mean $40,240,000.

  


 

  

" _Tax_ " (and, with correlative meaning, "Taxes," "Taxable" and "Taxing")
shall mean any net income, capital gains, gross income, gross receipts, sales,
use, transfer, ad valorem, franchise, profits, license, capital, withholding,
payroll, estimated, employment, excise, goods and services, severance, stamp,
occupation, premium, property, social security, environmental (including
Section 59A of the Code), alternative or add-on, value added, registration,
occupancy, capital stock, unincorporated business, unemployment, disability,
workers compensation, accumulated earnings, personal holding company, annual
reports, windfall profits or other taxes, duties, charges, fees, levies or
other assessments imposed by any Governmental Authority, or any interest,
penalties or additions thereto incurred under applicable Laws.

  


 

  

" _Tax Return_ " shall mean any report, return (including any information
return), declaration, claim for refund or other filing required or permitted
to be supplied to any Taxing Authority or jurisdiction with respect to Taxes,
including any amendments or attachments to such reports, returns, declarations
or other filings.

  


 

  

" _Taxing Authority_ " shall mean any Governmental Authority responsible for
the administration or the imposition of any Tax.

  


 

  

" _Termination Date_ " shall have the meaning set forth in _Section 8.1(b)_.

  


 

  

" _Third Party Claim_ " shall have the meaning set forth in _Section_ 9.4(b).

  


 

  

" _Third Party Insurance_ " shall mean, with respect to any Person, any
insurance provided by any other Person not Affiliated with such Person, and
excluding any self-insurance, risk management program or other funds set aside
by such Person in connection therewith.

  


 

  

" _Third Party Interests_ " shall have the meaning set forth in _Section
3.1(e)_.

  


 

  

" _Transaction Tax Benefit Amount_ " shall mean the product of: ( _A_ ) 38.5%
_multiplied by_ ( _B_ ) the sum of:

  


 

  

    | (i) | seventy percent (70%) of the portion of the Financial Advisor
Fees that are contingent on a successful closing of the Merger;  
---|---|--- 
  

  


 

  

    | (ii) | the aggregate amount of any cash transaction bonuses granted
in accordance with Section 5.8(e) of the Disclosure Letter;  
---|---|--- 
  

  


 

  

    | (iii) | the amount paid in respect of the Options pursuant to this
Agreement, including the Optionholders' proportionate share of the amounts
paid into an escrow pursuant to Sections 2.10(b)(ii), (iii) and (iv), assuming
such amounts were released in full to the Optionholders;  
---|---|--- 
  

  


 

  


 

  

 

14  

  


 

  


 

  

    | (iv) | the amount of any prepayment penalties, premium, original
issue discount and other expenses paid, and the amount of unamortized fees and
expenses written off, in connection with the pay-off of the Indebtedness of
the Company or the Subsidiaries pursuant to this Agreement, including, for the
avoidance of doubt, any costs with respect to the termination of any swap
related to such Indebtedness;  
---|---|--- 
  

  


 

  

    | (v) | 60% of any legal or accounting fees and expenses paid by the
Company or any Subsidiary in connection with the transactions contemplated by
this Agreement; and  
---|---|--- 
  

  


 

  

    | (vi) | the amount of any legal or accounting fees and expenses, in
each case paid by the Company or any Subsidiary in connection with the
contemplated initial public offering of equity securities of the Company, but
only to the extent the initial public offering and the Merger are not
"mutually exclusive" (within the meaning of Treas. Reg. ยง 1.263(a)-5(c)(8))
transactions.  
---|---|--- 
  

  


 

  

For the avoidance of doubt, neither the Transaction Tax Benefit Amount nor any
amount included in clause (B) of this definition shall be taken into account
in determining Working Capital.

  


 

  

" _Unresolved Claims_ " shall have the meaning set forth in _Section 9.6(b)_.

  


 

  

" _Unresolved Items_ " shall have the meaning set forth in _Section 2.11(e)_.

  


 

  

" _Virus_ " shall mean malicious code, whether or not capable of replication
or attachment to disks or other files, that is capable of performing an
illicit activity or replicating itself on a computer or network of computers
and thereby damaging other computer programs or data located on such computer
or network or otherwise causing any computer data, memory or related hardware
to become, without specific user instructions, erased, altered or unusable.
The term shall include viruses, Trojan horses, worms or similar malicious
software, programs or files.

  


 

  

" _WARN Act_ " shall mean the Worker Adjustment and Retraining Notification
Act of 1988, as amended, and any applicable state or local mass layoff or
plant-closing Laws.

  


 

  

" _Withholding Taxes_ " shall have the meaning set forth in _Section
2.10(c)(vi)_.

  


 

  

" _Working Capital_ " shall have the meaning set forth on _Exhibit A_ and
shall be prepared in accordance with the Applicable Accounting Principles.

  


 

  

" _Working Capital Adjustment Amount_ " shall have the meaning set forth in
_Section 2.11(g)(ii)_.

  


 

  


 

  

 

15  

  


 

  


 

  

ARTICLE II

  


 

  

MERGER OF MERGER SUB INTO THE COMPANY

  


 

  

2.1 _Merger_. Upon the terms and subject to the conditions set forth in this
Agreement, at the Effective Time, Merger Sub shall be merged with and into the
Company in accordance with the terms of, and subject to the conditions set
forth in, this Agreement and the DGCL. Following the Merger, the Company shall
continue as the Surviving Corporation and the separate corporate existence of
Merger Sub shall cease.

  


 

  

2.2 _Closing_.

  


 

  

(a) The Closing shall take place at the offices of Debevoise and Plimpton LLP,
919 Third Avenue, New York, New York 10022 at 10:00 A.M. on (i) the date that
is three (3) Business Days after the satisfaction or waiver of the conditions
precedent set forth in _Article VI_ and _Article VII_ (other than those
conditions that by their terms are to be satisfied by actions taken at the
Closing, but subject to the satisfaction or waiver of those conditions at such
time); _provided_ , _however_ , that if on such date the Specified Permit
Assurances have not been obtained, and the failure to obtain such Specified
Permit Assurances would create a substantial risk that the Company and the
Subsidiaries would not be able to operate in, or distribute products to
customers in, the applicable jurisdiction, then notwithstanding the Parties'
reasonable best efforts to obtain such Specified Permit Assurances, Parent may
elect to postpone the Closing (and will deliver a written notice to the
Company of such election) until the earlier of (A) November 25, 2015 and (B)
the date that is three (3) Business Days after the date on which such
Specified Permit Assurances have been obtained, subject to the continued
satisfaction or waiver of the conditions precedent set forth in _Article VI_
and _Article VII_ (other than those conditions that by their terms are to be
satisfied by actions taken at the Closing, but subject to the satisfaction or
waiver of those conditions at such time); _provided_ , _further_ that
notwithstanding the foregoing, Parent may elect to postpone the Closing until
the date that is 30 days after the date of this Agreement, or (ii) such other
date, time and place as may be agreed by Parent, the Company and the
Representative. The date on which the Closing actually occurs in accordance
with the preceding sentence is referred to in this Agreement as the " _Closing
Date_ ".

  


 

  

(b) At or prior to the Closing, the Company shall deliver the following to
Parent:

  


 

  

(i) the Existing Lender Pay-off Letters;

  


 

  

(ii) the CDandR Pay-off Letter;

  


 

  

(iii) a certificate, dated the Closing Date, of an officer of the Company to
the effect set forth in _Sections 6.1,_ _6.2_ and _6.5_ ;

  


 

  

(iv) a certificate, dated the Closing Date, duly completed and executed,
certifying that the Company was not a "United States real property holding
corporation" within the meaning of Section 897(c)(2) of the Code at any time
during the five-year period ending on the Closing Date, in form and substance
required under Treasury Regulation Sections 1.1445-2(c)(3) and 1.897-2(h) and
the accompanying applicable requirements regarding notice to the Internal
Revenue Service;

  


 

  


 

  

 

16  

  


 

  


 

  

(v) the Purchase Price Adjustment Escrow Agreement executed by the
Representative which shall be in full force and effect (assuming execution and
delivery by Parent and the Escrow Agent); and

  


 

  

(vi) the Indemnification Escrow Agreement executed by the Representative which
shall be in full force and effect (assuming execution and delivery by Parent
and the Escrow Agent).

  


 

  

(c) At or prior to the Closing, Parent and Merger Sub shall deliver the
following to the Representative:

  


 

  

(i) certificates, dated the Closing Date, of an officer of each of Parent and
Merger Sub to the effect set forth in _Sections 7.1_ and _7.2_ ;

  


 

  

(ii) the Purchase Price Adjustment Escrow Agreement executed by Parent which
shall be in full force and effect (assuming execution and delivery by the
Representative and the Escrow Agent); and

  


 

  

(iii) the Indemnification Escrow Agreement executed by Parent which shall be
in full force and effect (assuming execution and delivery by the
Representative and the Escrow Agent).

  


 

  

2.3 _Effective Time_. Contemporaneously with the Closing, the parties hereto
shall cause a Certificate of Merger meeting the requirements of Section 251 of
the DGCL (the " _Certificate of Merger_ ") to be properly executed and filed
with the Secretary of State of the State of Delaware in accordance with the
terms and conditions of the DGCL. The Merger shall become effective at the
time of filing of the Certificate of Merger with the Secretary of State of the
State of Delaware in accordance with the DGCL, or at such later time which the
parties hereto shall have agreed upon and designated in the Certificate of
Merger as the effective time of the Merger (the " _Effective Time_ ").

  


 

  

2.4 _Effects of the Merger_. The Merger shall have the effects set forth in
the applicable provisions of the DGCL. Without limiting the generality of the
foregoing and subject thereto, at the Effective Time, all the property,
rights, privileges, immunities, powers and franchises of the Company and
Merger Sub shall vest in the Surviving Corporation, and all debts,
liabilities, obligations and duties of the Company and Merger Sub shall become
the debts, liabilities, obligations and duties of the Surviving Corporation.

  


 

  

2.5 _Certificate of Incorporation and By-Laws_. Until amended in accordance
with applicable law, the certificate of incorporation and by-laws of Merger
Sub in effect immediately prior to the Effective Time shall be the certificate
of incorporation and by-laws of the Surviving Corporation as of the Effective
Time, except that all references therein to Merger Sub shall be automatically
amended and shall become references to the Surviving Corporation.

  


 

  

2.6 _Directors and Officers_. Until duly removed or until successors are duly
elected or appointed and qualified, the directors of Merger Sub immediately
prior to the Effective Time shall be the directors of the Surviving
Corporation as of the Effective Time, and the officers of the Company
immediately prior to the Effective Time shall be the officers of the Surviving
Corporation as of the Effective Time.

  


 

  


 

  

 

17  

  


 

  


 

  

2.7 _Conversion of Shares_. At the Effective Time, by virtue of the Merger and
without any action on the part of any party:

  


 

  

(a) Each share of common stock, par value $0.01 per share, of Merger Sub
issued and outstanding immediately prior to the Effective Time shall be
converted into and become one share of common stock, par value $0.01 per
share, of the Surviving Corporation, so that, after the Effective Time, Parent
shall be the holder of all of the issued and outstanding shares of the
Surviving Corporation's common stock.

  


 

  

(b) Each share of Common Stock issued and outstanding immediately prior to the
Effective Time (other than Dissenting Shares and shares to be canceled
pursuant to _Section 2.7(c)_ ) and all rights in respect thereof, shall, by
virtue of the Merger and without any action on the part of the holder thereof,
be converted into the right to receive the applicable payments set forth in
_Section 2.10(c)_, _Section 2.11(i)_, _Section 9.6(b)_ and _Section 9.6(c)_ in
cash, payable to the holder thereof without interest, upon the satisfaction of
the conditions set forth in _Section 2.10(c)(i)_, and such shares shall
otherwise cease to be outstanding, shall be canceled and retired and cease to
exist.

  


 

  

(c) Each share of Common Stock held by the Company or a Subsidiary or held in
the treasury of the Company, immediately prior to the Effective Time, shall be
canceled and retired without any conversion thereof, and no payment or
distribution shall be made with respect thereto.

  


 

  

(d) Each Option outstanding immediately prior to the Effective Time and all
rights in respect thereof, shall by virtue of the Merger and without any
action on the part of the holder thereof, be converted into, and shall
represent solely, the right to receive the payments set forth in _Section
2.10(c)_, _Section 2.11(i)_, _Section 9.6(b)_ and _Section 9.6(c)_ , in cash,
payable to the holder thereof without interest, and such Options shall
otherwise cease to be outstanding, shall be canceled and cease to exist.

  


 

  

2.8 _Dissenting Shares_. Notwithstanding any other provision of this Agreement
to the contrary, shares of Common Stock that are outstanding immediately prior
to the Effective Time and which are held by stockholders who shall have not
voted in favor of the Merger or consented thereto in writing and who shall
have properly demanded and are entitled to appraisal for such shares in
accordance with Section 262 of the DGCL (collectively, the " _Dissenting
Shares_ ") shall not be converted into or represent the right to receive the
Per Share Common Stock Merger Consideration (and, if any, the Post-Closing
Payments). Such stockholders instead shall be entitled to receive payment of
the appraised value of such shares of Common Stock held by them in accordance
with the provisions of Section 262 of the DGCL, except that all Dissenting
Shares held by stockholders who shall have failed to perfect or who
effectively shall have withdrawn or otherwise are not entitled to appraisal of
such shares of Common Stock under such Section 262 of the DGCL shall thereupon
be deemed to have been converted into and to have become exchangeable, as of
the Effective Time, for the right to receive, without any interest thereon,
the appropriate Per Share Common Stock Merger Consideration (and, if any, the
Post-Closing Payments) upon surrender in the manner provided in _Section
2.10_, of the Certificate or Certificates that, immediately prior to the
Effective Time, evidenced such shares of Common Stock. The Company and the
Representative shall ( _i_ ) give Parent prompt notice of any notice or demand
for appraisal or payment for shares of Common Stock or any withdrawals of such
demands received by the Company or the Representative, ( _ii_ ) give Parent
the opportunity to participate in and direct all negotiations and proceedings
with respect to any such demands and ( _iii_ ) not, without the prior written
consent of Parent, make any payment with respect to, or settle, offer to
settle or otherwise negotiate any such demands.

  


 

  


 

  

 

18  

  


 

  


 

  

2.9 _Options_. At the Effective Time, the Surviving Corporation shall pay to
each Optionholder, subject to any applicable Withholding Taxes, the applicable
Per Option Merger Consideration due to such Optionholder under _Section
2.10(b)(vii)_ with respect to each Option. Further payments, if any, to the
Surviving Corporation for payment to each Optionholder from the Purchase Price
Adjustment Escrow Account, the Indemnification Escrow Account or otherwise
pursuant to this Agreement shall be made if and when an amount is released or
paid pursuant to the terms of the Purchase Price Adjustment Escrow Agreement,
the Indemnification Escrow Agreement or this Agreement and any such further
payments shall be paid at the same time, as nearly as reasonably practicable,
as related payments are made to the Common Stockholders.

  


 

  

2.10 _Payment of Merger Consideration_.

  


 

  

(a) For purposes of this Agreement, the " _Estimated Merger Consideration_ "
will be an aggregate amount equal to the sum of:

  


 

  

(i) $2,575,000,000;

  


 

  

(ii) the Estimated Closing Cash Amount;

  


 

  

(iii) the difference (the " _Estimated Working Capital Adjustment_ ") between
the Target Working Capital and the Estimated Working Capital, expressed as (
_A_ ) a positive number if the Estimated Working Capital is more than
$1,000,000 greater than the Target Working Capital, ( _B_ ) a negative number
if the Estimated Working Capital is more than $1,000,000 less than the Target
Working Capital or ( _C_ ) zero if the Estimated Working Capital is not more
than $1,000,000 greater or less than the Target Working Capital; and

  


 

  

(iv) the Estimated Transaction Tax Benefit Amount.

  


 

  

(b) At the Closing, Parent shall, or shall cause the Company, Merger Sub or
the Surviving Corporation to, apply the Estimated Merger Consideration as
follows:

  

 


 

  

(i) to pay, satisfy and discharge the amount of all Closing Indebtedness,
including principal of, interest on, premium, if any, and expenses, break fees
and other amounts owing to (A) the Existing Lenders in respect of the Existing
Credit Agreements, or such lesser amounts as negotiated between the Company
and the Existing Lenders, as such amounts are set forth in the pay-off,
termination and discharge letters, in form and substance reasonably
satisfactory to Parent, executed by the Existing Lenders and delivered to PHC
and Parent at the Closing (the " _Existing Lenders Pay-off Letters_ ") and (B)
each other holder of Closing Indebtedness; 
 

  

 

19  

 

  


 

  

(ii) to pay and deposit $51,500,000 (the " _Indemnification Escrow Amount_ ")
to the escrow account under the Indemnification Escrow Agreement (the "
_Indemnification Escrow Account_ ");

  


 

  

(iii) to pay and deposit $2,500,000 (the " _Representative Escrow Amount_ ")
to an account designated by the Representative in writing prior to the Closing
Date (the " _Representative Escrow Account_ ");

  


 

  

(iv) to pay and deposit $5,000,000 (the " _Purchase Price Adjustment Escrow
Amount_ ") to the escrow account under the Purchase Price Adjustment Escrow
Agreement (such account, the " _Purchase Price Adjustment Escrow Account_ ");

  


 

  

(v) to pay ( _A_ ) all accrued and unpaid management and consulting fees and
expenses, investment banking and financial advisory fees under the CDandR
Consulting Agreement, including in respect of the transactions contemplated by
this Agreement, as such amounts are set forth in the pay-off, termination and
discharge letter, in form and substance reasonably satisfactory to Parent,
executed by Clayton, Dubilier and Rice, LLC and delivered to the Company and
Parent at the Closing (the " _CD andR Pay-off Letter_"), and ( _B_ ) fees and
expenses to JP Morgan, Credit Suisse and any other third party financial
advisors as investment banking and financial advisory fees (the fees and
expenses referred to in this clause (B), the " _Financial Advisor Fees_ ");

  


 

  

(vi) to pay, satisfy and discharge in full all other then-outstanding Seller
Transaction Expenses set forth in the Funds Flow Memo; and

  


 

  

(vii) to pay to the Surviving Corporation for payment to each Optionholder, an
amount equal to the Per Option Merger Consideration for each Option (vested or
unvested) held by such Optionholder immediately prior to the Effective Time,
subject to any deductions or withholding for Withholding Taxes in accordance
with _Section 2.10(c)(vi)_.

  


 

  

Each of the foregoing payments shall be made by wire transfer of immediately
available funds to such account or accounts as are indicated by the
Representative in a funds flow memo (the " _Funds Flow Memo_ ") to be
delivered to Parent no later than three (3) Business Days prior to the Closing
Date. The proceeds from the Estimated Merger Consideration less the amounts
set forth in clauses (b)(i)-(b)(vi) above are referred to as the " _Fully-
Diluted Stockholder Proceeds_ ".

  


 

  

(c) At the Closing, Parent shall pay out of the Fully-Diluted Stockholder
Proceeds, in accordance with the Funds Flow Memo, to each Common Stockholder,
an amount equal to the Per Share Common Stock Merger Consideration for each
share of Common Stock held by such Common Stockholder; _provided_ , that if
Parent has not received the requisite documents pursuant to this clause (c)
prior to the Closing with respect to a Common Stockholder, Parent shall not be
required to make payment to such Common Stockholder at the Closing and instead
shall make such payment to such Common Stockholder promptly following the
receipt of the requisite documents pursuant to this clause (c) for such Common
Stockholder. The Company and the Representative shall comply with the
following provisions applicable to payment of the Per Share Common Stock
Merger Consideration, the Per Option Merger Consideration and the Post-Closing
Payments.

  


 

  


 

  

 

20  

  


 

  


 

  

(i) At or prior to the Effective Time, the Company will mail or will cause to
be mailed to each record holder of Certificates a letter of transmittal
substantially in the form attached hereto as _Exhibit B_ (the " _Letter of
Transmittal_ "), which shall specify that delivery shall be effected, only
upon proper delivery of the Certificates prior to, on or within thirty (30)
calendar days following the Closing Date, as applicable, to the
Representative, and instructions for use in surrendering such Certificates and
receiving the Per Share Common Stock Merger Consideration in respect of the
Common Stock evidenced thereby. Upon the surrender of each such Certificate or
a properly completed and duly executed Letter of Transmittal, as applicable,
and promptly after the Effective Time, Parent or the Surviving Corporation
shall pay the holder of such Certificate an amount from the Fully-Diluted
Stockholder Proceeds as determined in accordance with _Section 2.10(b)_, in
consideration therefor, and such Certificate shall forthwith be canceled.
Until so surrendered, each such Certificate (other than Certificates
representing Dissenting Shares or Certificates representing Common Stock held
by the Company or a Subsidiary or held in the treasury of the Company which
shall be canceled at the Effective Time pursuant to _Section 2.7(c)_) shall
represent solely the right to receive the Per Share Common Stock Merger
Consideration (and, if any, the Post-Closing Payments) relating thereto.

  


 

  

(ii) After the Effective Time, there shall be no transfers on the stock
transfer books of the Surviving Corporation of any shares of Common Stock that
were outstanding immediately prior to the Effective Time. If, after the
Effective Time, Certificates formerly representing shares of Common Stock are
presented to the Surviving Corporation or the Representative, they shall be
surrendered and canceled as provided in this _Article II_.

  


 

  

(iii) Other than under the Indemnification Escrow Agreement and the Purchase
Price Adjustment Escrow Agreement, no interest shall accrue or be paid on the
cash payable upon the delivery of Certificates or Letters of Transmittal. None
of the Representative, Parent, the Surviving Corporation or any of their
respective Affiliates shall be liable to a Common Stockholder or Optionholder
for any cash or interest thereon delivered to a public official pursuant to
any applicable abandoned property, escheat or similar Laws. Any amounts
remaining unclaimed by Optionholders one (1) year after the Effective Time (or
such earlier date, immediately prior to such time when the amounts would
otherwise escheat to or become property of any Governmental Authority) shall
become, to the extent permitted by applicable Law, the property of the
Surviving Corporation free and clear of any claim or interest of any Person
previously entitled thereto.

  


 

  

(iv) The Representative will deliver or will cause to be delivered to the
Surviving Corporation copies of all surrendered Certificates and Letters of
Transmittal on the Closing Date. After the Effective Time, any Common
Stockholders and any Optionholders will be entitled to look only to the
Surviving Corporation for payment of their respective claims for the
consideration set forth in this _Section 2.10_, without interest thereon, but
will have no greater rights against the Surviving Corporation, as the case may
be, than may be accorded to general creditors thereof under applicable Law.

  


 

  


 

  

 

21  

  


 

  


 

  

(v) In the event that any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the Person claiming
such Certificate to be lost, stolen or destroyed, Parent or the Surviving
Corporation will issue, or will cause to be issued, in exchange for such lost,
stolen or destroyed Certificate the payments with respect to such Certificate
to which such Person is entitled pursuant to this _Article II_; _provided_ ,
that the Person to whom such payments are made shall, as a condition precedent
to the payment thereof, indemnify the Representative, Parent and the Surviving
Corporation against any claim that may be made against the Representative,
Parent, Merger Sub or the Surviving Corporation with respect to the
Certificate claimed to have been lost, stolen or destroyed.

  


 

  

(vi) Notwithstanding anything in this Agreement to the contrary, the Parent,
Merger Sub and the Surviving Corporation shall be entitled to deduct and
withhold from any amounts payable pursuant to this Agreement any withholding
or stock transfer Taxes and such other amounts as are required under the Code
or any applicable provision of state, local or foreign Tax law (collectively,
the " _Withholding Taxes_ "). To the extent that amounts are so deducted or
withheld, such deducted or withheld amounts shall be treated for all purposes
of this Agreement as having been paid to the respective holder of the
Certificate or Option or other person in respect of which such deduction or
withholding was made, and the Parent, Merger Sub or the Surviving Corporation,
as applicable, shall provide to the respective holder of such Certificate or
Option or other person written notice of the amounts so deducted or withheld.
Any amounts so withheld shall be applied by the Parent, Merger Sub or the
Surviving Corporation, as applicable, to satisfy Withholding Taxes. The
Parent, Merger Sub or the Surviving Corporation, as applicable, shall remit
any such amounts deducted or withheld from any such payment to the applicable
Taxing Authority.

  


 

  

(vii) If payment of any portion of the Merger Consideration in respect of the
Common Stock is to be made to a Person other than the Person in whose name a
surrendered certificate of Common Stock is registered, it shall be a condition
to such payment that the certificate of Common Stock so surrendered shall be
properly endorsed or shall be otherwise in proper form for transfer and that
the Person requesting such payment shall have paid any transfer and other
Taxes required by reason of such payment in a name other than that of the
registered holder of the certificate surrendered or shall have established to
the reasonable satisfaction of the Surviving Corporation that such Taxes
either have been paid or are not payable.

  


 

  

2.11 _Merger Consideration Adjustment_.

  


 

  

(a) _Pre-Closing Statement_. At least four (4) Business Days prior to the
anticipated Closing Date, the Company shall deliver to Parent a statement
consisting of the Company's good faith estimates of the following amounts: (
_i_ ) an estimated calculation of the Closing Cash Amount (the " _Estimated
Closing Cash Amount_ "), ( _ii_ ) an estimated calculation of the Seller
Transaction Expenses as of the Closing Date (the " _Estimated Seller
Transaction Expenses_ "), ( _iii_ ) an estimated calculation of the Closing
Indebtedness (the " _Estimated Closing Indebtedness_ "), ( _iv_ ) an estimated
calculation of Closing Working Capital (the " _Estimated Working Capital_ ")
and the Estimated Working Capital Adjustment, ( _v_ ) an estimated calculation
of the Transaction Tax Benefit Amount (the " _Estimated Transaction Tax
Benefit Amount_ ") and ( _vi_ ) a calculation of the Estimated Merger
Consideration (in each case together with backup calculations). Parent may
submit any objections in writing to the Company until 5:00 p.m., New York City
time, two Business Days prior to the anticipated Closing Date and the Company
will cooperate in good-faith with Parent to revise the draft statement to
reflect the mutual agreement of the Company and Parent with respect to the
estimated amounts set forth in the preceding sentence (as so revised and
agreed, the " _Pre-Closing Statement_ "); _provided_ , that if the Company and
Parent cannot reach an agreement with respect to the amounts set forth in the
preceding sentence, the Pre-Closing Statement will reflect the Company's good-
faith estimates with respect to such amounts. The Estimated Merger
Consideration shall be subject to adjustment pursuant to this _Section 2.11_
(as adjusted, the " _Merger Consideration_ "). The Estimated Closing Cash
Amount and the Estimated Working Capital shall be prepared in accordance with
the Applicable Accounting Principles.

  


 

  


 

  

 

22  

  


 

  


 

  

(b) _Closing Statement_. Within sixty (60) calendar days following the Closing
Date, Parent shall prepare and deliver to the Representative a statement (the
" _Closing Statement_ ") consisting of ( _i_ ) a calculation of the Closing
Cash Amount, ( _ii_ ) a calculation of the Seller Transaction Expenses, (
_iii_ ) a calculation of the Closing Indebtedness, ( _iv_ ) a calculation of
Closing Working Capital (the " _Final Working Capital_ ") and the Working
Capital Adjustment Amount, ( _v_ ) a calculation of the Transaction Tax
Benefit Amount and ( _vi_ ) a calculation of the amount, if any, payable
pursuant to _Section 2.11(i)_. The Closing Cash Amount and the Final Working
Capital shall be prepared in accordance with the Applicable Accounting
Principles. Parent shall provide the Representative with reasonable supporting
documentation as requested to facilitate its review of the Closing Statement.

  


 

  

(c) _Dispute Notice_. The Closing Statement shall become final, binding and
conclusive upon Parent and the Fully-Diluted Stockholders on the sixtieth
(60th) calendar day following the Representative's receipt of the Closing
Statement, unless prior to such sixtieth (60th) calendar day the
Representative has delivered to Parent a written notice (a " _Dispute Notice_
") stating that the Representative believes the Closing Statement contains
mathematical errors or was not prepared in accordance with the Applicable
Accounting Principles or the terms of this Agreement and specifying in
reasonable detail each item that the Representative disputes (each, a "
_Disputed Item_ "), and to the extent the Representative is reasonably able to
so specify, the amount in dispute for each Disputed Item and the reasons
supporting the Representative's positions. If the Representative delivers a
Dispute Notice and Parent does not deliver to the Representative, within ten
(10) Business Days following the receipt by Parent of such Dispute Notice, a
written notice (a " _Notice of Disagreement_ ") stating that Parent disputes
all or any of the Disputed Items specified in such Dispute Notice, specifying
in reasonable detail each Disputed Item that Parent disputes, the amount in
dispute for each such Disputed Item and the reasons supporting Parent's
positions, Parent shall be deemed to have irrevocably accepted the changes to
the Closing Statement set forth in the Dispute Notice.

  


 

  


 

  

 

23  

  


 

  


 

  

(d) _Resolution Period_. If the Representative delivers a Dispute Notice and,
within ten (10) Business Days following the receipt by Parent of such Dispute
Notice, Parent delivers to the Representative a Notice of Disagreement with
respect to all or any of the Disputed Items specified in such Dispute Notice,
then the Representative and Parent shall seek in good faith to resolve the
Disputed Items during the fifteen (15) Business Day period beginning on the
date the Representatives receives the Notice of Disagreement (such period, the
" _Resolution Period_ "). If the Representative and Parent reach agreement
with respect to any Disputed Items, Parent shall revise the Closing Statement
to reflect such agreement.

  


 

  

(e) _Independent Accountant_. If the Representative and Parent are unable to
resolve all of the Disputed Items during the Resolution Period, then the
Representative and Parent shall jointly engage and submit the unresolved
Disputed Items (the " _Unresolved Items_ ") to the Independent Accountant,
_provided_ that if the Representative and Parent do not appoint an Independent
Accountant within ten (10) calendar days after the end of the Resolution
Period, they shall request the American Arbitration Association to appoint as
the Independent Accountant a partner in the New York office of a nationally
recognized independent registered public accounting firm that has not had a
material relationship with the Representative, Parent or the Company within
the preceding two (2) years, and such appointment shall be final, binding and
conclusive on the Representative and Parent. The Independent Accountant shall
act as an expert, and not as an arbitrator, to determine, based solely on
presentations by the Representative and Parent and not by independent review,
only whether the Unresolved Items that were properly included in the Dispute
Notice were prepared without mathematical errors and in accordance with the
Applicable Accounting Principles and the terms of this Agreement. The parties
shall agree, promptly after the Independent Accountant has been appointed, on
procedures governing the resolution of any dispute by the Independent
Accountant, _provided_ that if the parties fail to agree on such procedures,
the dispute resolution procedures determined by the Independent Accountant
shall govern. The Representative and Parent shall use their reasonable best
efforts to cause the Independent Accountant to issue its written determination
regarding the Unresolved Items within thirty (30) calendar days after such
items are submitted for review. The Independent Accountant shall make a
determination with respect to the Unresolved Items only and in a manner
consistent with this _Section 2.11_ and the Applicable Accounting Principles,
and in no event shall the Independent Accountant's determination of the
Unresolved Items be for an amount that is outside the range of Parent's and
the Representative's disagreement. Each party shall use its reasonable best
efforts to furnish to the Independent Accountant such work papers and other
documents and information pertaining to the Unresolved Items as the
Independent Accountant may reasonably request. The determination of the
Independent Accountant shall be final, binding and conclusive upon the
Representative and Parent absent manifest error, and Parent shall revise the
Closing Statement to reflect such determination upon receipt thereof. The
fees, expenses and costs of the Independent Accountant shall be borne equally
by Parent and the Fully-Diluted Stockholders, with the portion to be borne by
the Fully-Diluted Stockholders being paid solely out of the Purchase Price
Adjustment Escrow Account.

  


 

  

(f) _Access to Information_. Each party shall use its reasonable best efforts
to provide promptly to the other party all information and reasonable access
to employees as such other party shall reasonably request in connection with
review of the Pre-Closing Statement, the Closing Statement, the Dispute Notice
or the Notice of Disagreement, as the case may be, including all work papers
of the accountants who audited, compiled or reviewed such statements or
notices (subject to the Representative and its representatives entering into
any undertakings required by Parent's accountants in connection herewith), and
shall otherwise cooperate in good faith with such other party to arrive at a
final determination of the Closing Statement.

  


 

  


 

  

 

24  

  


 

  


 

  

(g) Conclusive Merger Consideration. The "Conclusive Merger Consideration"
shall be an amount in cash equal to:

  


 

  

(i) the Estimated Merger Consideration;

  


 

  

(ii) _increased_ (if the Working Capital Adjustment Amount as determined in
accordance with this _Section 2.11(g)(ii)_ is greater than zero) or
_decreased_ (if the Working Capital Adjustment Amount as determined in
accordance with this _Section 2.11(g)(ii)_ is less than zero) by an amount
(the " _Working Capital Adjustment Amount_ ") equal to the sum of:

  


 

  

(A) the difference between Final Working Capital and Target Working Capital,
expressed as (1) a positive number if Final Working Capital is more than
$1,000,000 greater than Target Working Capital, (2) a negative number if Final
Working Capital is more than $1,000,000 less than Target Working Capital or
(3) zero if Final Working Capital is not more than $1,000,000 greater or less
than Target Working Capital; and

  


 

  

(B) the Estimated Working Capital Adjustment (which amount shall be expressed
as (x) a positive number, if such amount was subtracted in accordance with
_Section 2.10(a)(iii)_ or (y) a negative number, if such amount was added in
accordance with _Section 2.10(a)(iii)_);

  


 

  

(iii) _increased_ if the Closing Cash Amount exceeds the Estimated Closing
Cash Amount by an amount equal to such excess, or _decreased_ if the Estimated
Closing Cash Amount exceeds the Closing Cash Amount by an amount equal to such
excess;

  


 

  

(iv) _decreased_ if the Seller Transaction Expenses exceeds the Estimated
Seller Transaction Expenses by an amount equal to such excess, or _increased_
if the Estimated Seller Transaction Expenses exceeds the Seller Transaction
Expenses by an amount equal to such excess;

  


 

  

(v) _decreased_ if the Closing Indebtedness exceeds the Estimated Closing
Indebtedness by an amount equal to such excess, or _increased_ if the
Estimated Closing Indebtedness exceeds the Closing Indebtedness by an amount
equal to such excess; and

  


 

  

(vi) _increased_ if the Transaction Tax Benefit Amount exceeds the Estimated
Transaction Tax Benefit Amount by an amount equal to such excess, or
_decreased_ if the Estimated Transaction Tax Benefit Amount exceeds the
Transaction Tax Benefit Amount by an amount equal to such excess.

  


 

  

(h) _Final Adjustment Amount_. The " _Final Adjustment Amount_ " shall be the
difference, if any, between the Conclusive Merger Consideration and the
Estimated Merger Consideration. The Final Adjustment Amount (if any) shall be
(i) the " _Additional Merger Consideration_ " if the Conclusive Merger
Consideration is more than the Estimated Merger Consideration or (ii) the "
_Excess Amount_ " if the Conclusive Merger Consideration is less than the
Estimated Merger Consideration.

  


 

  


 

  

 

25  

  


 

  


 

  

(i) Post-Closing Payments.

  


 

  

(i) If the Final Adjustment Amount is zero or if Additional Merger
Consideration is determined to be due in accordance with this _Section 2.11_,
then, within two (2) Business Days after the date the Closing Statement is
finalized pursuant to clause (b), (c) or (d) of this _Section 2.11_ (the "
_Conclusive Date_ "), ( _A_ ) Parent shall deliver, or shall cause to be
delivered, promptly by wire transfer of immediately available funds ( _x_ ) to
each Common Stockholder, an amount in cash equal to such Common Stockholder's
Ownership Percentage (in respect of Common Stock held by such Common
Stockholder immediately prior to the Effective Time) of the Additional Merger
Consideration, if any, and ( _y_ ) to the Surviving Corporation, an amount in
cash equal to the remainder of the Additional Merger Consideration, if any,
and ( _B_ ) the parties shall provide a joint written instruction to the
Escrow Agent to deliver promptly from the Purchase Price Adjustment Escrow
Account by wire transfer of immediately available funds ( _x_ ) to each Common
Stockholder, an amount in cash equal to such Common Stockholder's Ownership
Percentage (in respect of Common Stock held by such Common Stockholder
immediately prior to the Effective Time) of the remainder balance of the
Purchase Price Adjustment Escrow Account, and ( _y_ ) to the Surviving
Corporation, an amount in cash equal to the remainder balance of the Purchase
Price Adjustment Escrow Account. Upon receipt of any such amounts pursuant to
this _Section 2.11(i)(i)_ and subject to _Section 2.10(c)(vi)_, the Surviving
Corporation shall promptly pay to each Optionholder its applicable Ownership
Percentage (in respect of Options held by such Optionholder immediately prior
to the Effective Time) of the Additional Merger Consideration (if any) and of
the balance of the Purchase Price Adjustment Escrow Amount.

  


 

  

(ii) If there is an Excess Amount determined to be due in accordance with this
_Section 2.11_ , then, within two (2) Business Days after the Conclusive Date,
the parties shall provide a joint written instruction to the Escrow Agent to:
(A) in the event the Excess Amount is equal to or less than the Purchase Price
Adjustment Escrow Amount, deliver promptly from the Purchase Price Adjustment
Escrow Account by wire transfer of immediately available funds (I) to an
account designated by Parent, an amount in cash equal to the Excess Amount,
and (II) to each Common Stockholder, an amount in cash equal to such Common
Stockholder's Ownership Percentage (in respect of Common Stock held by such
Common Stockholder immediately prior to the Effective Time) of the balance of
the Purchase Price Adjustment Escrow Account and (III) to the Surviving
Corporation, an amount in cash equal to the remainder balance of the Purchase
Price Adjustment Escrow Account (after payment of the Excess Amount); and (B)
in the event that the Excess Amount is greater than the Purchase Price
Adjustment Escrow Amount, (I) deliver promptly from the Purchase Price
Adjustment Escrow Account by wire transfer of immediately available funds to
an account designated by Parent, an amount in cash equal to the Purchase Price
Adjustment Escrow Amount and (II) deliver promptly from the Indemnification
Escrow Account by wire transfer of immediately available funds to an account
designated by Parent, an amount in cash equal to the difference between the
Excess Amount and the Purchase Price Adjustment Escrow Amount (up to the
amount contained in the Indemnification Escrow Account). In the case of clause
(A) of the prior sentence, upon receipt of any such amounts from the Escrow
Agent and subject to _Section 2.10(c)(vi)_, the Surviving Corporation shall
promptly pay to each Optionholder its applicable Ownership Percentage (in
respect of Options held by such Optionholder immediately prior to the
Effective Time) of the remainder balance of the Purchase Price Adjustment
Escrow Account.

  


 

  


 

  

 

26  

  


 

  


 

  

(iii) Absent fraud, for the avoidance of doubt, Parent's sole and exclusive
recourse for the Excess Amount shall be limited to collection from the funds
available in the Purchase Price Adjustment Escrow Account and the
Indemnification Escrow Account in accordance with the terms of this Agreement
and the Purchase Price Adjustment Escrow Agreement and the Indemnification
Escrow Agreement.

  


 

  

(j) _Tax Treatment_. Any amount paid in respect of adjustments to the Merger
Consideration made pursuant to this _Section 2.11_ shall be treated as an
adjustment to the Merger Consideration for Tax purposes, except to the extent
otherwise required by applicable Law.

  


 

  

ARTICLE III

  


 

  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  


 

  

The Company hereby represents and warrants to Parent and Merger Sub that,
except as set forth in ( _i_ ) the Form S-1 publicly filed with the SEC by the
Company prior to the date of this Agreement (together with any amendments and
exhibits thereto that have been publicly filed with the SEC by the Company
prior to the date of this Agreement, the " _Registration Statement_ "), other
than any disclosures contained in the "Risk Factors" or "forward-looking
statements" sections or in any other section to the extent such disclosure
constitutes a predictive, cautionary or forward-looking statement, or ( _ii_ )
the Disclosure Letter (it being understood and agreed that each disclosure set
forth in the Disclosure Letter shall qualify or modify each of the
representations and warranties set forth in this _Article III_ to the extent
the applicability of such disclosure to such representation and warranty is
reasonably apparent on the face of such disclosure):

  


 

  

3.1 _Due Incorporation; Capitalization_.

  


 

  

(a) Each of the Company and the Subsidiaries is duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
incorporation or organization. Each of the Company and the Subsidiaries has
all requisite power and authority to own, lease and operate its respective
assets and properties as they are now being owned, leased and operated and to
carry on its business as now conducted. The Company and the Subsidiaries are
duly qualified to do business and are in good standing (where such concept is
recognized) in all jurisdictions in which they are required to be so qualified
or in good standing, except where the failure to be so qualified or in good
standing would not reasonably be expected, individually or in the aggregate,
to have a Material Adverse Effect. The Company has delivered to Parent
complete copies of the Organizational Documents of the Company and each of the
Subsidiaries as of the date hereof and as currently in effect and none of the
Company and the Subsidiaries is in violation of any provision of such
Organizational Documents in any material respect.

  


 

  


 

  

 

27  

  


 

  


 

  

(b) The entire authorized capital stock of the Company is 5,000,000 shares of
common stock, par value $0.01 per share (the " _Common Stock_ "). Of such
authorized shares, subject to the issuance of Common Stock after the date of
this Agreement upon exercise of Options in accordance with their terms as of
the date of this Agreement, ( _x_ ) only 373,257.559 shares of Common Stock
are issued and outstanding, and ( _y_ ) 46,622 shares of Common Stock are
currently subject to Options. Section 3.1(b) of the Disclosure Letter contains
a complete and correct list, as of the date of this Agreement, of (1) each
holder of Common Stock, including the number of shares of the Common Stock
held by such holder, and (2) each holder of Options, specifying, on a holder-
by-holder basis (i) the name of each holder, (ii) the number of shares subject
to each such award, (iii) the grant date of each such award, (iv) the vesting
schedule of each such award, (v) the exercise price for each such Option and
(vi) the expiration date of each such Option. No Option is intended to qualify
as an "incentive stock option" under Section 422 of the Code. All of the
outstanding shares of the Company's capital stock are duly authorized, validly
issued, fully paid and nonassessable. Such shares have been issued in
compliance with all applicable state and federal Laws concerning the issuance
of securities. No Subsidiary owns any share of Common Stock. No shares of the
Company's capital stock are subject to (other than pursuant to an Employee
Stock Subscription Agreement) or were issued in violation of the preemptive
rights of any shareholder or any purchase option, call option, right of first
refusal, subscription right or any similar right under any provision of the
DGCL, the Certificate of Incorporation or by-laws of the Company or any
agreement to which the Company is a party or otherwise bound. Except as set
forth in this _Section 3.1_, there are no ( _i_ ) issued and outstanding
shares of capital stock of or other voting or equity interests in the Company,
( _ii_ ) securities of the Company convertible into or exercisable or
exchangeable for shares of capital stock of or other voting or equity
interests in the Company, ( _iii_ ) options, warrants or other rights or
agreements, commitments or understandings of any kind to acquire from the
Company, or other obligation of the Company to issue, deliver, transfer or
sell, or cause to be issued, delivered, transferred or sold, any shares of
capital stock of or other voting or equity interests in the Company or
securities convertible into or exercisable or exchangeable for shares of
capital stock of or other voting or equity interests in the Company, ( _iv_ )
other than each Employee Stock Subscription Agreement and the Organizational
Documents of the Subsidiaries, voting trusts, proxies or other similar
agreements or understandings to which the Company or any of the Subsidiaries
is a party or by which the Company or any of the Subsidiaries is bound with
respect to the voting of any shares of capital stock of or other voting or
equity interests in the Company or any of the Subsidiaries, ( _v_ ) other than
each Employee Stock Subscription Agreement and the Organizational Documents of
the Company and the Subsidiaries and the Existing Credit Agreements,
contractual obligations or commitments of any character restricting the
transfer of, or requiring the registration for sale of, any shares of capital
stock of or other voting or equity interests in the Company or any of the
Subsidiaries, or ( _vi_ ) outstanding or authorized appreciation rights,
rights of first offer, performance shares, "phantom" stock rights or other
agreements or obligations of any character (contingent or otherwise) pursuant
to which any Person is or may be entitled to receive any payment or other
value based on the revenues, earnings or financial performance, or stock price
performance or other attribute of the Company or any of the Subsidiaries or
any of their businesses or assets are calculated in accordance therewith (the
items in clauses (i), (ii) and (iii) being referred to collectively as the "
_Company Securities_ "). Other than as may be set forth in an Employee Stock
Subscription Agreement, there are no outstanding obligations of the Company or
any of the Subsidiaries to repurchase, redeem or otherwise acquire any Company
Securities.

  


 

  


 

  

 

28  

  


 

  


 

  

(c) All of the outstanding shares of capital stock of and other voting or
equity interests in each Subsidiary have been duly authorized and validly
issued, fully paid and nonassessable and are owned beneficially and of record
by the Company or one of the Subsidiaries as set forth in Section 3.1(c) of
the Disclosure Letter, free and clear of any Liens (other than Permitted Liens
referred to in clause (i) of the definition thereof). Such shares have been
and are issued in compliance with all applicable state and federal Laws
concerning the issuance of securities. No shares of capital stock of any
Subsidiary are subject to or were issued in violation of the preemptive rights
of any shareholder or any purchase option, call option, right of first
refusal, subscription right or any similar right under any provision of the
DGCL, the Organizational Documents of any applicable Subsidiary or any
agreement to which the Company or any of the Subsidiaries is a party or
otherwise bound. There are no outstanding ( _i_ ) shares of capital stock of
or other voting or equity interests in any Subsidiary, except for shares owned
by the Company or another Subsidiary ( _ii_ ) securities of the Company or any
of the Subsidiaries convertible into or exercisable or exchangeable for shares
of capital stock of or other voting or equity interests in any Subsidiary or (
_iii_ ) options or other rights or agreements, commitments or understandings
of any kind to acquire from the Company or any of the Subsidiaries, or other
obligation of the Company or any of the Subsidiaries to issue, transfer or
sell, or cause to be issued, transferred or sold, any shares of capital stock
of or other voting or equity interests in any Subsidiary or securities
convertible into or exercisable or exchangeable for shares of capital stock of
or other voting or equity interests in any Subsidiary (the items in clauses
(i), (ii) and (iii) being referred to collectively as the " _Subsidiary
Securities_ "). There are no outstanding obligations of the Company or any of
the Subsidiaries to repurchase, redeem or otherwise acquire any Subsidiary
Securities. _Section 3.1(c)_ of the Disclosure Letter sets forth a true and
correct list of the Subsidiaries.

  


 

  

(d) The Company and the Subsidiaries have no outstanding Indebtedness, other
than in respect of the Existing Credit Agreements, and there are no
outstanding guarantees by the Company or any of the Subsidiaries of
Indebtedness of any other Person. The Company has provided to Parent true and
complete copies of the Existing Credit Agreements (including all amendments
and modifications thereto). Neither the Company nor any of the Subsidiaries
has outstanding bonds, debentures, notes or, other than as referred to in this
_Section 3.1_, other securities, the holders of which have the right to vote
(or which are convertible into or exercisable for securities having the right
to vote) with the stockholders of the Company on any matter.

  


 

  

(e) Neither the Company nor any of the Subsidiaries owns any shares of capital
stock of or other voting or equity interests in (including any securities
exercisable or exchangeable for or convertible into shares of capital stock of
or other voting or equity interests in) any third party Person (collectively,
" _Third Party Interests_ "). Neither the Company nor any of the Subsidiaries
have any rights to, or are bound by any commitment or obligation to, acquire
by any means, directly or indirectly, any Third Party Interests or to make any
investment in, or equity contribution or similar advance to, any Person.

  


 

  


 

  

 

29  

  


 

  


 

  

3.2 _Due Authorization_.

  


 

  

(a) The Company has full power and authority to enter into this Agreement and,
subject to receipt of the Stockholder Consent, to consummate the transactions
contemplated hereby and perform its obligations hereunder. The execution,
delivery and performance by the Company of this Agreement, and the
consummation by the Company of the applicable transactions contemplated
hereby, including the Merger, have been duly and validly approved by the board
of directors of the Company and will be duly and validly approved by the
Consenting Stockholders within twenty-four hours of the execution of this
Agreement, and no other corporate actions or proceedings on the part of the
Company or its stockholders shall be necessary to authorize this Agreement and
the transactions contemplated hereby. The Company has duly and validly
executed and delivered this Agreement. This Agreement constitutes a legal,
valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, moratorium, reorganization or similar Laws
in effect which affect the enforcement of creditors' rights generally and by
equitable principles.

  


 

  

(b) Prior to the date of this Agreement, the Company and its board of
directors have taken all action necessary to exempt under or make not subject
to (i) the provisions of Section 203 of the DGCL, (ii) any other Takeover Law
or (iii) any provision of the Organizational Documents of the Company and the
Subsidiaries that would require any corporate approval other than that
otherwise required by the DGCL or other applicable state Law: (x) the
execution of this Agreement, (y) the Merger and (z) any of the other
transactions contemplated by this Agreement. The Company does not have in
effect any "poison pill" or shareholder rights plan.

  


 

  

3.3 _Consents and Approvals; No Violations_. Except for (a) filings under
_Section 2.3_, (b) filings under the HSR Act and (c) as set forth in Section
3.3 of the Disclosure Letter, the execution, delivery and performance by the
Company of this Agreement and the consummation of the transactions
contemplated hereby will not (i) violate any Law applicable to the Company or
any of the Subsidiaries or by which any of their respective properties or
assets are bound or affected; (ii) require any notification to or filing or
registration by the Company or any of the Subsidiaries with, or consent or
approval with respect to the Company or any of the Subsidiaries of or other
action by, any Governmental Authority; (iii) violate or conflict with any
provision of the Certificate of Incorporation or by-laws of the Company or any
of the Organizational Documents of the Subsidiaries; (iv) require any consent
of or other action by any Person under, constitute a default or an event that,
with or without notice or lapse of time or both, would constitute a default
under, or cause or permit termination, cancellation, acceleration or other
change of any right or obligation or the loss of any benefit under, any
provision of any Material Contract ( _provided_ that this representation and
warranty shall be made for all contracts and agreements for purposes of
determining if the exception set forth in clause (y) of this sentence is
applicable) or any Permit, affecting the assets or business of the Company and
the Subsidiaries; or (v) result in the creation or imposition of any Lien
other than Permitted Liens on any properties or assets of the Company or any
of the Subsidiaries, except in the case of clauses (ii), (iv) and (v), where
any such violation, conflict, breach, default or Lien, or failure to notify,
file or register with, or to obtain any consent or approval from, any
Governmental Authority, would not individually or in the aggregate, (x)
reasonably be expected to be material and adverse to the Company and the
Subsidiaries, taken as a whole, (y) reasonably be expected to materially
impair the ability of the Company to perform its obligations under this
Agreement or consummate the Merger or the other transactions contemplated
hereby or (z) reasonably be expected to materially impair the ability of the
Surviving Corporation or the Subsidiaries to continue to conduct their
respective businesses following the Closing.

  


 

  


 

  

 

30  

  


 

  


 

  

3.4 _Financial Statements; No Undisclosed Liabilities; Registration
Statement_.

  


 

  

(a) The Financial Statements (i) have been prepared from and are in accordance
with the books and records of the Company and the Subsidiaries, (ii) have been
prepared in accordance with GAAP, consistently applied (except as set forth in
the footnotes attached thereto) and (iii) present fairly, in all material
respects, the consolidated financial position of the Company and the
Subsidiaries as of the dates thereof and the results of operations, and cash
flows of the Company and the Subsidiaries for the periods covered thereby,
except that the Interim Financial Statements omit footnotes and are subject to
normal year-end adjustments and accruals. The Company has provided Parent with
true, complete and correct copies of the Financial Statements in _Section
1.1(a)_ of the Disclosure Letter.

  


 

  

(b) Since the Balance Sheet Date, the Company and the Subsidiaries have not
incurred material liabilities, debts, claims or obligations of any nature,
whether known, unknown, accrued, absolute, direct or indirect, contingent or
otherwise, whether due or to become due (" _Liabilities_ "), except (i)
Liabilities disclosed in Section 3.4(b) of the Disclosure Letter, (ii)
Liabilities incurred in the ordinary course of business consistent with past
practice since the Balance Sheet Date, (iii) Liabilities incurred in
connection with or as a result of the transactions contemplated by this
Agreement that are required to be paid from the Merger Consideration as of the
Effective Time pursuant to _Section 2.10(b)_ and (iv) Liabilities not required
to be disclosed on a balance sheet (or the footnotes thereto) of the Company
and the Subsidiaries prepared in accordance with GAAP in a manner consistent
with the Financial Statements.

  


 

  

(c) The Company maintains a system of internal accounting controls that is
sufficient to provide reasonable assurance that (i) transactions are executed
in accordance with management's general or specific authorizations; (ii)
transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (iii)
access to assets is permitted only in accordance with management's general or
specific authorization; and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences.

  


 

  

(d) The Registration Statement did not as of the date thereof contain any
untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading.

  


 

  

3.5 _Title to Assets, etc_. Each of the Company and the Subsidiaries has good
and valid title to, or a valid leasehold interest in or valid license to, each
of its assets and properties reflected in the Financial Statements or that are
material to its business as conducted as of the date of this Agreement and as
of the Closing (the " _Assets_ "), except for inventory sold following the
date of the Financial Statements in the ordinary course of business consistent
with past practice, in each case, free and clear of any Lien, except for
Permitted Liens. Any Permitted Liens on the Assets, individually or in the
aggregate, do not materially interfere with the current use of any such Asset
by the Company or any of the Subsidiaries or materially detract from the value
of any such Asset. The Assets constitute all of the material properties and
assets used or held for use for the conduct of the business of the Company and
the Subsidiaries as conducted as of the date of this Agreement and as of the
Closing. The Assets are sufficient in all material respects for the conduct of
the respective businesses, activities and operations of the Company and the
Subsidiaries as of the date of this Agreement and as of the Closing. To the
Knowledge of the Company, there are no facts or conditions affecting any
Assets that, with or without notice or the lapse of time, or both, would
reasonably be expected, individually or in the aggregate, to interfere in any
material respect with the use, occupancy or operation of such Assets as of the
date of this Agreement and as of the Closing. Except for any Assets disposed
of in accordance with this Agreement, all of the material Assets shall be
owned by or available for use by the Surviving Corporation and the
Subsidiaries immediately after the Effective Time on terms and conditions
identical to those under which the Company or the Subsidiaries owned or used
such Assets immediately prior to the Effective Time.

  


 

  


 

  

 

31  

  


 

  


 

  

3.6 _Intellectual Property_.

  


 

  

(a) Section 3.6(a) of the Disclosure Letter contains a true and complete list
as of the date of this Agreement of all of the (x) patents, patent
applications, trademarks, trade names, service marks and domain names that are
registered or subject to an application for registration, and (y) copyrights
and Software that are material to the Company's business and that, in each
case of (x) and (y) are owned by the Company and the Subsidiaries (" _Owned
Intellectual Property_ "). (i) Neither the Company nor any Subsidiary has
granted any license to a third party or agreed to pay to or receive from a
third party any royalty or other payment in respect of any of such Owned
Intellectual Property, (ii) to the Knowledge of the Company, the Company and
the Subsidiaries have not infringed on, and the continued operation of their
businesses as currently conducted will not infringe on, the Intellectual
Property rights of any Person, (iii) there are no claims, proceedings or
litigation pending or, to the Knowledge of the Company, threatened alleging
infringement or misappropriation by the Company or any Subsidiary of any third
party Intellectual Property rights, except where such claims, proceedings or
litigation would not reasonably be expected to be materially adverse to the
Company and the Subsidiaries, taken as a whole and (iv) since January 1, 2014,
no third party has asserted any claim in writing or, to the Knowledge of the
Company, no third party has asserted any claim since January 1, 2014, (1)
challenging or seeking to deny or restrict in any material respect the rights
of the Company or the Subsidiaries in any Intellectual Property owned by the
Company or the Subsidiaries or (2) alleging that the Company, any of the
Subsidiaries or any employee, independent contractor or agent of the Company
or any of the Subsidiaries has infringed, misappropriated or otherwise
violated in any material respect any Intellectual Property of any third party.

  


 

  

(b) The Company and each of the Subsidiaries have taken commercially
reasonable measures to ensure the protection of Intellectual Property owned by
their respective businesses under any applicable Law (including making and
maintaining in full force and effect all necessary filings, registrations and
issuances).

  


 

  

(c) Each of the Company and the Subsidiaries has used commercially reasonable
efforts to maintain the secrecy of all confidential Intellectual Property
currently used in its businesses. To the Knowledge of the Company, none of the
Company or the Subsidiaries is using any Intellectual Property owned by them
that is material to their respective businesses in a manner that would
reasonably be expected to result in the cancellation or unenforceability of
such Intellectual Property.

  


 

  


 

  

 

32  

  


 

  


 

  

(d) Section 3.6(d) of the Disclosure Letter lists all agreements (other than
"shrink-wrap," "click-wrap" or "web-wrap" licenses in respect of commercially
available Software) to which the Company or any of the Subsidiaries is a party
or by which any of them is otherwise bound as of the date hereof, that (i)
license Intellectual Property to the Company or any of the Subsidiaries by any
other Person (a "License"), (ii) grant or restrict the right to use
Intellectual Property owned by the Company or the Subsidiaries, and (iii)
transfer, assign, or indemnify with respect to, or otherwise relating to,
material Intellectual Property used or held for use in the business of the
Company and the Subsidiaries, in each case to the extent material to their
businesses.

  


 

  

(e) Except as set forth in this Section 3.6(e), (i) the Company or one of the
Subsidiaries is the sole and exclusive owner (including, as applicable, record
owner) of all material Owned Intellectual Property, (ii) the Company and the
Subsidiaries own all right, title and interest in and to, or have the right to
use pursuant to a valid and enforceable written License, all other
Intellectual Property used in and necessary for the operation of their
businesses as conducted as of the date of this Agreement, in each case free
and clear of all Liens other than Permitted Liens and (iii) the consummation
of the transactions contemplated hereby will not adversely affect such rights.

  


 

  

(f) No current or former employee, consultant or contractor has any valid
claim of ownership, in whole or in part, to any Owned Intellectual Property
that is material to, and is used or held for use in, the conduct of the
Company's and the Subsidiaries' businesses, or has asserted any such claim of
ownership or right. Any Person and any current or former employee who, either
alone or with others, creates, develops, invents or has created, developed or
invented, any Owned Intellectual Property for the Company or the Subsidiaries
has entered into a written agreement with the Company or the Subsidiaries that
obliges such Person or employee to disclose and to assign such Intellectual
Property to the Company or the Subsidiaries, or such Owned Intellectual
Property has been developed on a work-made-for-hire basis by such Person or
employees.

  


 

  

(g) No Software owned by the Company or the Subsidiaries contains or is
derived from Open Source Code or similar Software. The Company and the
Subsidiaries (i) are in compliance in all material respects with the terms of
any and all licenses and agreements that govern the use, modification and
distribution of any Open Source Code used or licensed to the Company or the
Subsidiaries and (ii) under the licenses or agreements that govern the use,
modification and distribution of such Open Source Code, the Company and the
Subsidiaries are not required to disclose or distribute any source code of the
Owned Intellectual Property. The Company and the Subsidiaries have implemented
reasonable backup, security and disaster recovery technology, plans,
procedures and facilities consistent with industry practice.

  


 

  

(h) The Company and each of the Subsidiaries are in compliance with all
applicable contractual and legal requirements pertaining to data protection or
information privacy and security, including any privacy policy concerning the
collection or use of such data or information used in their businesses. The
Internal IT Systems (i) are in good repair and operating condition and (ii) to
the Knowledge of the Company, (A) do not contain any Virus that would
reasonably be expected to materially interfere with the ability of the Company
and the Subsidiaries to conduct their businesses, and (B) have not suffered
any material breaches (including any breaches that have resulted in (i) the
disclosure or loss of any confidential information material to the businesses
of the Company or the Subsidiaries or (ii) a third party obtaining
unauthorized access to any such material confidential information).

  


 

  


 

  

 

33  

  


 

  


 

  

3.7 _Contracts_.

  


 

  

(a) Section 3.7 of the Disclosure Letter contains an accurate and complete
list, as of the date of this Agreement of all contracts, agreements,
commitments, arrangements and other instruments, in effect as of the date
hereof, of the following types to which the Company or a Subsidiary is a party
or bound or to which any of the Assets is subject (whether or not actually
listed in Section 3.7 of the Disclosure Letter, the " _Material Contracts_ "):

  


 

  

(i) any collective bargaining agreement with respect to its employees;

  


 

  

(ii) any (A) of the following agreements with any current (or, to the extent
there are on-going obligations, former) officer, employee, consultant or
director of any Health Care Provider, the Company or the Subsidiaries:
employment agreement, change of control agreement, severance agreement,
retention agreements or any other contract or agreement entered into outside
of the ordinary course of business, or (B) Affiliate Agreement (excluding in
each case employment agreements that are not material);

  


 

  

(iii) any contract or agreement that (A) restricts the Company or its
Affiliates from engaging in any material line of business, developing,
marketing or distributing products or services or obligates the Company or its
Affiliates not to compete with another Person or in any geographic area or
during any period of time or (B) contains exclusivity obligations or
restrictions binding on the Company or any of its Affiliates;

  


 

  

(iv) any material agreement that binds any party to any exclusive business
arrangements, including arrangements in which the Company or any Subsidiary
must use a provider or supplier exclusively (other than agreements that were
entered into in the ordinary course of business with a manufacturer,
distributor or reseller that require a particular manufacturer's products to
be purchased from such manufacturer or an authorized distributor or reseller);

  


 

  

(v) any material agreement or series of related agreements, including any
option agreement, providing for the acquisition or disposition, directly or
indirectly, of any business, capital stock or material assets or any material
real property (whether by merger, sale of stock, sale of assets or otherwise);

  


 

  

(vi) any agreement relating to any interest rate, foreign exchange,
derivatives or hedging transaction;

  


 

  


 

  

 

34  

  


 

  


 

  

(vii) any agreement (including any "take-or-pay" or keepwell agreement) under
which (A) any Person has directly or indirectly guaranteed any liabilities or
obligations of the Company or any of the Subsidiaries or (B) the Company or
any of the Subsidiaries has directly or indirectly guaranteed, assumed or
endorsed any liabilities or obligations of any other Person, in each case
other than endorsements for the purpose of collection in the ordinary course
of business;

  


 

  

(viii) any (a) Licenses or (b) agreements governing the provision of any
information technology related services (other than any Software or any other
agreements described in _Section 3.6(d)_ ), by or to the Company or any of the
Subsidiaries, in each case to the extent material to their respective
businesses;

  


 

  

(ix) any Leases;

  


 

  

(x) any agreement that prohibits the payment of dividends or distributions in
respect of the capital stock of the Company or any of the Subsidiaries,
prohibits the pledging of the capital stock of the Company or any of the
Subsidiaries or prohibits the issuance of guarantees by the Company or any of
the Subsidiaries, in each case that will not be terminated at or prior to the
Effective Time;

  


 

  

(xi) any agreement that contains any material indemnification rights or
obligations, or credit support relating to such indemnification rights or
obligations, other than any of such indemnification rights or obligations
incurred in the ordinary course of business;

  


 

  

(xii) any (A) agreement that is a settlement or similar agreement with any
Governmental Authority, or (B) an Order or consent of a Governmental Authority
to which the Company or any of the Subsidiaries is subject, involving material
ongoing performance obligations by the Company or any of the Subsidiaries
after the date of this Agreement;

  


 

  

(xiii) any agreement pursuant to which the Company or any of the Subsidiaries
has an obligation to make an investment in or loan to any other Person;

  


 

  

(xiv) any agreement or series of related agreements (other than purchase
orders) (i) pursuant to which the Company or any of the Subsidiaries has
purchased, licensed or sold, during calendar year 2014, or pursuant to which
the Company or any Subsidiary has agreed to or otherwise has an obligation to
purchase, license or sell in calendar year 2015, goods, equipment or other
personal property or services that involved or is expected to involve payment
by or to the Company and the Subsidiaries in excess of $3,000,000 during such
period, or (ii) that provides for minimum purchase requirements in excess of
such amount over the remaining term of such agreement;

  


 

  

(xv) any credit agreement, loan agreement, indenture, note, mortgage, security
agreement, loan commitment or other contract or instrument relating to
Indebtedness owed by or to the Company or a Subsidiary;

  


 

  


 

  

 

35  

  


 

  


 

  

(xvi) any contract containing most favored nation pricing provisions or
granting to any Person a right of first refusal, a right of first offer or an
option to purchase, acquire, sell or dispose of any Assets (other than
inventory in the ordinary course of business) valued at an amount in excess of
$500,000;

  


 

  

(xvii) any partnership, joint venture, limited liability company or other
similar agreements, but excluding the Organizational Documents of any of the
Subsidiaries;

  


 

  

(xviii) any operating leases involving annual payments in excess of $100,000;

  


 

  

(xix) any contract or agreement relating to any capital expenditure or
leasehold improvement with remaining payments in excess of $2,000,000 in the
aggregate that has (A) commenced but is not yet completed or (B) that
obligates the Company or any of the Subsidiaries to incur expenditures with
respect to a project that is not yet commenced;

  


 

  

(xx) any settlement agreement (A) involving material performance by the
Company or any of the Subsidiaries after the date of this Agreement or (B) for
an amount in excess of $250,000, in each case entered into within the past two
(2) years;

  


 

  

(xxi) any material contract or agreement with a group purchasing organization
(" _GPO_ "); and

  


 

  

(xxii) any contract containing obligations of the Company or a Subsidiary
under conditional sale or other title retention agreements relating to any
property purchased by the Company or such Subsidiary.

  


 

  

(b) Each Material Contract is a valid and binding agreement of the Company or
one or more of the Subsidiaries, on the one hand, and to the Knowledge of the
Company, each other party thereto, on the other, and is in full force and
effect, and none of the Company, any of the Subsidiaries or, to the Knowledge
of the Company, any other party thereto, is in default or breach in any
material respect under (or is alleged to be in default or breach in any
material respect under) the terms of, or has provided or received any notice
of any intention to terminate, any such Material Contract, and, to the
Knowledge of the Company, no event or circumstance has occurred that, with or
without notice or lapse of time or both, would constitute an event of default
thereunder or result in or give any Person a right of acceleration or early
termination thereof (other than pursuant to _Section 5.15_ hereof). The
Company has made available to Parent and Merger Sub a true and complete copy
of (x) each Material Contract (including all material modifications and
amendments thereto and waivers thereunder) or form of Material Contract and
(y) all form contracts, agreements or instruments used in and material to the
businesses of the Company and the Subsidiaries. For the purposes of this
_Section 3.7(b)_ , the term "Material Contract" shall be deemed to include any
Contract that, if entered into prior to the date of this Agreement, would
qualify as a Material Contract.

  


 

  

3.8 _Insurance_. Section 3.8 of the Disclosure Letter contains an accurate and
complete list, as of the date of this Agreement, of all material policies of
fire, liability, workmen's compensation and other forms of insurance
maintained by or for the benefit of the Company or a Subsidiary, the Assets or
the employees, officers and directors of the Company and the Subsidiaries. The
Company has made available to Parent true, correct and complete copies of all
such policies. All premiums payable under such policies have been timely paid,
and the Company and the Subsidiaries have otherwise complied in all material
respects with the terms and conditions of such policies. To the Knowledge of
the Company, since the time any such policies were last renewed or issued,
there has not been any threatened termination of or alteration of coverage
under any of such policies. All such policies are in full force and effect in
accordance with their terms and, to the Knowledge of the Company, no notice of
cancellation or non-renewal of such policies has been received, and there is
no existing breach, default or event which, with or without notice or the
lapse of time or both, would constitute a material breach or default or permit
termination or modification of any such policies. Each of the Company and the
Subsidiaries is, and since January 1, 2014 has been, insured with respect to
the Assets and the conduct of each of their respective businesses in such
amounts and against such risks as are sufficient for compliance with Laws in
all material respects and as are reasonably adequate to protect the Assets and
the conduct of their respective businesses in accordance with customary
industry practice. The Company or a Subsidiary is a "named insured" or an
"insured" under each such insurance policy. None of the Company or any of the
Subsidiaries have been refused any insurance, nor has any of their coverage
been materially limited, by any insurance carrier to which any of them have
applied for insurance or with which any of them has carried insurance since
January 1, 2014. There is no material claim by or with respect to the Company
or any Subsidiary pending under any of such policies as to which coverage has
been questioned, denied or disputed by the underwriters of such policies or in
respect of which such underwriters have reserved their rights. All premiums
payable under such policies have been timely paid, and the Company and the
Subsidiaries have otherwise materially complied with the terms and conditions
of such policies. To the Knowledge of the Company, since the time any such
policies were last renewed or issued, there has not been any threatened
termination of, premium increase with respect to or alteration of coverage
under any of such policies.

  


 

  


 

  

 

36  

  


 

  


 

  

3.9 _Employee Benefit Plans_.

  


 

  

(a) _General_. Section 3.9(a) of the Disclosure Letter lists as of the date of
this Agreement all material " _Benefit Plans_." For purposes of this
Agreement, "Benefit Plans" means all employee benefit plans (as defined in
Section 3(3) of ERISA), whether or not subject to ERISA, and all bonus, stock
option, stock purchase, restricted stock, incentive, deferred compensation,
retiree medical or life insurance, supplemental retirement, severance or other
benefit plans, programs or arrangements, and all retention, bonus, employment,
termination, severance or other contracts or agreements to which the Company
or any Subsidiary or any of ERISA Affiliates is a party and with respect to
which the Company or any Subsidiary or any ERISA Affiliate has any current or
future obligation or that are maintained, contributed to or sponsored by the
Company or any Subsidiary or any ERISA Affiliate for the benefit of any
current or former employee, officer, director or independent contractor of the
Company or any Subsidiary or any ERISA Affiliates.

  


 

  

(b) _Plan Documents and Reports_. A true and correct copy of each of the
material Benefit Plans has been made available to Parent. True and correct
copies of the two most recent annual reports and all attachments thereto,
summary plan descriptions and Internal Revenue Service determination letters
or opinion letters with respect to each Benefit Plan, to the extent
applicable, along with all material communications received from or sent to
the Internal Revenue Service, the Pension Benefit Guaranty Corporation, the
Department of Labor or any other Governmental Authority (including a written
description of any material oral communication) pertaining to each Benefit
Plan, and any related trust agreements, annuity contracts, insurance contracts
or documents or other funding arrangements have been made available to Parent
by the Company. The Company has made available to Parent and Merger Sub all
current employee handbooks and manuals. Except as specifically provided in the
foregoing documents delivered or made available to Parent and Merger Sub,
there are no amendments to any material Benefit Plans that have been adopted
or approved nor has the Company or any of its Subsidiaries undertaken to make
any such amendments or to adopt or approve any new material Benefit Plans. No
Benefit Plan is maintained outside the jurisdiction of the United States, or
covers any employee residing or working outside of the United States.

  


 

  


 

  

 

37  

  


 

  


 

  

(c) _Compliance with Laws; Liabilities_. As to all Benefit Plans that are
intended to be qualified under Section 401(a) of the Code, each such Benefit
Plan is the subject of a favorable determination letter or opinion letter from
the Internal Revenue Service or a request for a favorable determination letter
or opinion letter has been timely filed with the Internal Revenue Service,
and, to the Knowledge of the Company, there are no existing circumstances or
events that would reasonably be expected to adversely affect the qualified
status of each such Benefit Plan. ( _i_ ) All Benefit Plans comply and have
been operated in all material respects in accordance with their terms and the
requirements of Law applicable thereto, (ii) there are no actions, suits or
claims (other than routine claims for benefits) pending or, to the Knowledge
of the Company, threatened, involving any Benefit Plan and (iii) the Company
and the Subsidiaries have not engaged in, and to the Knowledge of the Company,
there has not been, any non-exempt transaction prohibited by ERISA or by
Section 4975 of the Code with respect to any Benefit Plan or their related
trusts, if any, in the case of each of clauses (ii) and (iii) which would
reasonably be expected to result in a material liability of the Company. No
Benefit Plan is under audit or is the subject of an audit, administrative
proceeding or, to the Knowledge of the Company, investigation by the IRS, the
Department of Labor, or any other Governmental Authority, nor is any such
audit, investigation or other administrative proceeding, to the Knowledge of
the Company, threatened. Except as would not reasonably be expected to result
in a material liability to the Company, all contributions, reimbursements,
premium payments and other payments required to have been made under or with
respect to each Benefit Plan as of or prior to the date hereof have been made
on a timely basis in accordance with applicable Law. None of the Company, its
ERISA Affiliates, the Subsidiaries or any predecessor thereof sponsors,
maintains or contributes to, or has in the past six (6) years sponsored,
maintained or contributed to, any pension plan subject to Title IV of ERISA.

  


 

  

(d) _Post-Retirement Benefits_. Neither the Company nor any of the
Subsidiaries has any liability under any Benefit Plan or otherwise for
providing post-retirement health, medical and life insurance benefits for
retired, former or current employees, other than statutory liability for
providing group health plan continuation coverage under Part 6 of Subtitle B
of Title I of ERISA and Section 4980B of the Code or applicable Law where such
continuation coverage is provided at the recipient's sole expense.

  


 

  

(e) _Multiemployer Plans_. Neither the Company nor any of its ERISA Affiliates
contributes to or is obligated to contribute to, or within the six (6) years
preceding this Agreement contributed to, or was obligated to contribute to, a
Multiemployer Plan or a Multiple Employer Plan, and neither the Company nor
any of its ERISA Affiliates has incurred any liability to a Multiemployer Plan
or Multiple Employer Plan as a result of a complete or partial withdrawal (as
those terms are defined in Part I of Subtitle E of Title IV of ERISA) from
such Multiemployer Plan or Multiple Employer Plan.

  


 

  


 

  

 

38  

  


 

  


 

  

(f) The per-share exercise price of each Option is less than the Per Share
Common Stock Merger Consideration. Each Option has been granted with an
exercise price that is at least equal to the fair market value, as determined
under Section 409A of the Code, of a share of Common Stock on the applicable
date of grant.

  


 

  

(g) All contributions required to be made by the Company or any Subsidiary to
any Benefit Plan by applicable Law or by any plan document or other
contractual undertaking, and all premiums due from or payable by the Company
or any Subsidiary with respect to insurance policies funding any Benefit Plan,
for any period through the date hereof, have been made or paid within the time
period prescribed by any such plan, agreement or applicable Law.

  


 

  

(h) There does not now exist, nor do any circumstances exist that would
reasonably be expected to result in, any Controlled Group Liability (as
hereinafter defined) that would be a liability following the Closing of the
Company, any of its Subsidiaries or any of their respective ERISA Affiliates.
Without limiting the generality of the foregoing, none of the Company, any of
its Subsidiaries or any of their respective ERISA Affiliates has engaged in
any transaction described in Section 4069 or Section 4204 or 4212 of ERISA.
For the purposes of this Section 3.9, "Controlled Group Liability" means any
and all liabilities under Title IV of ERISA, (ii) under Section 302 of ERISA,
(iii) under Sections 412, 430 and 4971 of the Code, and (iv) as a result of a
failure to comply with the continuation coverage requirements of Section 601
et seq. of ERISA and Section 4980B of the Code, in each case, as a result of
the Company or any Subsidiary being an ERISA Affiliate of another Person
(other than the Company or any Subsidiary) prior to the Closing.

  


 

  

(i) _Effect of the Transaction_. Except as otherwise contemplated by this
Agreement, the execution, delivery and performance of this Agreement by the
Company and the consummation by the Company of the transactions contemplated
by this Agreement will not (alone or in combination with any other event) (
_i_ ) entitle any current or former employee, consultant, officer or director
of the Company or any Subsidiary to severance pay or any other payment, ( _ii_
) result in any payment becoming due, accelerate the time of payment or
vesting of benefits, or increase the amount of compensation due to any current
or former employee, consultant, officer or director, ( _iii_ ) result in any
forgiveness of Indebtedness, trigger any funding obligation under any Benefit
Plan or impose any restrictions or limitations on the Company's or any
Subsidiary's rights to administer, amend, merge, terminate or receive a
reversion of assets from any Benefit Plan or ( _iv_ ) result in any payment
(whether in cash or property or the vesting of property) to any "disqualified
individual" (as such term is defined in Treasury Regulation Section 1.280G-1)
that could reasonably be construed, individually or in combination with any
other such payment, to constitute an "excess parachute payment" (as defined in
Section 280G(b)(1) of the Code). No person is entitled to receive any
additional payment (including any tax gross-up or other payment) from the
Company or any Subsidiary as a result of the imposition of the excise taxes
required by Section 4999 of the Code or any taxes required by Section 409A of
the Code.

  


 

  


 

  

 

39  

  


 

  


 

  

(j) There are no pending or, to the Knowledge of the Company, threatened
claims (other than claims for benefits in the ordinary course), lawsuits or
arbitrations which have been asserted or instituted, and, to the Knowledge of
the Company, no set of circumstances exists which may reasonably give rise to
a claim or lawsuit, against the Benefit Plans, any fiduciaries thereof with
respect to their duties to the Benefits Plans or the assets of any trusts
under any of the Benefit Plans which would reasonably be expected to result in
any material liability of the Company or any of its Subsidiaries to the
Pension Benefit Guaranty Corporation, the Department of Treasury, the
Department of Labor, any Multiemployer Plan, a Multiple Employer Plan, any
participant in a Benefit Plan, or any other party.

  


 

  

3.10 _Taxes_.

  


 

  

(a) All Tax Returns required to be filed by or with respect to the Company and
the Subsidiaries have been timely filed, such Tax Returns are complete and
correct in all material respects and all Taxes shown on such Tax Returns and
all other material Taxes required to be paid by, or that could give rise to a
Lien on the assets of, the Company or any of the Subsidiaries have been timely
paid.

  


 

  

(b) All material Taxes required to be withheld by the Company and the
Subsidiaries have been timely withheld and all withheld Taxes have been timely
paid over to the proper Taxing authorities or properly set aside in accounts
for such purpose.

  


 

  

(c) (i) No waivers or extensions of statutes of limitations or periods of
assessment or collection of any Taxes with respect to the material Taxes or
the material Tax Returns of the Company or any of the Subsidiaries have been
filed or entered into with any Taxing Authority; (ii) the time for filing any
income Tax Return with respect to the Company or any of the Subsidiaries has
not been extended to a due date later than the date of this Agreement; (iii)
no material Taxes or material Tax Returns with respect to the Company or any
of the Subsidiaries are currently the subject of any judicial or
administrative proceeding, audit, examination or investigation, and no such
proceeding, audit, examination or investigation has been threatened in
writing; (iv) no Taxing Authority has asserted in writing any deficiency,
claim or issue with respect to Taxes or any adjustment to Taxes against the
Company or any of the Subsidiaries with respect to any Taxable period for
which the period of assessment or collection remains open; and (v) no
jurisdiction (whether within or without the United States) in which the
Company or any of the Subsidiaries has not filed a particular type of Tax
Return has asserted in writing that the Company or such Subsidiary is required
to file such Tax Return in its jurisdiction.

  


 

  

(d) Neither the Company nor any of the Subsidiaries ( _i_ ) has received or
applied for a Tax ruling or entered into a closing agreement pursuant to
Section 7121 of the Code (or any predecessor provision or any similar
provision of state, local or foreign Law), in either case that would be
binding upon the Company or any of the Subsidiaries after the Closing Date, (
_ii_ ) is or has been a member of any affiliated, consolidated, combined or
unitary group for purposes of filing Tax Returns or paying Taxes (other than a
group the common parent of which is the Company) or ( _iii_ ) has any
liability for the Taxes of any Person (other than for the Company or any
Subsidiary) whether under Treasury Regulation Section 1.1502-6 or any similar
provision of state, local or foreign Law, as a transferee or successor,
pursuant to any Tax sharing or indemnity agreement or other contractual
agreements (other than any commercial contracts entered into in the ordinary
course of business that do not relate primarily to Taxes), or otherwise.

  


 

  


 

  

 

40  

  


 

  


 

  

(e) Neither the Company nor any of the Subsidiaries will be required to
include any item of income in, or exclude any item of deduction from, Taxable
income for any Taxable period (or portion thereof) ending after the Closing
Date, as a result of any (i) change in method of accounting for a Taxable
period (or portion thereof) ending on or prior to the Closing Date under
Section 481 of the Code (or any corresponding provision of state, local or
foreign income Tax Law), (ii) installment sale, intercompany transaction or
open transaction disposition made on or prior to the Closing Date, (iii)
prepaid amount received on or prior to the Closing Date or (iv) election
pursuant to Section 108(i) of the Code (or any similar provision of state,
local or foreign Law) made with respect to any Taxable period (or portion
thereof) ending on or prior to the Closing Date. Neither the Company nor any
of the Subsidiaries has participated in a "listed transaction" within the
meaning of Treasury Regulation Section 1.6011-4(c) (or any similar provision
of state, local or foreign law). Neither the Company nor any of the
Subsidiaries has been a "distributing corporation" or a "controlled
corporation" within the meaning of Section 355 of the Code (x) in the two (2)
years prior to the date of this Agreement or (y) in a distribution that could
otherwise constitute a "plan" or "series of related transactions" in
conjunction with the transactions contemplated by this Agreement.

  


 

  

(f) Neither the Company nor any of the Subsidiaries is organized outside of
the United States.

  


 

  

(g) There is no Tax sharing, allocation, indemnity or similar agreement or
arrangement between the Company or any of the Subsidiaries, on the one hand,
and any of the Fully-Diluted Stockholders, on the other hand.

  


 

  

3.11 _L_ _itigation_. ( _i_ ) None of the Company, the Subsidiaries or the
Assets is subject to any outstanding or unsatisfied Order and there is no
claim, action, suit, arbitration, proceeding, hearing or investigation of any
nature (civil, criminal, regulatory or otherwise) in Law or in equity ("
_Litigation_ "), of, before or in any court or quasi-judicial or
administrative agency or official of any federal, state, local or foreign
jurisdiction, arbitrator or mediator, pending, or, to the Knowledge of the
Company, threatened against or affecting any of the Company, the Subsidiaries
or the Assets, ( _ii_ ) there are no settlements or similar written agreements
with material continuing performance obligations between the Company or any
Subsidiary, on the one hand, and any Governmental Authority, on the other hand
and (iii) there is no Litigation involving the Company, any of the
Subsidiaries or the Assets pending or, to the Knowledge of the Company,
threatened, that questions or challenges (A) the validity of this Agreement or
(B) any action taken or to be taken by the Company or any of the Subsidiaries
pursuant to this Agreement or in connection with the transactions contemplated
hereby.

  


 

  

3.12 _Compliance with Laws; Permits_.

  


 

  

(a) Each of the Company and the Subsidiaries is, and since January 1, 2014 has
been, in compliance in all material respects with all laws, statutes, Orders,
rules, and regulations of any Governmental Authority applicable to their
respective businesses or operations, including, to the extent applicable, 42
U.S.C. Section 1320a-7b (the Federal Anti-Kickback Law), 42 U.S.C. Section
1320a-7a (Civil Monetary Penalty Statute), 31 U.S.C. Sections 3729-3733 (the
False Claims Act), Pub. L. No. 111-5 (the Health Information Technology for
Economic and Clinical Health Act), 42 U.S.C. Section 1320d et seq. (the Health
Insurance Portability and Accountability Act of 1996 and any comparable state
or local laws), 42 U.S.C. ยง 1320a-7a(a)(5) (the Anti-Inducement Law), 31
U.S.C. ยงยง 3729 et seq. (the civil False Claims Act), 42 U.S.C. ยง 1320a-7b(a)
(the administrative False Claims Law), 42 U.S.C. ยง 1320a-7 (the exclusion
Laws), 21 U.S.C. ยงยง 301 et seq. (the Food Drug and Cosmetic Act) (the " _FD andC
Act_"), 21 U.S.C. ยงยง 801 et seq (the Controlled Substances Act), Title XVIII
of the Social Security Act (the Medicare Program), 42 U.S.C. ยง 1395w-3a
(requirements of Medicare average sales price reporting), 38 U.S.C. ยง 8126
(the VA Federal Supply Schedule) and state pharmaceutical assistance programs
and regulations under such laws (collectively, " _Laws_ ").

  


 

  


 

  

 

41  

  


 

  


 

  

(b) (i) The operations of the Company and each Subsidiary are, and since
January 1, 2014 have been, in compliance in all material respects with the
applicable requirements of the FDA and DEA, (ii) since January 1, 2014,
neither the Company nor a Subsidiary has received any written notice that it
is subject to any pending or threatened civil, criminal or administrative
action, suit or proceeding from the FDA or any similar Governmental Authority
that is adverse to the Company or a Subsidiary, including a consent decree,
injunction, or suspension of compounding, (iii) all compounding facilities of
the Company and each Subsidiary are operated in compliance in all material
respects with the FDandC Act and its implementing regulations, (iv) the Company
and each Subsidiary is, and since January 1, 2014 has been, in compliance in
all material respects with all applicable legal requirements of the FDA and
FDandC Act pertaining to development, approval, sale, registration, record-
keeping, reporting, listing, labeling, advertising and promotion, pre- and
post-marketing adverse event reporting, testing, and applicable cGMP
regulations pursuant to 21 CFR Parts 210 and 211 (and applicable guidance
under the Interim Guidance for Human Drug Compounding Outsourcing Facilities
Under Section 503B of the FDandC Act (July 2014)) and all other applicable
compounding practices, including United States Pharmacopeia requirements, of
pharmaceutical products, in each case to the extent applicable to the Company
or any Subsidiary and (v) the Company and each Subsidiary has not since
January 1, 2014 introduced into commercial distribution any products that upon
their shipment by the Company or a Subsidiary were adulterated or misbranded
as defined by the FDandC Act, except, in each case, for such instances or
occurrences that, individually or in the aggregate, would not reasonably be
expected to be material to the Company and the Subsidiaries, taken as a whole.

  


 

  

(c) Since January 1, 2014, none of the Company's or any of the Subsidiaries'
products have been recalled (as defined in 21 CFR ยง 7.3(g) or comparable state
Laws) or subjected to an FDA or other Governmental Authority request for
corrective or removal action, and neither the Company nor any of the
Subsidiaries has received written notice from the FDA or another Governmental
Authority of any proceeding seeking a recall, correction, removal or seizure
of any such products, except, in each case, for such instances or occurrences
that, individually or in the aggregate, would not reasonably be expected to be
material to the Company and the Subsidiaries, taken as a whole.

  


 

  

(d) As of the date hereof, none of the Company, any of the Subsidiaries or, to
the Knowledge of the Company, any individual employed by the Company or any of
the Subsidiaries, has been disqualified or debarred by the FDA pursuant to the
FDandC Act, or been convicted under Law for misconduct relating to development,
approval, sale, registration, record-keeping, reporting, listing, labeling,
advertising and promotion, pre- and post-marketing adverse event reporting,
testing, applicable cGMP regulations and guidelines pursuant to 21 CFR Parts
210 and 211 and all other applicable compounding practices, including United
States Pharmacopeia requirements, of pharmaceutical products, including the
products compounded by the Company or any of the Subsidiaries.

  


 

  


 

  

 

42  

  


 

  


 

  

(e) The Company has made available to Parent true, correct and complete copies
of (i) the Company's internal records for tracking (A) customer complaints
relating to products of the Company or any of its Subsidiaries and (B)
MedWatch forms received by the Company or any of its Subsidiaries or, to the
Knowledge of the Company, filed with the FDA since January 1, 2014, (ii) all
warning letters, untitled letters, regulatory letters, notices of inspectional
observations (Form FDA 483s), establishment inspection reports (EIRs) of the
FDA, the DEA, State Boards of Pharmacy and other similar Governmental
Authorities relating to the Company's or any of the Subsidiaries' products'
compliance with, and the Company's and the Subsidiaries' compliance with,
Laws, and all of the Company's and the Subsidiaries', as applicable, written
responses thereto, since January 1, 2014 and (iii) all written audit reports
issued to the Company or any of the Subsidiaries since January 1, 2014
pertaining to assessment of compliance with cGMP requirements by the Company
and the Subsidiaries.

  


 

  

(f) All material approvals, permits, franchises, licenses, consents,
exemptions and similar authorizations (collectively, " _Permits_ ") of all
Governmental Authorities that are required to permit the Company and the
Subsidiaries to carry on their businesses have been obtained and are in full
force and effect except for Permits that absence of which would not reasonably
be expected to be material to the Company and the Subsidiaries, taken as a
whole. There has been no violation, default, cancellation or revocation, nor,
to the Knowledge of the Company, any threatened cancellation or revocation, of
any Permit, except for any violation, default, cancellation or revocation that
would not reasonably be expected to be materially adverse to the Company and
the Subsidiaries, taken as a whole.

  


 

  

3.13 _Environmental Matters_.

  


 

  

(a) To the Knowledge of the Company, all of the existing Phase I and Phase II
environmental site assessment reports, and all preliminary assessment reports
under ISRA, in each case in the possession of the Company or any Subsidiary
for their respective currently owned, leased or operated real properties and
prepared after October 1, 2010 have been made available for inspection by
Parent and, to the Knowledge of the Company, were accurate and complete in all
material respects as of the date of such reports.

  


 

  

(b) Except as described in Section 3.13(b) of the Seller Disclosure Letter:

  


 

  

(i) the Company and the Subsidiaries (i) are in compliance and, for the last
five years, have complied with all applicable Environmental Laws, including
the possession of and compliance with all Permits required under applicable
Environmental Laws to operate the business as currently conducted (the "
_Environmental Permits_ ") and (ii) possess or have applied for any
Environmental Permits necessary to operate the business at the Company's
Dayton, NJ facility, in each of cases (i) and (ii) except to the extent such
noncompliance or failure to possess would not reasonably be expected to be
materially adverse to the Company and the Subsidiaries, taken as a whole;

  


 

  


 

  

 

43  

  


 

  


 

  

(ii) neither the Company nor any Subsidiary has received notice of a civil,
criminal or administrative suit, claim, action, proceeding or investigation
under any Environmental Law relating to any property or facility currently or
formerly owned, operated or leased by any of them, except to the extent that
any such matter would not reasonably be expected to be materially adverse to
the Company and the Subsidiaries, taken as a whole;

  


 

  

(iii) neither the Company nor any Subsidiary has received from any
Governmental Authority written notice that it has been named or may be named
as a responsible or potentially responsible party under any Environmental Law
for any site Contaminated by Hazardous Substances;

  


 

  

(iv) except to the extent such Contamination would not reasonably be expected
to be materially adverse to the Company and the Subsidiaries, taken as a
whole, to the Knowledge of the Company, no portion of any property currently
owned, leased or occupied by the Company or a Subsidiary is Contaminated;

  


 

  

(v) none of the Company, any of the Subsidiaries or, during the period of
ownership, lease, operation or use of the relevant real property or facility
by the Company or any Subsidiary, any third party has caused or taken any
action that would reasonably be expected to result in any material liability
or obligation of the Company or any Subsidiary relating to the environmental
conditions (including any material liability or obligation of the Company or
any Subsidiary relating to any Release of or exposure to any Hazardous
Substances present in the indoor or outdoor environment) at, on, above, under,
about or emanating from any properties or assets currently or formerly owned,
leased, operated or used by the Company or any of the Subsidiaries; and

  


 

  

(vi) except to the extent that any such matter would not reasonably be
expected to be materially adverse to the Company and the Subsidiaries, taken
as a whole, neither the Company nor any of the Subsidiaries has arranged, by
contract, agreement, or otherwise, for the transportation, disposal or
treatment of Hazardous Substances at any location that would reasonably be
expected to be subject to liability for Response Actions pursuant to
Environmental Laws.

  


 

  

(c) The Company and its Subsidiaries will have as of the Closing complied in
all material respects with any requirements under ISRA arising or resulting in
connection with the Transaction.

  


 

  

3.14 _Absence of Changes_. Since the Balance Sheet Date and prior to the date
hereof, the businesses of the Company and the Subsidiaries have been conducted
in the ordinary course of business consistent with past practice and there has
not been any action taken by the Company or any of the Subsidiaries that, if
taken during the period from the date of this Agreement through the Effective
Time, would constitute a breach of _Section 5.2_. Since the Balance Sheet
Date, there has not been any change, event, fact, effect or occurrence (or
with respect to any change, event, fact, effect or occurrence existing prior
to the Balance Sheet Date, any worsening thereof) that has had, or would
reasonably be expected to have, either individually or in the aggregate, a
Material Adverse Effect.

  


 

  


 

  

 

44  

  


 

  


 

  

3.15 _Labor Relations; Compliance_.

  


 

  

(a) Neither the Company nor any Subsidiary is a party to, or otherwise bound
by, any collective bargaining agreement or other labor contract and there are
no labor unions representing, purporting to represent or attempting to
represent any employees employed by the Company or any Subsidiary. Since
January 1, 2014, there has not occurred and, to the Knowledge of the Company,
there is not threatened, ( _a_ ) any strike, slowdown, picketing, work
stoppage, employee grievance, concerted refusal to work overtime by, or
lockout of, or organizing campaign with respect to, any employees of the
Company or any Subsidiary, ( _b_ ) any proceeding against or materially
affecting the Company or any Subsidiary relating to the alleged violation of
any Laws pertaining to labor relations or employment matters, including any
charge or complaint filed by an employee or union with the National Labor
Relations Board, the Equal Employment Opportunity Commission, or any
comparable Governmental Authority, or ( _c_ ) any application for
certification of a collective bargaining agent. The Company and each
Subsidiary is in material compliance with all applicable Laws respecting
labor, employment, fair employment practices, terms and conditions of
employment, applicant and employee background checking, immigration, workers'
compensation, occupational safety and health requirements, plant closings,
wages and hours, worker classification, withholding of taxes, employment
discrimination, disability rights or benefits, equal opportunity, labor
relations, employee leave issues and unemployment insurance and related
matters. To the Knowledge of the Company, each individual who renders services
to Company or any of its Subsidiaries who is classified by the Company or such
Subsidiary, as applicable, as having the status of an independent contractor
or other non-employee status for any purpose (including for purposes of
taxation and tax reporting and under Benefit Plans) is properly so
characterized.

  


 

  

(b) Neither the Company nor any Subsidiary has effectuated a "plant closing"
or "mass layoff" as those terms are defined in the WARN Act, affecting in
whole or in part any site of employment, facility, operating unit or employee
of the Company, without complying with all provisions of the WARN Act, or
implemented any early retirement, separation or window program within the
twelve (12) months prior to the date of this Agreement, nor has the Company or
any of the Subsidiaries announced any such action or program for the future.

  


 

  

3.16 _Real Property_.

  


 

  

(a) _Leased Real Property_. Section 3.16(a) of the Disclosure Letter contains
a complete and correct list of all material leases, subleases or other
occupancy agreements (together with any and all amendments and modifications
thereto and any guarantees thereof) (collectively, the " _Leases_ ") pursuant
to which the Company or a Subsidiary, as of the date of this Agreement,
leases, subleases or occupies real property as tenant, subtenant or occupant
(the " _Leased Real Property_ "). The Company or one of the Subsidiaries have
good and valid title to the leasehold estate under the Leases free and clear
of any Liens other than Permitted Liens and none of the Company or any
Subsidiary is in default under any such Lease in any material respect. Neither
the Company nor any Subsidiary is a lessor, sublessor or grantor under any
lease, sublease or other instrument granting to another Person any right to
the possession, lease, occupancy or enjoyment of the Leased Real Property or
the Owned Real Property.

  


 

  


 

  

 

45  

  


 

  


 

  

(b) _Owned Real Property_. Section 3.16(b) of the Disclosure Letter contains a
complete and correct list of all real property owned by the Company or a
Subsidiary as of the date of this Agreement (which real property, together
with all structures, facilities, improvements and fixtures presently or
hereafter located thereon or attached thereto, the " _Owned Real Property_ "
and, together with the Leased Real Property, the " _Company Real Property_ ").
The Company or one of the Subsidiaries have good, valid and marketable fee
simple title to all of the Owned Real Property, free and clear of any Lien
other than Permitted Liens. None of the Owned Real Property is subject to any
first refusal, purchase option, right to purchase or other similar right.

  


 

  

(c) There does not exist any actual or, to the Knowledge of the Company,
threatened or contemplated condemnation or eminent domain proceedings that
affect any Company Real Property or any part thereof, and, to the Knowledge of
the Company, neither the Company nor any Subsidiary has received any written
notice of the intention of any Governmental Authority or other Person to take
or use all or any part thereof.

  


 

  

3.17 _Brokers and Finders_. There is no investment banker, broker or finder
retained by or authorized to act on behalf of the Company, any of the
Subsidiaries or any of the Company's stockholders or Affiliates who might be
entitled to any fee, commission or reimbursement of expenses from the Company
or any of the Subsidiaries in connection with the transactions contemplated
hereby other than (a) Clayton, Dubilier and Rice, LLC, whose fees and expenses
shall be paid pursuant to _Section 2.10(b)(v)(A)_, and (b) JP Morgan, Credit
Suisse and any other third party financial advisors, whose fees and expenses
shall be paid pursuant to _Section 2.10(b)(v)(B)_.

  


 

  

3.18 _Affiliate Agreements_. Section 3.18 of the Disclosure Letter lists all
agreements and transactions to which the Company or any Subsidiary, on the one
hand, and any Affiliate (other than the Company or the Subsidiaries) or any
stockholder of the Company, including any portfolio company of such
stockholder or Affiliate (other than the Company or the Subsidiaries), on the
other hand, are parties (each, an " _Affiliate Agreement_ "), other than any
employee agreements, agreements entered into under the Stock Incentive Plan,
any Benefit Plan and any arm's length commercial agreement or transaction
entered into in the ordinary course of business with a portfolio company of
funds affiliated with Clayton, Dubilier and Rice LLC that is not material to the
business of the Company and the Subsidiaries, taken as a whole (and such
agreements and transactions shall not be deemed to be "Affiliate Agreements").
No Affiliate of the Company and the Subsidiaries (other than the Company or
the other Subsidiaries), stockholder of the Company or controlled Affiliate of
such a stockholder, owns any material Asset. To the Knowledge of the Company,
no officer or director of the Company or any Subsidiary has any direct or
indirect ownership interest in any Person with which the Company or any of the
Subsidiaries has a business relationship, except that ( _a_ ) officers or
directors of the Company or any of the Subsidiaries may have direct or
indirect ownership interests in Clayton, Dubilier and Rice, LLC or one of its
Affiliates and (b) officers or directors of the Company or any of the
Subsidiaries and members of their immediate families may own stock in
publicly-traded companies that may have a business relationship with or
compete with the Company or the Subsidiaries.

  


 

  


 

  

 

46  

  


 

  


 

  

3.19 _Significant Customers and Suppliers_.

  


 

  

(a) _Section 3.19_ ( _a_ ) of the Disclosure Letter lists (i) the five (5)
most significant group purchasing organizations (measured by dollar volume of
sales sold to its members for the twelve-month period ended December 31, 2014)
and (ii) the ten (10) most significant customers (measured by dollar volume of
sales to such customer for the twelve-month period ended December 31, 2014),
in each case, of the Company and the Subsidiaries, taken as a whole (the "
_Significant Customers_ "), and the approximate dollar amount of the aggregate
sales for each such Significant Customer during such period. As of the date
hereof, (i) none of the Significant Customers has terminated its relationship
with the Company or the Subsidiaries and (ii) neither the Company nor any of
the Subsidiaries has received any written or, to the Knowledge of the Company,
oral notice that any Significant Customer has ceased, or will cease, to use
the products or services of the Company or any of the Subsidiaries or has
substantially reduced, or will substantially reduce, the use of such products
or services.

  


 

  

(b) _Section 3.19(b)_ of the Disclosure Letter lists the names of each of (i)
the ten (10) most significant pharmaceutical manufacturers from which the
Company and the Subsidiaries, taken as a whole, purchased drugs (measured by
dollar volume of purchases from such suppliers) for the twelve-month period
ended December 31, 2014 and (ii) the ten (10) most significant other suppliers
from which the Company and the Subsidiaries, taken as a whole, purchased
products or services (measured by dollar volume of purchases from such
suppliers) for the twelve-month period ended December 31, 2014 (such
suppliers, in clauses (i) and (ii) are collectively referred to as "
_Significant Suppliers_ ") and the amount for which each such Significant
Supplier invoiced the Company or any of the Subsidiaries during such period.
As of the date hereof, (i) none of the Significant Suppliers has terminated
its relationship with the Company or the Subsidiaries and (ii) neither the
Company nor any of the Subsidiaries has received any written or, to the
Knowledge of the Company, oral notice that any Significant Supplier has ceased
or will cease after the date hereof, to supply products (including drugs) or
services to the Company or any of the Subsidiaries on terms and conditions
similar in all material respects to those imposed on sales to the Company and
the Subsidiaries over the nine (9) months prior to the date of this Agreement
(other than in respect of terms and conditions that are not adverse to the
Company and the Subsidiaries).

  


 

  

3.20 _Sourcing Arrangements_. All of the pharmaceutical products and medical
consumables purchased, sourced or otherwise obtained by the Company and the
Subsidiaries are purchased, sourced or otherwise obtained from a Person that
is the original manufacturer or its authorized distributor.

  


 

  

3.21 _Certain Business Practices_.

  


 

  

(a) Neither the Company nor any of its Subsidiaries, nor any of its or their
directors, officers or employees, nor, to the Knowledge of the Company, any
agents, independent contractors and other parties acting on behalf of the
Company or any of its Subsidiaries or Affiliates, has violated any material
provision of the Foreign Corrupt Practices Act of 1977, as amended, the U.K.
Bribery Act of 2010 or any other similar Law in any jurisdiction applicable to
the Company or any of its Subsidiaries (collectively, the " _Anti-Corruption
Laws_ ").

  


 

  


 

  

 

47  

  


 

  


 

  

(b) To the Knowledge of the Company, there is no investigation of, written
allegation by, or request for information from the Company or any of its
Subsidiaries by any Governmental Authority regarding the Anti-Corruption Laws
that would reasonably be expected to result in any material fine, penalty or
enforcement action by such Governmental Authority.

  


 

  

(c) To the Knowledge of the Company, neither the Company nor any of its
Subsidiaries, nor any current or former directors, officers, employees,
agents, independent contractors or other parties acting on behalf of the
Company or any of its Subsidiaries or Affiliates, has materially violated or
operated in material noncompliance with any export restrictions, anti-boycott
regulations, embargo regulations or other similar applicable Laws of any
Governmental Authority.

  


 

  

3.22 _N_ _O OTHER REPRESENTATIONS OR WARRANTIES_. EXCEPT FOR THE
REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS _ARTICLE III_ OR THE
CERTIFICATE TO BE DELIVERED TO PARENT PURSUANT TO _SECTION 2.2(b)(iii)_ ,
NEITHER THE COMPANY NOR ANY OTHER PERSON ON ITS BEHALF MAKES ANY OTHER EXPRESS
OR IMPLIED REPRESENTATION OR WARRANTY WITH RESPECT TO THE COMPANY, THE
SUBSIDIARIES OR THEIR CONDITION OR BUSINESSES.

  


 

  

ARTICLE IV

  


 

  

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  


 

  

Parent and Merger Sub jointly and severally represent and warrant to the
Company that:

  


 

  

4.1 _Due Incorporation_. Each of Parent and Merger Sub is a corporation duly
organized, validly existing and in good standing under the laws of the State
of Delaware with all requisite power and authority to own and operate its
assets and properties as they are now being owned and operated and to carry on
its business as now conducted. All of the issued and outstanding capital stock
of Merger Sub is owned directly by Parent free and clear of Liens of any kind.

  


 

  

4.2 _Due Authorization_. Each of Parent and Merger Sub has full power and
authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution, delivery and performance by each of Parent
and Merger Sub of this Agreement have been duly authorized by all necessary
corporate or other action of Parent and Merger Sub. Each of Parent and Merger
Sub has duly and validly executed and delivered this Agreement. This Agreement
constitutes the legal, valid and binding obligation of each of Parent and
Merger Sub, enforceable against them in accordance with its terms, except as
such enforceability may be limited by applicable bankruptcy, insolvency,
moratorium, reorganization or similar Laws in effect which affect the
enforcement of creditors' rights generally and by equitable principles.

  


 

  

4.3 _Consents and Approvals; No Violations_. Except for (a) filings under
_Section 2.3_ and (b) filings under the HSR Act, the execution, delivery and
performance by Parent and Merger Sub of this Agreement will not (i) violate
any Law applicable to Parent or Merger Sub; (ii) require any filing or
registration by Parent or Merger Sub with, or consent or approval with respect
to Parent or Merger Sub of, or other action by, any Governmental Authority;
(iii) violate or conflict with or result in a breach or default under any
contract to which Parent or Merger Sub is a party or by which Parent or Merger
Sub or any of their assets or properties are bound; or (iv) violate or
conflict with any provision of the Organizational Documents of Parent or
Merger Sub, except, in the case of clause (iii), where any such violation,
conflict, breach or default would be reasonably expected to be, individually
or in the aggregate, materially adverse to Parent and Merger Sub, or
materially impair the ability of Parent and Merger Sub to perform their
obligations under this Agreement or consummate the Merger or the other
transactions contemplated hereby.

  


 

  


 

  

 

48  

  


 

  


 

  

4.4 _Investigation; Limitation on Warranties_.

  


 

  

(a) Each of Parent and Merger Sub acknowledges and agrees that it (i) has made
its own inquiry and investigations into and, based thereon, has formed an
independent judgment concerning the Company, the Subsidiaries, and the Assets,
(ii) has been provided with adequate access to such information, documents and
other materials relating to the Company, the Subsidiaries, and the Assets as
it has deemed necessary to enable it to form such independent judgment, (iii)
has had such time as it deems necessary and appropriate to fully and
completely review and analyze such information, documents and other materials
and (iv) has been provided an opportunity to ask questions of the Company with
respect to such information, documents and other materials and has received
satisfactory answers to such questions.

  


 

  

(b) Parent and Merger Sub acknowledge and agree that neither the Company nor
any Subsidiary, nor any other Person acting on behalf of the Company or any of
their respective Affiliates or representatives, has made any representation or
warranty, express or implied, as to the accuracy or completeness of any
information regarding the Company or any Subsidiary or their respective
businesses or assets, except as expressly set forth in _Article III_ or the
certificate to be delivered to Parent pursuant to _Section 2.2(b)(iii)_ , and
that, except as expressly set forth in _Article III_ or the certificate to be
delivered to Parent pursuant to _Section 2.2(b)(iii)_ , the Company, the
Subsidiaries, and the Assets are being sold "as is" and "where is".

  


 

  

(c) In connection with Parent's and Merger Sub's investigation of the Company
and the Subsidiaries, Parent and Merger Sub have received from or on behalf of
the Company certain projections, including projected statements of operating
revenues and income from operations of the Company and the Subsidiaries and
certain business plan information of the Company and the Subsidiaries. Parent
and Merger Sub acknowledge that there are uncertainties inherent in attempting
to make such estimates, projections and other forecasts and plans, that Parent
and Merger Sub are familiar with such uncertainties, and that neither the
Company nor any Subsidiary, nor any other Person acting on behalf of the
Company or any of their respective Affiliates or representatives, nor CDandR
Investor or any of its Affiliates makes representations or warranties
whatsoever with respect to such estimates, projections and other forecasts and
plans (including the reasonableness of the assumptions underlying such
estimates, projections and forecasts).

  


 

  

4.5 _No Fraudulent Intent_ . No transfer of property is being made and no
obligation is being incurred in connection with the transactions contemplated
by this Agreement at the direction or otherwise on behalf of Parent or Merger
Sub with the intent to hinder, delay or defraud either present or future
creditors of the Company or the Subsidiaries.

  


 

  


 

  

 

49  

  


 

  


 

  

4.6 _Acquisition for Investment_. The capital stock and other interests of the
Surviving Corporation and the Subsidiaries acquired by Parent pursuant to this
Agreement are being acquired for investment only and not with a view to any
public distribution thereof, and Parent will not offer to sell or otherwise
dispose of such stock or interests so acquired by it in violation of any of
the registration requirements of the Securities Act or any comparable state
Law. Parent (either alone or together with its advisors) has sufficient
knowledge and experience in financial and business matters so as to be capable
of evaluating the merits and risks of its investment in the Common Stock and
is capable of bearing the economic risks of such investment.

  


 

  

4.7 _Plant Closings and Mass Layoffs_. As of the date hereof, Parent does not
intend to effect any "plant closings" or "mass layoffs" as those terms are
defined in the WARN Act, affecting in whole or in part any site of employment,
facility, operating unit or employee of the Company or the Subsidiaries
without complying with the provisions of the WARN Act.

  


 

  

4.8 _Brokers and Finders_. Neither Parent nor Merger Sub is committed to pay
any investment banker's, brokers' or finders' fees, commissions or expense
reimbursement in connection with the transactions contemplated by this
Agreement.

  


 

  

4.9 _Sufficient Funds_. As of immediately prior to or substantially
simultaneously with the Closing, Parent will have sufficient funds to pay the
Merger Consideration and to effect all other transactions contemplated by this
Agreement and the Purchase Price Adjustment Escrow Agreement.

  


 

  

4.10 _Litigation_. As of the date of this Agreement, there is no Litigation
pending against, or, to the Knowledge of Parent, threatened against, Parent or
Merger Sub before any court or arbitrator or any Governmental Authority which
in any manner challenges or seeks to prevent, enjoin, alter or materially
delay the transactions contemplated by this Agreement.

  


 

  

4.11 _Operations of Merger Sub_. Merger Sub was formed specifically for the
transactions contemplated by this Agreement and has conducted no operations
and incurred no obligations other than those incidental to its formation and
in connection with the transactions contemplated by this Agreement.

  


 

  

ARTICLE V

  


 

  

COVENANTS

  


 

  

5.1 _Access to Information and Facilities_.

  


 

  

(a) From the date of this Agreement until the earlier of the Closing Date or
the date this Agreement is terminated, subject to the Confidentiality
Agreement, the Company shall, and shall cause the Subsidiaries to, give Parent
and Merger Sub and Parent's and Merger Sub's representatives, upon reasonable
notice, reasonable access during normal business hours to the offices,
facilities, books and records of the Company and the Subsidiaries, and shall
make the officers and employees of the Company and the Subsidiaries available
to Parent and Merger Sub and their representatives as Parent, Merger Sub and
their representatives shall from time to time reasonably request, in each case
to the extent that such access and disclosure would not obligate the Company
or a Subsidiary to take any actions that would unreasonably disrupt the normal
course of their businesses; _provided_ , _however_ , that nothing herein shall
require the Company to provide access or to disclose any information to Parent
if such access or disclosure would (x) violate applicable Laws (including the
HSR Act) or (y) cause a risk of a loss of privilege protection to the Company
or any of the Subsidiaries ( _provided_ that the Company shall use
commercially reasonable efforts to develop an alternative to providing such
information reasonably acceptable to Parent).

  


 

  


 

  

 

50  

  


 

  


 

  

(b) From and after the date of this Agreement to the Closing Date, Parent and
Merger Sub shall not, without the prior consent of the Company (which need not
be in writing and which will not be unreasonably withheld, delayed or
conditioned) have any contact or discussions with any employee, customer,
supplier or other material business relation of the Company or the
Subsidiaries with respect to the transactions contemplated by this Agreement;
_provided_ , _however_ , that the foregoing restriction shall not prevent (i)
discussions by Parent and Merger Sub with any Person unrelated to the
transactions contemplated by this Agreement (such as commercial discussions
with Persons with whom Parent has existing or prospective business
relationships unrelated to the transactions contemplated by this Agreement),
(ii) discussions by Parent and Merger Sub with any Persons (other than the
Persons in clause (iv), to which such clause applies) regarding other
arrangements with Parent and its Affiliates (including how such arrangements
may be affected by the transactions contemplated by this Agreement), (iii)
Parent responding to inquiries regarding the transactions contemplated by this
Agreement from Persons with whom Parent has existing business relationships
and (iv) Parent communicating, at such reasonable times and in such reasonable
manners determined in consultation with the Company as do not disrupt the
Company's workplaces, with employees of the Company and the Subsidiaries
regarding employee benefits and post-Closing terms of employment. Promptly
following the date of this Agreement and during the period from the date of
this Agreement to the Closing Date, Parent and the Company will work in good
faith to facilitate discussions (subject to any limitations under applicable
Law) by Parent with the customers, suppliers and other material business
relations of the Company and the Subsidiaries for purposes of integration
planning and other similar matters.

  


 

  

(c) Parent, Merger Sub and their representatives shall treat and hold strictly
confidential any Confidential Information (as defined in the Confidentiality
Agreement) in accordance with the terms of the Confidentiality Agreement.

  


 

  

5.2 _Preservation of Business_. From the date of this Agreement until the
Effective Time, other than (i) as expressly permitted or required by this
Agreement, (ii) with the prior written consent of Parent (not to be
unreasonably withheld, delayed or conditioned), (iii) as required by
applicable Law or (iv) as set forth in Section 5.2 of the Disclosure Letter,
the Company shall, and shall cause the Subsidiaries to, be operated in the
ordinary course of business and consistent with past practice in all material
respects. From the date of this Agreement until the Effective Time, other than
as expressly permitted or required by this Agreement, the Purchase Price
Adjustment Escrow Agreement or the Indemnification Escrow Agreement, as set
forth in Section 5.2 of the Disclosure Letter, as required by applicable Law
or with the prior written consent of Parent (not to be unreasonably withheld,
delayed or conditioned), the Company shall, and shall cause the Subsidiaries
to, use commercially reasonable efforts to preserve intact their businesses,
the Assets and their relationships with customers, suppliers and others having
business dealings with them in all material respects, and keep available the
services of their present officers and significant employees. Without limiting
the generality of the foregoing, the Company shall not, and shall cause the
Subsidiaries not to, other than (w) as otherwise expressly permitted or
required by this Agreement, the Purchase Price Adjustment Escrow Agreement or
the Indemnification Escrow Agreement, (x) with the prior written consent of
Parent (it being understood that such consent shall not be unreasonably
withheld, delayed or conditioned), (y) as required by applicable Law or (z) as
set forth in _Section 5.2_ of the Disclosure Letter: 
 


 

  

(a) amend or otherwise change in any material respect their respective
Organizational Documents;

  

 

  


 

  

 

51  

  


 

  

(b) sell, lease, transfer, license, assign or otherwise dispose of any Asset
having a value in excess of $2,000,000 individually or in the aggregate, other
than the disposition of inventory in the ordinary course of business
consistent with past practice;

  


 

  

(c) (i) grant or pay any severance or termination pay to (or amend any such
existing arrangement with) any current or former director, officer, employee
or independent contractor of the Company or any of the Subsidiaries (other
than payments in accordance with the terms of any existing agreements,
severance policies or termination pay policies as in effect on the date of
this Agreement), (ii) increase benefits payable under any existing severance
or termination pay policies or employment agreements, (iii) establish, adopt
or amend an employment, severance, termination, retention or change of
control, deferred compensation or other similar agreement entered into with
any current or former director, officer, employee or independent contractor of
the Company or any of the Subsidiaries, (iv) establish, adopt, amend or
terminate any collective bargaining, bonus, profit-sharing, thrift, pension,
retirement, deferred compensation, stock option, restricted stock or other
benefit plan or arrangement covering any current or former director, officer,
employee or independent contractor of the Company or any of the Subsidiaries,
(v) amend, modify, terminate or interpret any existing Benefit Plan in any
manner that would increase the liability of the Company or any of the
Subsidiaries, other than increases that are not material arising due to
customary renewals of third party vendor arrangements in the ordinary course
of business, (vi) grant any new equity awards to any current or former
director, officer, employee or independent contractor of the Company or any of
the Subsidiaries, (vii) except as provided in _Section 2.9_, accelerate the
vesting or payment of, or fund or in any other way secure the payment,
compensation or benefits under, any Benefit Plan to the extent not required by
the terms of this Agreement or such Benefit Plan as in effect on the date of
this Agreement, (viii) otherwise grant, award or increase, or commit to grant,
award or increase, salaries, bonuses or other compensation or benefits payable
to any current or former director, officer, employee or independent contractor
of the Company or any of the Subsidiaries (except with regard to employees who
are not directors or officers, increases in base salaries or base wages
arising in connection with promotions in the ordinary course of business
consistent with past practice that do not exceed 4% of current pay or
compensation or as required pursuant to the terms of any Benefit Plan or as in
effect on the date of this Agreement) or (ix) hire or terminate the employment
of any individual who has (in the case of individuals to be terminated) or
would have (in the case of individuals to be hired) target total compensation
(cash and target incentive) of $140,000 or more;

  


 

  


 

  

 

52  

  


 

  


 

  

(d) except for the cancellation of the Options in accordance with this
Agreement and the issuance of shares of Common Stock upon exercise of Options
in accordance with the terms thereof as in effect as of the date hereof,
issue, sell or grant options, warrants or rights to purchase or subscribe to,
enter into any arrangement or contract with respect to the issuance or sale
of, or redeem or repurchase, any Company Securities or any Subsidiary
Securities or make any changes (by split, combination, reorganization,
reclassification or otherwise) in the capital structure of the Company or any
of the Subsidiaries;

  


 

  

(e) incur any Indebtedness, except pursuant to the Existing Credit Agreements;

  


 

  

(f) create or incur any Lien on any Asset, other than in the ordinary course
of business consistent with past practice, Permitted Liens and Liens securing
Indebtedness under the Existing Credit Agreements;

  


 

  

(g) declare, set aside or pay any dividend or other distribution with respect
to the capital stock of the Company;

  


 

  

(h) merge or consolidate with any other Person or acquire a material amount of
stock or assets of any other Person or effect any business combination,
recapitalization or similar transaction (other than the Merger);

  


 

  

(i) (i) (A) except in the ordinary course of business consistent with past
practice (including extensions at the end of a term in the ordinary course of
business consistent with past practice), transfer or terminate, or materially
modify or amend, or (B) release, assign or otherwise change any material
rights under or (C) waive any material right under or discharge any other
party of any material obligation under, any Material Contract or (ii) enter
into any Material Contract other than those described in clauses (v), (viii),
(xii), (xiv), (xviii) or (xix) (to the extent permitted by clause (n) below)
of _Section 3.7(a)_ ;

  


 

  

(j) make any material loan, advance or capital contribution to or investment
in any Person other than loans, advances or capital contributions to or
investments in the Subsidiaries in the ordinary course of business consistent
with past practice;

  


 

  

(k) acquire any real property or any direct or indirect interest in any real
property;

  


 

  

(l) make any material change to its accounting policies or practices, except
as required by GAAP or applicable Law;

  


 

  


 

  

 

53  

  


 

  


 

  

(m) make, change or revoke any material Tax election, change any Tax
accounting period or any material method of Tax accounting, amend any material
Tax Returns or file any claims for material Tax refunds, enter into any
closing agreement, settle or compromise any material Tax claim, audit,
assessment or other proceeding or surrender any right to claim a material Tax
refund, offset or other reduction in Tax liability;

  


 

  

(n) fail to make capital expenditures in the amounts and for the purposes set
forth in the Company's capital expenditures budget existing as of the date of
this Agreement, or make any other capital expenditures or commitments for
capital expenditures in an amount in excess of $500,000 in the aggregate;

  


 

  

(o) forgive, cancel or compromise any material debt or claim, or waive,
release or assign any right or claim of material value, other than in the
ordinary course of business consistent with past practice;

  


 

  

(p) fail to pay or satisfy any material account payable or other liability
incurred in the ordinary course of business consistent with past practice
(including in each case, the timing of any such payments), other than any such
liability that is being contested by the Company or the Subsidiaries in good
faith;

  


 

  

(q) make any material payments, grant material discounts or any other
consideration to customers or suppliers, other than in the ordinary course of
business consistent with past practice;

  


 

  

(r) make any material changes in the management of Working Capital, other than
in the ordinary course of business consistent with past practice;

  


 

  

(s) settle or compromise any material Litigation;

  


 

  

(t) adopt or enter into a plan or agreement of complete or partial liquidation
or dissolution, merger, consolidation, restructuring, recapitalization or
other reorganization of the Company or any of the Subsidiaries (other than the
Merger);

  


 

  

(u) grant, modify, cancel, abandon, dispose of or terminate, or agree to
grant, modify, cancel, abandon, dispose of or terminate, any rights, or enter
into any contract (other than licenses for immaterial, commercially available,
non-customized software), relating to any Intellectual Property used or held
for use in the business of the Company and the Subsidiaries, or otherwise
permit any of their rights relating to any such Intellectual Property to
lapse; or

  


 

  

(v) authorize any of, or agree or commit to do any of, the foregoing actions.

  


 

  

5.3 _Exclusivity_. From the date of this Agreement until the earlier of the
Closing Date or termination of this Agreement in accordance with its terms,
the Company shall not, and shall cause the Subsidiaries and their respective
officers, directors, employees, agents, partners, Affiliates and other
representatives not to, directly or indirectly, solicit, initiate, encourage,
assist or respond to the submission of any proposal or offer from any Person
relating, with respect to the Company or any Subsidiary, to any (a)
liquidation, dissolution or recapitalization, (b) merger or consolidation, (c)
acquisition or purchase of all or a significant portion of the assets of, or
any equity interest in, the Company or any Subsidiary or (d) similar
transaction or business combination (a " _Competing Transaction_ "), nor
participate in any or continue any ongoing discussions or negotiations
regarding, or furnish to any other Person any information with respect to, or
otherwise cooperate in any way with, or assist or participate in, facilitate
or encourage, any effort or attempt by any Person to pursue or effect a
Competing Transaction or enter into any agreement with respect to a Competing
Transaction. The Company shall, and shall cause all Persons acting on its
behalf to, (i) immediately cease any existing activities, discussions and
negotiations with any Persons with respect to any of the foregoing, (ii) not
make any other filings with the SEC other than in connection with withdrawing
the Registration Statement, which it may elect to do at its option, and (iii)
immediately cease all marketing activities in connection with the contemplated
initial public offering of equity securities of the Company. As soon as
reasonably practicable after the date hereof, the Company shall instruct each
Person (other than Parent and Merger Sub and their representatives) in
possession of confidential information about the Company that was furnished
pursuant to a confidentiality agreement within the prior twelve (12) months in
connection with any actual or potential proposal by such Person to acquire the
Company (or any portion thereof, other than pursuant to the offering
contemplated by the Registration Statement) to promptly return or destroy all
such information.

  


 

  


 

  

 

54  

  


 

  


 

  

5.4 _Efforts_.

  


 

  

(a) Subject to the terms and conditions hereof, each party hereto shall use
its reasonable best efforts to take, or cause to be taken, all actions and to
do, or cause to be done, all things reasonably necessary, proper or advisable
under applicable Law ( _i_ ) to consummate and make effective the transactions
contemplated hereby as promptly as practicable, including using its reasonable
best efforts to obtain or make all necessary or appropriate filings required
under applicable Law, ( _ii_ ) to lift any injunction or other legal bar to
the consummation of the transactions contemplated by this Agreement and (
_iii_ ) to cause the waiting periods, approvals or other requirements under
the HSR Act and all other Competition Laws to terminate or expire or be
obtained as promptly as practicable after the date of this Agreement,
including by seeking "early termination" under the HSR Act. None of the
parties shall knowingly take, cause or permit to be taken any action which
would reasonably be expected to materially delay or prevent consummation of
the transactions contemplated by this Agreement.

  


 

  

(b) The Company shall use its reasonable best efforts to obtain the Specified
Permit Assurances and any consents required pursuant to the Material Contracts
in connection with the consummation of the transactions contemplated by this
Agreement, and Parent shall use its reasonable best efforts to cooperate with
the Company in such efforts. Anything to the contrary in this Agreement
notwithstanding, (i) nothing herein shall obligate or be construed to obligate
the Company or any of its Affiliates to make, or to cause to be made, any
payment to any third party in order to obtain the consent or approval of such
third party under any Material Contract or otherwise and (ii) the actual
receipt of any such required consents or approvals (other than as contemplated
by _Sections 6.3_ and _7.3_ ) shall not be a condition to the consummation of
the transactions contemplated hereby.

  


 

  


 

  

 

55  

  


 

  


 

  

(c) The Company and Parent will, within ten (10) Business Days after the date
hereof, file with the United States Federal Trade Commission (the " _FTC_ ")
and the Antitrust Division of the United States Department of Justice (the "
_DOJ_ ") the notification and report forms required for the transactions
contemplated hereby, and subsequent to such filings, any supplemental
information that may be requested in connection therewith pursuant to the HSR
Act, which notification and report forms and supplemental information will
comply in all material respects with the requirements of the HSR Act. Each of
Parent and the Company will promptly furnish to the other (x) all necessary
information as the other may reasonably request in connection with the
preparation of any filing or submission pursuant to the HSR Act and (y) copies
of all written communications (and memoranda setting forth the substance of
any oral communication) with the FTC or the DOJ in connection with the
transactions contemplated by this Agreement. To the extent reasonably
practicable and permitted by Law, each of Parent and the Company will consult
with the other prior to any meetings, by telephone or in person, with the
staff of the FTC or the DOJ in connection with the transactions contemplated
by this Agreement, and each of Parent and the Company will have the right to
have a representative present at any such meeting to the extent permitted by
such Governmental Authority. Parent shall pay all filing fees required with
respect to the notification, report and other requirements of the HSR Act.

  


 

  

(d) The parties shall (i) respond as promptly as practicable to any inquiries
or requests for documentation or information or any request for additional
information (a "second request") received from the FTC or the DOJ and to all
inquiries and requests received from any other Governmental Authority in
connection with Competition Law matters, and (ii) use their reasonable best
efforts to resolve objections, if any, as may be asserted by any Governmental
Authority with respect to the transactions contemplated by this Agreement
under any Competition Laws and to cause the waiting periods, approvals or
other requirements under the HSR Act and all other Competition Laws to
terminate or expire or be obtained at the earliest possible date.

  


 

  

(e) Without limiting the generality of the foregoing, each party to this
Agreement shall: (i) cooperate fully with the other parties hereto, shall
execute and deliver such further documents, certificates, agreements and
instruments and shall take such other actions as may be reasonably requested
by any other party hereto to evidence or reflect the Merger (including the
execution and delivery of all documents, certificates, agreements and
instruments reasonably necessary for all filings hereunder); (ii) give all
notices (if any) required to be made and given by such party in connection
with the Merger and the other transactions contemplated by this Agreement;
(iii) use reasonable best efforts to obtain each approval, consent,
ratification, permission, waiver or authorization required to be obtained by
such party in connection with the Merger or any of the other transactions
contemplated by this Agreement (including as may be necessary to allow the
Company and the Subsidiaries to continue to utilize the Permits following the
Effective Time); and (iv) use reasonable best efforts to lift any restraint,
injunction or other legal bar to the Merger. In furtherance of the foregoing,
each of Parent and Merger Sub agrees to provide such assurances as to
financial capability, resources and creditworthiness as may be reasonably
requested by any Governmental Authority or other Person whose consent or
approval is sought hereunder. For purposes of this Agreement, "reasonable best
efforts" shall not include nor require either party or its subsidiaries to (A)
sell, or agree to sell, hold or agree to hold separate, or otherwise dispose
or agree to dispose of any asset, in each case if such sale, separation or
disposition or agreement with respect thereto would, individually or in the
aggregate, reasonably be expected to have a material adverse effect on the
expected benefits of the transactions contemplated by this Agreement to such
party, (B) conduct or agree to conduct its business in any particular manner
if such conduct or agreement with respect thereto would, individually or in
the aggregate, reasonably be expected to have a material adverse effect on the
expected benefits of the transactions contemplated by this Agreement to such
party or (C) agree to any order, action or regulatory condition of any
regulatory body, whether in an approval proceeding or another regulatory
proceeding, that, if effected, would cause a material reduction in the
expected benefits to Parent of the Merger and the other transactions
contemplated this Agreement (any of the foregoing effects, a " _Burdensome
Effect_ "). In the event that any action or proceeding is threatened or
instituted challenging the Merger as violative of any Law, Parent and the
Company shall use reasonable best efforts to avoid or resolve such action;
_provided_ , _however_ , that no party shall be required to take any action
that constitutes a Burdensome Effect. The parties shall take reasonable
efforts to share information protected from disclosure under the attorney-
client privilege, work product doctrine, joint defense privilege or any other
privilege pursuant to this section so as to preserve any applicable privilege.

  


 

  


 

  

 

56  

  


 

  


 

  

5.5 _Maintenance of Insurance_. The Company and the Subsidiaries will continue
to carry their existing insurance through the Closing, and shall not allow any
material breach, default or cancellation (other than expiration and
replacement of policies in the ordinary course of business consistent with
past practice) by the Company or the Subsidiaries of such insurance policies
or agreements that are material to the Company and the Subsidiaries, taken as
a whole, to occur or exist without the consent of Parent.

  


 

  

5.6 _Supplemental Information_. From time to time prior to the Closing, the
Company will promptly disclose in writing to Parent any matter hereafter
arising of which it has Knowledge, which, if existing, occurring or known at
the date of this Agreement, would have been required to be disclosed to Parent
or which would render inaccurate any of the representations, warranties or
statements set forth in _Article III_ hereof in any material respect. No
information provided pursuant to this _Section_ 5.6 shall be deemed to cure
any breach of any representation, warranty, or covenant made in this
Agreement.

  


 

  

5.7 _Preservation of Records; Post-Closing Access and Cooperation; Litigation
Support_.

  


 

  

(a) For a period of five (5) years after the Closing Date or such other period
(if longer) required by applicable Law, the Surviving Corporation shall
preserve and retain all corporate, accounting, legal, auditing, human
resources and other books and records of the Surviving Corporation and the
Subsidiaries (including any documents relating to any governmental or non-
governmental Litigation) relating to the conduct of the business and
operations of the Surviving Corporation and the Subsidiaries prior to the
Closing Date in accordance with the policies of Parent with respect to
document preservation and retention; _provided_ , _however_ , that the
Surviving Corporation shall preserve and retain all such books, records and
documents related to any matters that are the subject of a claim for
indemnification pursuant to _Article IX_ until the final resolution of such
claim.

  


 

  

(b) Parent and the Surviving Corporation shall, after the Closing Date, afford
promptly to the Representative reasonable access during normal business hours
to the offices, facilities, books, records, officers and employees of the
Surviving Corporation and the Subsidiaries to the extent reasonably requested
by the Representative in connection with any tax-reporting matters, including
on behalf of any Fully-Diluted Stockholder, _provided_ that such access shall
not obligate the Surviving Corporation or any Subsidiary to take any actions
that would unreasonably disrupt the normal course of their businesses or
violate any applicable Law.

  


 

  


 

  

 

57  

  


 

  


 

  

5.8 _Employees and Benefits_.

  


 

  

(a) For a period beginning on the Closing Date and continuing until September
30, 2016, Parent shall, or shall cause the Surviving Corporation and the
Subsidiaries to, continue to provide all persons who are employed by the
Company and the Subsidiaries as of the Closing Date (including those on
temporary layoffs or approved leaves of absence) (" _Employees_ ") with
salary, annual bonus opportunity and employee benefits that are substantially
comparable in the aggregate to the salary, annual bonus opportunity and
employee benefits (excluding for all purposes equity-based compensation) being
provided to each such Employee immediately before the Closing Date; _provided_
, _however_ , that nothing herein shall be deemed to preclude the Surviving
Corporation and the Subsidiaries from amending or terminating any plan,
program or arrangement or terminating any Employee, and _provided_ , _further_
, that nothing herein shall be deemed to amend any Benefit Plan.

  


 

  

(b) In any termination or layoff of any Employee by Parent or the Surviving
Corporation on or after the Closing, Parent and the Surviving Corporation will
comply fully, if applicable, with the WARN Act and all other applicable
foreign, federal, state and local Laws, including those prohibiting
discrimination and requiring notice to employees. From the date of this
Agreement until the earlier of the Closing Date or the date this Agreement is
terminated, at the request of Parent, which shall not occur more frequently
than on a bi-weekly basis, the Company shall provide to Parent within seven
(7) calendar days of Parent's request a written schedule that reflects (i) the
number of employees of the Company who have experienced during such period an
"employment loss" (as defined in the WARN Act) and (ii) the title, position
and employment of each such employee of the Company. Parent shall use its
reasonable best efforts to not, and to cause the Surviving Corporation and the
Subsidiaries to not, at any time prior to sixty (60) calendar days after the
Closing Date, effectuate a "plant closing" or "mass layoff," as those terms
are defined in the WARN Act, affecting in whole or in part any facility, site
of employment, operating unit or employee of the Surviving Corporation or the
Subsidiaries without complying fully with the requirements of the WARN Act.
Parent and the Surviving Corporation will bear the cost of compliance with (or
failure to comply with) any such Laws.

  


 

  

(c) For periods on and after the Closing Date, the Surviving Corporation and
the Subsidiaries shall continue to have all obligations and liabilities under
and with respect to the Benefit Plans and to or with respect to all persons
entitled to benefits under the provisions of each such Benefit Plan in
accordance with their terms and subject to the provisions of this _Section
5.8_.

  


 

  

(d) This _Section 5.8_ shall be binding upon and inure solely to the benefit
of each of the parties to this Agreement, and nothing in this _Section 5.8_,
express or implied, is intended to confer upon any other Person any rights or
remedies of any nature whatsoever under or by reason of this _Section 5.8_.
Without limiting the foregoing, no provision of this _Section 5.8_ shall
create any third party beneficiary rights in any current or former employee,
director or consultant of the Company or any of the Subsidiaries in respect of
continued employment (or resumed employment) or any other matter.

  


 

  


 

  

 

58  

  


 

  


 

  

(e) Parent and the Company agree to the matters set forth in Section 5.8(e) of
the Disclosure Letter.

  


 

  

5.9 _Public Announcements_. The Company, Parent and Merger Sub will consult
with each other before issuing any press release or otherwise making any
public statements or disclosures with respect to the transactions contemplated
by this Agreement, including the terms hereof, and no party shall, without the
prior written consent of the other parties (which consent will not be
unreasonably withheld, delayed or conditioned), issue any such press release
or make any such public statement, except as may be required by applicable
Law.

  


 

  

5.10 _Indemnification of Directors and Officers_.

  


 

  

(a) For six (6) years from and after the Effective Time, Parent shall cause
the Surviving Corporation to indemnify and hold harmless all past and present
officers and directors of the Company and of the Subsidiaries to the same
extent such persons are currently indemnified by the Company and the
Subsidiaries pursuant to the Company's and the Subsidiaries' Organizational
Documents and any indemnification agreements set forth on Section 5.10 of the
Disclosure Letter as in effect on the date hereof for acts or omissions
occurring at or prior to the Effective Time, and for such period of time
Parent shall not, and shall not permit the Surviving Corporation or the
Subsidiaries to, amend, repeal or modify any provision in the Surviving
Corporation's or a Subsidiary's Organizational Documents relating to the
exculpation or indemnification of present and former officers and directors as
in effect immediately prior to the Effective Time, except (i) as required by
applicable Law or (ii) unless the provisions as so amended, repealed or
modified in connection with a restructuring in which the governing documents
of the Surviving Corporation include substantially equivalent exculpation or
indemnification provisions with respect to such acts or conduct for the
benefit of such persons ( _provided_ that the officers and directors of the
Company prior to the Closing shall continue to be entitled for such six-year
period to exculpation and indemnification under such provisions of the
Company's and the Subsidiaries' Organizational Documents as in effect on the
date hereof with respect to acts or omissions occurring at or prior to the
Effective Time).

  


 

  

(b) Parent shall cause the Surviving Corporation and the Subsidiaries to
maintain in effect for six (6) years from the Closing Date directors' and
officers' liability insurance covering those persons who are currently covered
by the Company's and the Subsidiaries' directors' and officers' liability
insurance policies for events occurring at or prior to the Effective Time ("
_D andO Insurance_") on terms not less favorable than such existing insurance
coverage; _provided_ that the Surviving Corporation and the Subsidiaries shall
not be required, and Parent shall not be required to cause the Surviving
Corporation and the Subsidiaries, to pay for the DandO Insurance in an annual
amount in excess of three hundred percent (300%) of the annual premium
currently paid as of the date hereof by the Company and the Subsidiaries for
such insurance; _provided_ , _further_ , that if the annual premiums of such
insurance coverage exceeds such amount, Parent or the Surviving Corporation
shall be obligated to obtain a policy with the greatest coverage available for
a cost not exceeding such amount. Notwithstanding anything to the contrary in
this Agreement, the Company and the Subsidiaries may, and at Parent's request
shall, prior to the Effective Time and at Parent's expense, purchase run-off
directors' and officers' liability insurance; _provided_ that payment for such
insurance coverage provided by such run-off directors' and officers' insurance
policy shall not exceed three hundred percent (300%) of the annual premium
currently paid as of the date hereof by the Company and the Subsidiaries for
such insurance. If the cost of such run-off insurance would require an
expenditure that exceeds such amount, the Surviving Corporation shall, and
Parent shall cause the Surviving Corporation to, obtain a policy with the
greatest coverage available for a cost not exceeding such amount. Any such
"tail" directors' and officers' insurance and indemnification policy will
satisfy Parent's obligation under this _Section 5.10_ ( _b_ ) to provide DandO
Insurance; _provided_ that in the event that any claim is brought under such
DandO Insurance, the policy shall be maintained until final disposition thereof.

  


 

  


 

  

 

59  

  


 

  


 

  

(c) In the event that Parent, the Surviving Corporation or the Subsidiaries or
any of their respective successors or assigns (i) consolidates with or merges
into any other Person, or (ii) transfers all or substantially all of its
properties or assets to any Person, then, and in each case, the successors and
assigns of Parent or the Subsidiaries, as the case may be, shall expressly
assume and be bound by the obligations set forth in this _Section 5.10._

  


 

  

5.11 _Tax Cooperation_.

  


 

  

(a) The Fully-Diluted Stockholders, the Representative, Parent and the
Surviving Corporation shall cooperate fully with each other in connection with
( _i_ ) the preparation and filing of any U.S. federal, state, local or
foreign Tax Returns that include the business and operations of the Company
and the Subsidiaries and ( _ii_ ) any audit or examination by any Taxing
Authority of the Tax Returns referred to in clause (i). Such cooperation shall
include the furnishing or making available of employees on a mutually
convenient basis and records, books of account or other materials of the
Company and the Subsidiaries necessary or helpful for the defense against
assertions of any Taxing Authority as to any Tax Returns referred to in clause
(i) above.

  


 

  

(b) Notwithstanding anything to the contrary in this Agreement, the Purchase
Price Adjustment Escrow Agreement, the Indemnification Escrow Agreement or any
other instrument or agreement delivered in connection herewith, none of
Parent, Merger Sub, the Surviving Corporation or any of their respective
Affiliates shall be required to provide a copy of, or otherwise disclose the
contents of, any consolidated, affiliated, combined, unitary or aggregate Tax
Return or any related document to any person, except to the extent such Tax
Return or document relates solely to the Company and the Subsidiaries.

  


 

  

5.12 _Transfer Taxes_. All federal, state, local and foreign transfer, excise,
sales, use, value added, registration, stamp, recording, property and similar
Taxes or fees (other than Withholding Taxes) imposed as a result of the Merger
(the "Transfer Taxes") shall be paid fifty percent (50%) by each of Parent and
the Representative (on behalf of the Fully-Diluted Stockholders).

  


 

  

5.13 _Section 280G Stockholder Approval_. If it is reasonably expected that,
absent the vote described below, there would be an imposition of Taxes under
Section 4999 of the Code with respect to any payment or benefit in connection
with the transactions contemplated by this Agreement, the Company shall take
all actions necessary to, reasonably in advance of the Closing Date, deliver
to its stockholders a disclosure statement in a form reasonably satisfactory
to Parent, which satisfies the Company's disclosure obligations under Section
280G(b)(5)(B) of the Code and the regulations thereunder, and which solicits
and recommends that its stockholders vote in favor of the transactions
disclosed therein through a vote meeting the requirements of Section
280G(b)(5)(B) of the Code and the regulations thereunder, and shall not make
any such payments or provide any such benefits that are subject to such vote
and are not so approved. The Company shall provide Parent and its
representatives with a copy of such disclosure statement within a reasonable
time prior to delivery to the Company's stockholders for Parent's approval,
with such approval not to be unreasonably withheld or delayed.

  


 

  


 

  

 

60  

  


 

  


 

  

5.14 _Section 338 Election_. Parent shall not make any election under Section
338 of the Code with respect to the acquisition of the Common Stock pursuant
to this Agreement.

  


 

  

5.15 _Termination of Affiliate Agreements_. At or prior to the Effective Time,
the Company shall use its reasonable best efforts to terminate, or otherwise
amend to exclude the Company and any Subsidiary as a party thereto, all
Affiliate Agreements other than those Affiliate Agreements set forth on
Section 5.15 of the Disclosure Letter.

  


 

  

5.16 _Appraisal Notice_. The Company shall cooperate with Parent to prepare
and mail an appraisal notice pursuant to Section 262 of the DGCL to the Fully-
Diluted Stockholders that complies with applicable Law, including providing
any financial statements of the Company required to be included in such
appraisal notice.

  


 

  

5.17 _Financing_.

  


 

  

(a) The Company shall use commercially reasonable efforts, and shall cause its
Subsidiaries to use commercially reasonable efforts, and shall use its
commercially reasonable efforts to cause its and its Subsidiaries' respective
officers, directors, employees, accountants, consultants, legal counsel,
agents and other representatives (collectively, the " _Company
Representatives_ ") to, at Parent's sole expense, provide any cooperation that
is reasonably necessary and customary and reasonably requested by Parent to
assist Parent in the arrangement of any bank financing for the purpose of
financing the Merger, the fees and expenses incurred in connection therewith
and the other transactions contemplated hereby (the " _Debt Financing_ "),
including assisting with the preparation of materials for presentations,
memoranda and similar documents required in connection with the Debt
Financing; _provided_ , _however_ , that (x) nothing herein shall require such
cooperation to the extent it would (A) unreasonably disrupt the conduct of the
Company's and the Subsidiaries' respective businesses, (B) require the Company
or any of the Subsidiaries or any of the Company Representatives to pay any
fees or expenses or otherwise incur any liability or give any indemnities
prior to the Effective Time (except to the extent any such fee or expense is
conditioned on the consummation of the Merger or Parent has advanced the
amount of such fees, expenses or liabilities to the Company or the
Subsidiaries), and (C) require the preparation or delivery of (i) financial
statements, other than those contemplated by _Section 5.17(d)_ , or (ii) pro
forma financial information or forecasts of the Company and the Subsidiaries
and (y) any documentation executed by the Company or any of its Subsidiaries
shall not become effective until the consummation of the Closing.
Notwithstanding anything to the contrary provided herein or in the
Confidentiality Agreement, Parent shall be permitted to share all information
subject to such agreement with its financing sources, subject to customary
confidentiality undertakings by such financing sources with respect thereto.

  


 

  


 

  

 

61  

  


 

  


 

  

(b) Parent shall indemnify and hold harmless each of the Company, the
Subsidiaries and their respective Company Representatives and any Seller
Indemnified Party from and against any and all Losses suffered or incurred by
them in connection with the arrangement of the Debt Financing and the
performance of their respective obligations under this _Section 5.17_. Parent
shall, promptly upon request of the Company, reimburse the Company and the
Subsidiaries for all out-of-pocket costs and expenses incurred by the Company
or the Subsidiaries (including those of their respective Company
Representatives) in connection with the cooperation required by this _Section
5.17_.

  


 

  

(c) Each of Parent and Merger Sub acknowledges and agrees that (i) the
obtaining of the Debt Financing is not a condition to the Closing, and (ii)
that none of Parent's or Merger Sub's respective obligations hereunder are
conditioned in any manner upon Parent or Merger Sub obtaining financing in
respect of the transactions contemplated hereby.

  


 

  

(d) If the Closing Date has not occurred on our prior to November 13, 2015,
the Company shall promptly deliver to Parent upon request unaudited
consolidated financial statements of the Company and the Subsidiaries as of
September 30, 2015, consisting of the consolidated balance sheet at such date
and the related consolidated statements of operations and cash flows for the
three- and nine-month periods then ended, in a form consistent with the
Interim Financial Statements.

  


 

  

5.18 _Regulatory Matters_.

  


 

  

(a) The Company shall, and shall cause the Subsidiaries to, keep Parent
reasonably apprised of all substantive developments with respect to its
interactions with the FDA or any similar Governmental Authority with respect
to the Company's and the Subsidiaries' compliance with applicable Laws, and
its response to the FDA in connection with any and all facility inspections,
Form 483 observations, warning letters, self reporting or similar matters, and
will, to the extent reasonably practicable, consult with Parent reasonably in
advance of any substantive response (including proposed operational responses
and timetables with respect thereto) in respect of any such matters and
consider in good faith any input provided by Parent and its advisors with
respect to any such responses (including giving due consideration to the
interests of Parent in light of the pendency of the transactions contemplated
by this Agreement and the Company and the Subsidiaries becoming Affiliates of
Parent following the Closing); _provided_ , _however_ that to the extent
Parent is not reasonably expedient in providing such input or it is not
practicable for the Company to request such input before delivering
substantive responses to relevant Governmental Authorities, the Company may
proceed with delivering substantive responses to relevant Governmental
Authorities; _provided_ , _further_ that the ultimate determination of the
manner in which the Company and the Subsidiaries will address the matters
contemplated in this Section 5.18(a) will be made by the Company and the
Subsidiaries. Without limiting the generality of _Section 5.1_ , the Company
shall, and shall cause the Subsidiaries to, provide Parent with all material
correspondence, letters, submissions and other written communications with the
FDA or any similar Governmental Authority (as well as with any third party
regulatory or cGMP auditor) with respect to such matters (including providing
all such materials received by the FDA or any such Governmental Authority
promptly upon receipt); _provided_ , _however_ , that nothing in this _Section
5.18_ shall require the Company to provide access or to disclose any
information to Parent if such access or disclosure would cause a risk of a
loss of privilege protection to the Company or any of the Subsidiaries (
_provided_ that the Company shall use commercially reasonable efforts to
develop an alternative to providing such information reasonably acceptable to
Parent).

  


 

  


 

  

 

62  

  


 

  


 

  

(b) Promptly following the execution of this Agreement, Parent and the Company
shall cooperate in good faith to develop a plan and strategy to approach the
FDA or any other Governmental Authority with regard to the Company becoming an
Affiliate of Parent and the involvement of Parent in addressing the matters
described in clause (a) above following the Effective Time.

  


 

  

ARTICLE VI

  


 

  

CONDITIONS PRECEDENT TO OBLIGATIONS

  

OF PARENT AND MERGER SUB

  


 

  

The obligations of Parent and Merger Sub at Closing under this Agreement are
subject to the satisfaction (or written waiver by Parent) of the following
conditions precedent at or before the Closing:

  


 

  

6.1 _Accuracy of Warranties_. Other than the representations and warranties of
the Company set forth in _Sections 3.1(b)_ , _3.1(c)_ , _3.2_ , and _3.17_
(collectively, the " _Fundamental Representations_ "), each of the
representations and warranties of the Company contained in _Article III_ shall
be true and correct in all respects when made and as of the Effective Time
with the same effect as though made as of the Effective Time (except to the
extent such representations and warranties are made as of an earlier date (in
which case, as of such earlier date)), except, in each case, for such failures
to be true and correct that do not constitute, either individually or in the
aggregate, a Material Adverse Effect. Each of the Fundamental Representations
shall be true and correct in all material respects as of the Effective Time
with the same effect as though made as of the Effective Time (except to the
extent such representations and warranties are made as of an earlier date (in
which case, as of such earlier date)).

  


 

  

6.2 _Compliance with Agreements and Covenants_. The Company and the
Representative shall have duly performed and complied in all material respects
with all of the covenants, obligations and agreements (other than _Section
5.17_ ) contained in this Agreement to be performed and complied with by them
at or prior to the Effective Time.

  


 

  

6.3 _HSR Clearance_. The applicable approvals, clearances or waiting periods
under the HSR Act shall have been obtained, expired or been earlier
terminated.

  


 

  

6.4 _No Prohibition_. No applicable Law shall have been adopted, promulgated
or entered by any Governmental Authority which restrains, enjoins or otherwise
prohibits the consummation of the transactions contemplated hereby.

  


 

  


 

  

 

63  

  


 

  


 

  

6.5 _No Material Adverse Effect_. No change, event, fact or occurrence shall
have occurred since the date of this Agreement that, individually or in the
aggregate, constitutes a Material Adverse Effect.

  


 

  

ARTICLE VII

  


 

  

CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY

  


 

  

The obligations of the Company at Closing under _Article II_ of this Agreement
are subject to the satisfaction (or written waiver by the Representative) of
the following conditions precedent at or before the Closing:

  


 

  

7.1 _Accuracy of Warranties_. Each of the representations and warranties of
Parent and Merger Sub contained in _Article IV_ (without giving effect to any
materiality or like qualifications therein) shall be true and correct in all
respects when made and as of the Effective Time with the same effect as though
made as of the Effective Time (except to the extent such representations and
warranties are made as of an earlier date (in which case, as of such earlier
date)), except for such failures to be true and correct as would not,
individually or in the aggregate, reasonably be expected to impair, prevent or
delay in any material respect the ability of any of the Parent or Merger Sub
to perform its obligations under this Agreement.

  


 

  

7.2 _Compliance with Agreements and Covenants_. Parent and Merger Sub shall
have duly performed and complied in all material respects with all of their
covenants, obligations and agreements contained in this Agreement to be
performed and complied with by them at or prior to the Effective Time.

  


 

  

7.3 _HSR Clearance_. The applicable approvals, clearances or waiting periods
under the HSR Act shall have been obtained, expired or been earlier
terminated.

  


 

  

7.4 _No Prohibition_. No applicable Law shall have been adopted, promulgated
or entered by any Governmental Authority which restrains, enjoins or otherwise
prohibits the consummation of the transactions contemplated hereby.

  


 

  

ARTICLE VIII

  


 

  

TERMINATION

  


 

  

8.1 _Termination_. This Agreement may be terminated at any time on or prior to
the Closing Date:

  


 

  

(a) With the mutual written consent of the Company, Parent and Merger Sub;

  


 

  

(b) By either the Company or Parent, if the Closing of the Merger shall not
have occurred on or before March 31, 2016 (the " _Termination Date_ ");
_provided_ , that, if, as of the Termination Date, all conditions to this
Agreement shall have been satisfied or waived (other than those that are
satisfied by action taken at the Closing), other than the conditions set forth
in _Section 6.3_ and _Section 7.3_, then the Company may extend the
Termination Date by no more than 30 calendar days;

  


 

  


 

  

 

64  

  


 

  


 

  

(c) By the Company, if Parent shall have breached or failed to perform any of
its representations, warranties, covenants or other agreements contained in
this Agreement, which breach or failure to perform ( _A_ ) would give rise, if
occurring or continuing at the Effective Time, to the failure of a condition
set forth in _Article VII_ and ( _B_ ) has not been or is incapable of being
cured by Parent prior to the earlier of the ( _x_ ) Termination Date and ( _y_
) thirtieth (30th) calendar day after its receipt of written notice thereof
from the Company;

  


 

  

(d) By Parent, if the Company shall have breached or failed to perform any of
its representations, warranties, covenants or other agreements contained in
this Agreement, which breach or failure to perform (A) would give rise, if
occurring or continuing at the Effective Time, to the failure of a condition
set forth in _Article VI_ and (B) has not been or is incapable of being cured
by the Company prior to the earlier of the (x) Termination Date and (y)
thirtieth (30th) calendar day after its receipt of written notice thereof from
Parent;

  


 

  

(e) By either the Company or Parent, if ( _i_ ) there shall be any Law that
makes consummation of the Merger illegal or ( _ii_ ) any Governmental
Authority having competent jurisdiction shall have issued an Order or taken
any other action permanently restraining, enjoining or otherwise prohibiting
the Merger, and such Order or other action shall have become final and
nonappealable; or

  


 

  

(f) By Parent, if a copy of the Stockholder Consent has not been delivered to
Parent within twenty-four (24) hours following the mutual execution of this
Agreement.

  


 

  

Notwithstanding anything else contained in this Agreement, the right to
terminate this Agreement under this _Section 8.1_ shall not be available to
any party whose breach of its (or in the case of the Company, its or the
Representative's) representations or warranties set forth herein or whose
failure to fulfill its obligations or to comply with its covenants under this
Agreement has been the primary cause of, or primarily resulted in, the failure
to satisfy any condition to the obligations of the other party hereunder.

  


 

  

8.2 _Expenses_. Whether or not the Merger is consummated and except as
otherwise provided in this Agreement or the other transaction documents to be
entered into in connection with this Agreement and the transactions
contemplated hereby, all expenses incurred in connection with this Agreement
and the transactions contemplated hereby shall be paid by the party incurring
such expenses.

  


 

  

8.3 _Effect of Termination_. In the event of termination of this Agreement by
either the Company or Parent as provided in _Section 8.1_, this Agreement will
forthwith become void and have no further force or effect, without any
Liability (other than as set forth in _Section 8.2_ and this _Section 8.3_) on
the part of Parent, Merger Sub, the Company or the Representative; _provided_
, _however_ , that no such termination (nor any provision of this Agreement)
shall relieve any party from liability for any damages (including claims for
damages based on the consideration that would have otherwise been payable by
Parent and Merger Sub) for fraud or material breach of this Agreement prior to
such termination. The provisions of _Section 8.2_, this _Section 8.3_,
_Sections 5.1(b)_, _10.6_ , _10.12_ , _10.13_ and _10.18_ will survive any
termination hereof.

  


 

  


 

  

 

65  

  


 

  


 

  

8.4 Specific Performance.

  


 

  

(a) The parties agree that irreparable damage would occur if any provision of
this Agreement were not performed in accordance with the terms hereof and that
the parties shall be entitled to an injunction or injunctions to prevent
breaches of this Agreement or to enforce specifically the performance of the
terms and provisions hereof in any court specified in _Section 10.12_, in
addition to any other remedy to which they are entitled at law or in equity.
The parties hereby waive, in any action for specific performance, the defense
of adequacy of a remedy at law and the posting of any bond or other security
in connection therewith.

  


 

  

(b) To the extent any party hereto brings any Litigation to enforce
specifically the performance of the terms and provisions of this Agreement
(other than Litigation to specifically enforce any provision that expressly
survives termination of this Agreement pursuant to _Section 8.3_ hereof) in
accordance with the terms of this Agreement, the Termination Date shall
automatically be extended by (i) the amount of time during which such
Litigation is pending, plus 20 Business Days, or (ii) such other time period
established by the court presiding over such Litigation.

  


 

  

ARTICLE IX

  


 

  

SURVIVAL; INDEMNIFICATION

  


 

  

9.1 _Survival_. The representations, warranties, covenants and agreements of
the Company, Parent and Merger Sub contained in this Agreement or in any
certificate delivered pursuant to _Section 2.2_ ( _b_ )( _iii_ ) or _Section
2.2_ ( _c_ )( _ii_ ), including any rights arising out of any breach of such
representations, warranties covenants and agreements and any right to
indemnification pursuant to _Sections 9.2_ and _9.3_ , shall survive the
Closing until December 15, 2016 (the " _Survival Termination Date_ ") (other
than any covenants which by their terms are to be performed (in whole or in
part) by the Parties following the Closing, which shall each survive until the
statute of limitations applicable to such covenant expires). The parties agree
that (i) in this _Article IX_ they intend to shorten (in the case of the
limited survival period specified in this _Section 9.1_ ) the applicable
statute of limitations period with respect to certain claims and (ii) no
Person shall be liable for any claim for indemnification under this _Article
IX_ unless a Claim Notice is delivered by the Person seeking indemnification
to the Person from whom indemnification is sought prior to the expiration of
the applicable survival period, in which case the representation, warranty,
covenant or agreement which is the subject of such claim shall survive, to the
extent of the claims described in such Claim Notice only, until such claim is
fully and finally resolved, whether or not the amount of the Losses resulting
from such breach has been determined at the time the Claim Notice is given and
(iii) any claims for indemnification under this _Article IX_ for which notice
is not timely delivered pursuant to this _Section 9.1_ shall be expressly
barred and hereby waived. Notwithstanding the foregoing, except as set forth
in _Section 8.3_ , no representation, warranty, covenant or agreement made in
this Agreement shall survive any termination of this Agreement in accordance
with its terms.

  


 

  

9.2 _Parent Parties Indemnification_. Subject to the provisions of this
_Article IX_ , after the Closing Date, Parent, the Surviving Corporation,
their respective Affiliates and the directors, officers, employees,
stockholders, agents, representatives, successors and assigns of each such
Person (collectively, the " _Parent Indemnified Parties_ ") shall be entitled
to indemnification solely from the Indemnification Escrow Account for any and
all Losses incurred or suffered by any of them, directly or indirectly, as a
result of, relating to or arising out of:

  

 


 

  

(a) the failure of any of the representations or warranties made by the
Company in this Agreement (other than the representations and warranties
contained in _Section 3.4(d))_ to be true and correct as of the Effective Time
(except for those representations and warranties that address matters only as
of a particular date, which need only be true and correct as of such date);

  

  

 

66  

  

  

(b) any breach by the Company or any Subsidiary of any of its covenants or
agreements contained herein (other than _Section 5.6_ (to the extent related
to any requirement to make a disclosure with respect to _Section 3.4(d)_ and
_Section 5.17_ ) which are to be performed by the Company at or before the
Effective Time;

 

  


 

  

(c) any demand, claim, suit, action, cause of action, proceeding or assessment
relating to the Merger or any of the other transactions contemplated by this
Agreement and brought by any current securityholder of the Company, including
(i) any amounts due to such securityholder as a result of the assertion by it
of appraisal, dissent or similar rights under any applicable Law (including
the DGCL) in excess of the amount that it would have received in respect of
(x) its Common Stock, if it had received the applicable Per Share Merger
Consideration for its Common Stock and (y) its Options, if it had received the
applicable Per Share Option Consideration in respect of its Options and (ii)
any Losses suffered as a result of any claim for breaches of fiduciary duties
owed to the Company or to any stockholder of the Company; and

  


 

  

(d) any Closing Indebtedness or any Seller Transaction Expenses to the extent
not reflected on the Closing Statement.

  


 

  

 _provided_ , that the aggregate amount of Losses with respect to which all
Parent Indemnified Parties may be entitled to indemnification under this
_Section 9.2_ shall not exceed the Indemnification Escrow Amount (less any
amount disbursed from the Indemnification Escrow Amount pursuant to _Section
2.11(i))_.

  


 

  

9.3 _Seller Indemnification_. Subject to the provisions of this _Article IX_ ,
after the Closing Date, the Fully-Diluted Stockholders and their respective
Affiliates and the directors, officers, employees, stockholders, agents,
representatives, successors and assigns of each such Person (collectively, the
" _Seller Indemnified Parties_ ") shall be entitled to indemnification for any
and all Losses incurred or suffered by any of them, directly or indirectly, as
a result of, relating to or arising out of:

  


 

  

(a) the failure of any of the representations or warranties made by Parent or
Merger Sub in this Agreement to be true and correct as of the Effective Time
(except for those representations and warranties that address matters only as
of a particular date, which need only be true and correct as of such date),
and

  


 

  

(b) any breach by Parent or Merger Sub of any of their respective covenants or
agreements contained herein which are to be performed by Parent or Merger Sub,
as applicable, at or before the Effective Time.

  


 

  


 

  

 

67  

  


 

  


 

  

 _provided_ , that the aggregate amount of Losses with respect to which all
Seller Indemnified Parties may be entitled to indemnification under this
_Section 9.3_ shall not exceed the Indemnification Escrow Amount (less any
amount disbursed from the Indemnification Escrow Account pursuant to _Section
2.11(i))_.

  


 

  

9.4 _Claims_.

  


 

  

(a) Any Person seeking indemnification under _Sections 9.2_ or _9.3_ (each, an
" _Indemnified Party_ ") shall promptly give the party from whom
indemnification is being sought (such notified party, the " _Responsible
Party_ ") notice (a " _Claim Notice_ ") of any matter which such Indemnified
Party has determined has given or reasonably expected to give rise to a right
of indemnification hereunder, stating:

  


 

  

(i) that the Indemnified Party believes it has incurred, or will incur,
liability for Losses for which such Indemnified Party believes it is or will
be entitled to indemnification pursuant to this Agreement, including a
reference to the provisions of this Agreement in respect of which such right
of indemnification is claimed or arises (it being agreed that the failure to
specify any provision of this Agreement in such Claim Notice shall not
preclude the Indemnified Party from asserting that there has been a breach of,
or inaccuracy in, or failure to perform such provision); and

  


 

  

(ii) specify in reasonable detail, to the extent known, the facts and
circumstances with respect to the subject matter of the claim including, to
the extent known and reasonably estimable, each individual item of Loss
included in the amount so stated, the date such item was paid (if paid), the
basis for any anticipated Liability and the nature of the misrepresentation,
breach of warranty, breach of covenant or agreement or claim to which each
such item is related and the computation of the amount to which such
Indemnified Party claims to be entitled hereunder;

  


 

  

 _provided_ , that the failure to so notify shall not relieve the Responsible
Party of its obligations hereunder, except to the extent that the Responsible
Party is materially prejudiced by such failure.

  


 

  

(b) If the Responsible Party has disputed a claim for indemnification under
_Sections 9.2_ or _9.3_ (including any Third Party Claim), the Responsible
Party and the Indemnified Party shall proceed in good faith to negotiate a
resolution to such dispute. In the event that the Responsible Party shall
object to the indemnification sought by an Indemnified Party from the
Responsible Party that does not involve a Third Party Claim (which is
addressed in _Section 9.4_ ( _c_ ) below) as set forth in a Claim Notice, the
Responsible Party shall deliver to the Indemnified Party within thirty (30)
days from its receipt of the Claim Notice a notice that the Responsible Party
disputes such claim (such notice, the " _Indemnification Dispute Notice_ ")
and the Responsible Party and the Indemnified Party shall, within the sixty
(60) day period beginning on the date of receipt by the Indemnified Party of
such Indemnification Dispute Notice, attempt in good faith to agree upon the
rights of the respective parties with respect to each of such claims to which
the Responsible Party shall have so objected. If the Indemnified Party and the
Responsible Party shall succeed in reaching agreement on their respective
rights with respect to any of such claims, the Indemnified Party and the
Responsible Party shall promptly prepare and sign a memorandum of agreement
setting forth such agreement. If the Responsible Party and the Indemnified
Party cannot resolve such dispute in sixty (60) days after delivery of the
Indemnification Dispute Notice, such dispute shall be resolved pursuant to the
terms of _Sections 10.6_ , _10.11_ and _10.12._

  


 

  


 

  

 

68  

  


 

  


 

  

(c) If a claim by a third party (a " _Third Party Claim_ ") is made against
any Indemnified Party, and if such Indemnified Party intends to seek indemnity
with respect thereto under _Sections 9.2_ or _9.3_ , such Indemnified Party
shall promptly notify the Responsible Party of such Third Party Claim;
_provided_ that the failure to so notify shall not relieve the Responsible
Party of its obligations hereunder, except to the extent that the Responsible
Party is materially prejudiced thereby. Other than in connection with a Third
Party Claim by a Governmental Authority (including any Taxing Authority), the
Responsible Party shall have fifteen (15) Business Days after receipt of such
notice to assume the conduct and control, through counsel reasonably
acceptable to the Indemnified Party at the expense of the Responsible Party,
of the settlement or defense thereof, and the Indemnified Party shall
cooperate with it in connection therewith; _provided_ , that the Responsible
Party shall permit the Indemnified Party to participate in such settlement or
defense through counsel chosen by such Indemnified Party ( _provided_ that the
fees and expenses of such counsel shall be borne by such Indemnified Party).
So long as the Responsible Party is reasonably contesting any such claim in
good faith, the Indemnified Party shall not pay or settle any such claim. In
any case where the Representative is acting on behalf of the Fully-Diluted
Stockholders in connection with a Third Party Claim, all expenses incurred by
the Representative in the defense or settlement of such Third Party Claim
shall be paid using funds from the Indemnification Escrow Account.
Notwithstanding the foregoing, the Indemnified Party shall have the right to
pay or settle any such claim; _provided_ that in such event it shall waive any
right to indemnity therefor by the Responsible Party or from the
Indemnification Escrow Account, as the case may be, for such claim unless the
Responsible Party shall have consented to such payment or settlement. If the
Responsible Party does not notify the Indemnified Party within fifteen (15)
Business Days after the receipt of the Indemnified Party's notice of a claim
of indemnity hereunder that it elects to undertake the defense thereof, the
Indemnified Party shall have the right to contest, settle or compromise the
claim, _provided_ that (i) the Indemnified Party shall not thereby waive any
right to indemnity therefor pursuant to this Agreement and (ii) the
Responsible Party shall not be deemed to have waived any right to assert that
the Indemnified Party was not entitled to indemnification therefor pursuant to
this Agreement. The Responsible Party shall not, except with the consent of
the Indemnified Party, enter into any settlement that (w) does not include as
an unconditional term thereof the giving by the Person or Persons asserting
such claim to all Indemnified Parties of an unconditional release from all
Liability with respect to such claim or consent to entry of any judgment, (x)
does not involve only the payment of money damages, (y) imposes an injunction
or other equitable relief upon the Indemnified Party or (z) includes any
admission of wrongdoing or misconduct by the Indemnified Party. In connection
with a Third Party Claim by a Governmental Authority (including any Taxing
Authority), the Indemnified Party shall have the right to assume the conduct
and control of the settlement or defense thereof, _provided_ that (1) the
Indemnified Party shall permit the Responsible Party to participate in such
settlement or defense through counsel chosen by such Responsible Party and (2)
the Responsible Party shall not have any liability for any Losses arising out
of or in connection with such Third Party Claim if such Third Party Claim is
settled, adjusted or compromised by the Indemnified Party without the consent
of the Responsible Party (such consent not to be unreasonably withheld,
conditioned or delayed).

  


 

  


 

  

 

69  

  


 

  


 

  

(d) Any Indemnified Party shall cooperate in all reasonable respects with the
Responsible Party and its attorneys in the investigation, trial and defense of
any Third Party Claim and any appeal arising therefrom and shall furnish such
records, information and testimony, and attend such conferences, discovery
proceedings, hearings, trials and appeals as may be reasonably requested in
connection therewith. Such cooperation shall include access during normal
business hours afforded to the Responsible Party and its agents and
representatives to, and reasonable retention by the Indemnified Party of,
records and information which have been identified by the Responsible Party as
being reasonably relevant to such Third Party Claim, and making employees
available on a mutually convenient basis to provide additional information and
explanation of any material provided hereunder. The parties shall cooperate
with each other in any notifications to insurers.

  


 

  

9.5 _Limitations on Indemnification Obligations._ The rights of the
Indemnified Parties to indemnification pursuant to the provisions of this
_Article IX_ are subject to the following limitations:

  


 

  

(a) With respect to each indemnification obligation in this _Article IX:_ (i)
the amount of any Loss will be determined on an After-Tax Basis, (ii) all
Losses shall be net of any Eligible Insurance Proceeds that have already been
paid at the time the amount of such Losses are determined and (iii) in no
event shall a Responsible Party have liability to the Indemnified Party for
any consequential, special, indirect or punitive damages, lost profits,
diminution in value or similar items, except if and to the extent any such
damages are recovered against an Indemnified Party pursuant to a Third Party
Claim.

  


 

  

(b) None of the Indemnified Parties shall be entitled to recover for any
particular Loss pursuant to _Sections 9.2_ ( _a_ ), _Section 9.2(b)_ (in
respect of a breach of _Section 5.6_ as it relates to the failure to disclose
any inaccuracy of any representation or warranty) or _9.3_ ( _a_ ) unless such
Loss (or series of related Losses) equals or exceeds $50,000 (each, a "
_Qualifying Loss_ "); _provided_ , _however_ , that this limitation shall not
apply to Losses in respect of claims for breaches of any Fundamental
Representation; _provided_ , _further_ that in respect of any inaccuracy of
any representation or warranty disclosed after the date of this Agreement
pursuant to _Section 5.6_ with respect to which ( _i_ ) the material facts,
events or conditions, as applicable, which caused such inaccuracy first
occurred after the date of this Agreement (or in the case of Litigation, a
notice is first received by the Company or any of its Subsidiaries after the
date of this Agreement) and ( _ii_ ) the Company first had Knowledge after the
date of this Agreement, only a Loss (or series of related Losses) with respect
to such supplementally disclosed matters in excess of $500,000 shall be deemed
to be a Qualifying Loss.

  


 

  

(c) None of the Parent Indemnified Parties or the Seller Indemnified Parties
shall be entitled to recover Qualifying Losses pursuant to _Sections 9.2(a)_
or _9.3(a)_ (as applicable) until the total amount of Qualifying Losses which
the Parent Indemnified Parties or Seller Indemnified Parties, respectively,
would recover under _Sections 9.2(a)_ , _Section 9.2(b)_ (in respect of a
breach of _Section 5.6_ as it relates to the failure to disclose any
inaccuracy of any representation or warranty _)_ or _9.3(a)_ , but for this
_Section 9.5(c)_ , exceeds $19,312,500 (the " _Deductible_ "), whereupon the
Parent Indemnified Parties and the Seller Indemnified Parties, respectively,
shall be entitled to indemnification only for such Qualifying Losses in excess
of the Deductible; _provided_ , _however_ , that the Deductible shall not
apply to Losses in respect of claims for breach of any Fundamental
Representation.

  


 

  


 

  

 

70  

  


 

  


 

  

(d) Notwithstanding anything contained herein to the contrary, nothing in this
_Section 9.5_ shall limit any Person's rights to recovery in respect of fraud.

  


 

  

(e) For all purposes of this _Article IX_ , any inaccuracy or breach of the
representations and warranties contained in this Agreement (other than the
Company's representations and warranties in the fourth sentence of _Section
3.5_ the first sentence of _Section 3.6 (a)_ , _Section 3.7(a)_ , the first
sentence of _Section 3.8_ , and _Sections 3.9(a)_ and _3.14_ ), shall be
determined without reference to the terms "material," "materially," "Material
Adverse Effect," "material adverse effect" or other similar qualifications as
to materiality contained or incorporated directly or indirectly in any such
representation or warranty.

  


 

  

(f) For purposes of determining the amount of any Losses subject to
indemnification under _Section 9.2_ , the amount of such Losses will be
determined net of all liabilities that are specifically accrued for the matter
subject to indemnification and reflected in the Final Working Capital.

  


 

  

(g) If any portion of Losses to be reimbursed by the Responsible Party is
determined to be covered, in whole or in part, by Third Party Insurance
coverage of the Company as of the date hereof and any DandO "tail" coverage
pursuant to _Section 5.10_ , the Indemnified Party shall promptly give notice
thereof to the Responsible Party (a " _Notice of Insurance_ "). If the
Responsible Party so requests within one hundred eighty (180) calendar days
after receipt of a Notice of Insurance, the Indemnified Party shall use its
commercially reasonable efforts to collect the maximum amount of insurance
proceeds thereunder, in which event all such proceeds actually received, net
of costs reasonably incurred by the Indemnified Party in seeking such
collection, shall be considered "Eligible Insurance Proceeds". Any amount
payable by a Responsible Party pursuant to this _Article IX_ shall be paid
promptly and payment shall not be delayed pending any determination of
Eligible Insurance Proceeds. In any case where an Indemnified Party recovers
from a third Person any Eligible Insurance Proceeds and/or any other amount in
respect of any Losses for which a Responsible Party has actually reimbursed
such Indemnified Party pursuant to this _Article IX_ , such Indemnified Party
shall promptly pay over to the Responsible Party such Eligible Insurance
Proceeds and/or the amount so recovered (after deducting therefrom the amount
of expenses incurred by it in procuring such recovery), but not in excess of
the sum of (i) any amount previously paid by the Responsible Party to or on
behalf of the Indemnified Party in respect of such claim and (ii) any amount
expended by the Responsible Party in pursuing or defending any claim arising
out of such matter.

  


 

  

(h) Any Indemnified Party shall take all commercially reasonable steps to
mitigate any Losses incurred by such party upon and after becoming aware of
any event or condition that would reasonably be expected to give rise to any
indemnification rights hereunder.

  


 

  

(i) If the Indemnified Party receives any payment from a Responsible Party in
respect of any Losses pursuant to _Sections 9.2_ or _9.3_ and the Indemnified
Party could have recovered all or a part of such Losses from a third party (a
" _Potential Contributor_ ") based on the underlying claim asserted against
the Responsible Party, the Indemnified Party shall assign such of its rights
to proceed against the Potential Contributor as are necessary to permit the
Responsible Party to recover from the Potential Contributor the amount of such
payment.

  


 

  


 

  

 

71  

  


 

  


 

  

9.6 _Indemnification Payments and Indemnification Escrow_.

  


 

  

(a) Claims for Losses specified in any Claim Notice to which a Responsible
Party shall not object in writing within thirty (30) calendar days of receipt
of such Claim Notice (other than a Third Party Claim, which is addressed in
_Section 9.4(c))_ , claims for Losses covered by a memorandum of agreement of
the nature described in _Section 9.4(b)_ , and claims for Losses the validity
and amount of which have been the subject of judicial determination as
described in _Section 9.4(b_ ) and _Section 10.8_ hereof or shall have been
settled as described in _Section 9.4(c)_ are hereinafter referred to,
collectively, as " _Agreed Claims_ ". Within ten (10) Business Days of the
determination of the amount of any Agreed Claim (or at such other time as the
Indemnified Party and the Responsible Party shall agree), the Responsible
Party shall pay to the Indemnified Party (except in the case where a payment
has been already effected pursuant to the Indemnification Escrow Agreement) an
amount equal to the Agreed Claim by wire transfer in immediately available
funds to the bank account or accounts designated by the Indemnified Party in a
notice to the Responsible Party not less than two (2) Business Days prior to
such payment. Amounts to be paid to Parent Indemnified Parties shall be paid
solely from the Indemnification Escrow Account pursuant to the Indemnification
Escrow Agreement and the terms hereof.

  


 

  

(b) On the Survival Termination Date, Parent and the Representative shall
provide a joint written instruction, pursuant to the Indemnification Escrow
Agreement, to the Escrow Agent to deliver promptly from the Indemnification
Escrow Account to the Representative and Surviving Corporation by wire
transfer of immediately available funds all or a portion of the cash held in
the Indemnification Escrow Account, such that, following such transfer, the
amount of cash remaining in the Indemnification Escrow Account equals only the
amount, if any, of claims for indemnification under _Section 9.2_ properly
asserted prior to such date by the Parent Indemnified Parties in writing in
accordance with this _Article IX_ , but not yet resolved as of the Survival
Termination Date (such claims, " _Unresolved Claims_ ," and such portion of
cash to be transferred, the " _Indemnification Escrow Remainder_ ") _._ The
Escrow Agent shall release (x) to the Representative, an amount in cash equal
to the Common Stockholders' aggregate Ownership Percentage (in respect of such
Common Stockholders' Common Stock) of the Indemnification Escrow Remainder and
(y) to the Surviving Corporation, an amount in cash equal to the remainder
portion of the Indemnification Escrow Remainder. Upon receipt of the foregoing
amounts from the Escrow Agent and subject to _Section 2.10(d)(vi)_ , the
Representative shall promptly pay to each Common Stockholder its applicable
Ownership Percentage (in respect of such Common Stockholder's Common Stock) of
the Indemnification Escrow Remainder, and the Surviving Corporation shall
promptly pay to each Optionholder its applicable Ownership Percentage (in
respect of such Optionholder's Options) of the Indemnification Escrow
Remainder. Upon final resolution of any Unresolved Claim in respect of which
an amount had been retained (to the extent not utilized to satisfy valid
claims for indemnification pursuant to _Section 9.2_ ), Parent and the
Representative shall provide a joint written instruction, pursuant to the
Indemnification Escrow Agreement, to the Escrow Agent to deliver such amount
promptly from the Indemnification Escrow Account by wire transfer of
immediately available funds and such amount shall be paid to each Common
Stockholder and each Optionholder in accordance with the process set forth in
the preceding sentence and the terms of the Indemnification Escrow Agreement.

  


 

  


 

  

 

72  

  


 

  


 

  

(c) Promptly upon any Person becoming entitled to release of amounts from the
Indemnification Escrow Account pursuant to this _Article IX_ or the
Indemnification Escrow Agreement, Parent and the Representative shall provide
joint written instructions, pursuant to the Indemnification Escrow Agreement,
to the Escrow Agent instructing the Escrow Agent to so release such amounts;
_provided_ that the Representative may issue a unilateral instruction for
release of amounts in respect of expenses incurred by the Representative in
the defense or settlement of a Third Party Claim pursuant to _Section 9.4_ (
_c_ ) _._

  


 

  

9.7 _Exclusive Remedy._ Anything to the contrary in this Agreement
notwithstanding, the parties hereby agree that, in addition to any remedy
available pursuant to _Section 8.4_ , following the Closing, absent fraud, the
sole and exclusive remedy of a party for any breach or inaccuracy of any
representation, warranty, covenant or agreement contained in this Agreement
(or any other claims relating to this Agreement and the other documents,
certificates or agreements delivered pursuant to this Agreement) shall be the
indemnification rights set forth in this _Article IX._

  


 

  

9.8 _Tax Treatment of Indemnity Payments._ The parties hereto agree to treat
any payment made pursuant to this _Article IX_ as an adjustment to the Merger
Consideration for all Tax purposes except to the extent otherwise required by
applicable Law.

  


 

  

ARTICLE X

  


 

  

MISCELLANEOUS

  


 

  

10.1 _Amendment_. Prior to the Effective Time, this Agreement may be amended,
modified or supplemented, but only in a writing signed by Parent, the Company
and the Representative. Following the Effective Time, this Agreement may be
amended, modified or supplemented, but only in writing signed by Parent, the
Surviving Corporation and the Representative.

  


 

  

10.2 _Notices_. To be effective under this Agreement, all notices, requests,
claims, demands and other communications under this Agreement shall be in
writing and shall be delivered through electronic mail followed within one
business day by either hand delivery via courier (providing proof of delivery)
or facsimile transmission (with confirmation) to the parties at the following
addresses (or at such other address for a party as shall be specified by like
notice):

  


 

  

(a) If to the Company, addressed as follows:

  


 

  


 

  

 

73  

  


 

  


 

      |  

PharMEDium Healthcare Holdings, Inc.

   
---|--- 
     |  

c/o PharMedium Healthcare Corporation

   
     |  

Two Conway Park

   
     |  

150 North Field Drive, Suite 350

   
     |  

Lake Forest, Illinois 60045

   
     |  

Attention:

  |  

William R. Spalding

   
     |  

Facsimile:

  |  

(847) 234-1394

   
     |  

Email:

  |  

bspalding@pharmedium.com

   
   


 

      |  

with copies to (which shall not constitute notice):

   
---|--- 
     |   
     |  

Clayton, Dubilier and Rice, LLC

   
     |  

375 Park Avenue, 18th Floor

   
     |  

New York, New York 10152

   
     |  

Attention:

  |  

Rick Schnall

   
     |  |  

George Jaquette

   
     |  

Facsimile:

  |  

(212) 407-5252

   
     |  

Email:

  |  

rschnall@cdr-inc.com

   
     |  |  

gjaquette@cdr-inc.com

   
     |  |   
     |  

Debevoise and Plimpton LLP

   
     |  

919 Third Avenue

   
     |  

New York, New York 10022

   
     |  

Attention:

  |  

Kevin A. Rinker

   
     |  

Facsimile:

  |  

(212) 521-7569

   
     |  

Email:

  |  

karinker@debevoise.com

   
     |  |   
     |  

KandL Gates LLP

   
     |  

70 West Madison Street, Suite 3100

   
     |  

Chicago, IL 60602

   
     |  

Attention:

  |  

Merrick D. Hatcher, Esq.

   
     |  

Facsimile:

  |  

(312) 827-8036

   
     |  

Email:

  |  

merrick.hatcher@klgates.com

   
     |  |   
    (b) | If to the Representative, addressed as follows:   
   


 

      |  

Clayton, Dubilier and Rice, LLC

   
---|--- 
     |  

375 Park Avenue, 18th Floor

   
     |  

New York, New York 10152

   
     |  

Attention:

  |  

Rick Schnall

   
     |  |  

George Jaquette

   
     |  

Facsimile:

  |  

(212) 407-5252

   
     |  

Email:

  |  

rschnall@cdr-inc.com

   
     |  |  

gjaquette@cdr-inc.com

   
     |  |   
   


 

  


 

  

 

74  

  


 

  


 

      |  

with copies to (which shall not constitute notice):

   
---|--- 
     |   
     |  

Debevoise and Plimpton LLP

   
     |  

919 Third Avenue

   
     |  

New York, New York 10022

   
     |  

Attention:

  |  

Kevin A. Rinker

   
     |  

Facsimile:

  |  

(212) 521-7569

   
     |  

Email:

  |  

karinker@debevoise.com

   
     |  |   
    (c) | If to Parent or Merger Sub, or after the Closing, the Surviving
Corporation, addressed as follows:  
   

      |  

AmerisourceBergen Corporation

   
---|--- 
     |  

Millennium III

   
     |  

227 Washington Street

   
     |  

Conshohocken, PA 19428

   
     |  

Attention:

  |  

John G. Chou

   
     |  

Facsimile:

  |  

(610) 727-3612

   
     |  

Email:

  |  

jchou@amerisourcebergen.com

   
     |   
     |  

With copies to (which shall not constitute notice):

   
     |   
     |  

Cravath, Swaine and Moore LLP

   
     |  

825 Eighth Avenue

   
     |  

New York, NY 10019

   
     |  

Facsimile:

  |  

(212) 474-3700

  |   
     |  

Attention:

  |  

Damien R. Zoubek

  |  

Robert I. Townsend, III

   
     |  

Email:

  |  

dzoubek@cravath.com

  |  

rtownsend@cravath.com

   
   


 

  

or to such other individual or address as a party hereto may designate for
itself by notice given as herein provided.

  


 

  

10.3 _Waivers_. The failure of a party hereto at any time or times to require
performance of any provision hereof shall in no manner affect its right at a
later time to enforce the same. No waiver by a party of any condition or of
any breach of any term, covenant, representation or warranty contained in this
Agreement shall be effective unless in writing, and no waiver in any one or
more instances shall be deemed to be a further or continuing waiver of any
such condition or breach in other instances or a waiver of any other condition
or breach of any other term, covenant, representation or warranty.

  


 

  

10.4 _Counterparts_. This Agreement may be executed in counterparts and such
counterparts may be delivered in electronic format (including by fax and
email). Such delivery of counterparts shall be conclusive evidence of the
intent to be bound hereby and each such counterpart and copies produced
therefrom shall have the same effect as an original. To the extent applicable,
the foregoing constitutes the election of the parties hereto to invoke any Law
authorizing electronic signatures.

  


 

  


 

  

 

75  

  


 

  


 

  

10.5 _Interpretation_. The headings preceding the text of Articles and
Sections included in this Agreement and the headings to Sections of the
Disclosure Letter are for convenience only and shall not be deemed part of
this Agreement or the Disclosure Letter or be given any effect in interpreting
this Agreement or the Disclosure Letter. The use of the masculine, feminine or
neuter gender herein shall not limit any provision of this Agreement. The use
of the terms "including" or "include" shall in all cases herein mean
"including, without limitation" or "include, without limitation,"
respectively. Underscored references to Articles, Sections or Exhibits shall
refer to those portions of this Agreement. Any singular term in this Agreement
shall be deemed to include the plural, and any plural term in this Agreement
the singular. "Writing", "written" and comparable terms refer to printing,
typing and other means of reproducing words (including electronic format) in a
visible form. If any action under this Agreement is required to be done or
taken on a day that is not a Business Day, then such action shall be required
to be done or taken not on such day but on the first succeeding Business Day
thereafter. The words "hereof", "herein" and "hereunder" and words of like
import used in this Agreement shall refer to this Agreement as a whole and not
to any particular provision of this Agreement. Any capitalized term used in
any Exhibit or the Disclosure Letter but not otherwise defined therein shall
have the meaning given to such term in this Agreement. References from or
through any date mean, unless otherwise specified, from and including or
through and including, respectively. All references to dollars or to "$" shall
be references to United States dollars.

  


 

  

10.6 _APPLICABLE LAW_. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND
ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT
GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF.

  


 

  

10.7 _Binding Agreement_. This Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and
permitted assigns.

  


 

  

10.8 _Assignment_. This Agreement and all of the provisions hereof shall be
binding upon and shall inure to the benefit of the parties hereto and their
respective heirs, successors and permitted assigns; _provided_ that neither
this Agreement nor any of the rights, interests or obligations hereunder shall
be assigned (including by operation of law) by Parent or the Surviving
Corporation without the prior written consent of the Company and the
Representative; _provided_ that Parent and Merger Sub may assign this
Agreement (in whole but not in part) to one or more Affiliates of Parent, but
no such assignment shall relieve Parent or Merger Sub of its obligations under
this Agreement. Any purported assignment in contravention of this _Section
10.8_ shall be null and void.

  


 

  

10.9 _Third Party Beneficiaries_. This Agreement is solely for the benefit of
the parties hereto and no provision of this Agreement shall be deemed to
confer upon third parties, either express or implied, any remedy, claim,
liability, reimbursement, cause of action or other right. Notwithstanding the
foregoing, the Fully-Diluted Stockholders and the Persons referred to in
_Section 5.10_ are hereby made third party beneficiaries of this Agreement,
with (x) the Fully-Diluted Stockholders having the limited right to pursue
claims for damages and other relief, including equitable relief, for Parent's
or Merger Sub's breach of this Agreement to the extent such remedies are
expressly available to the Company pursuant to the terms of this Agreement,
including _Sections 8.2_ and _8.4_ , and (y) the Persons referred to in
_Section 5.10_ having the rights to indemnification and insurance solely with
respect to _Section 5.10_, _provided_ , _however_ , that the rights granted to
the Fully-Diluted Stockholders pursuant to this _Section 10.10_ shall only be
enforceable by the Representative on their behalf in the Representative's sole
and absolute discretion (and not directly by any such Common Stockholder or
Optionholder) and under no circumstances shall any such rights of the Fully-
Diluted Stockholders be enforceable by such Common Stockholders, Optionholders
or by any other Person acting for or on their behalf (other than the
Representative).

  


 

  


 

  

 

76  

  


 

  


 

  

10.10 _Further Assurances_. Upon the reasonable request of Parent or the
Representative, each party will, on and after the Closing Date, execute and
deliver to the other parties such other documents, assignments and other
instruments as may be reasonably required to effectuate the Merger and to
effect and evidence the provisions of this Agreement and the transactions
contemplated hereby.

  


 

  

10.11 _Entire Understanding_. The Exhibits and the Disclosure Letter
identified in this Agreement are incorporated herein by reference and made a
part hereof. This Agreement and the Confidentiality Agreement set forth the
entire agreement and understanding of the parties hereto with respect to the
subject matter hereof and supersede any and all prior agreements, arrangements
and understandings among the parties with respect to the subject matter
hereof.

  


 

  

10.12 _JURISDICTION OF DISPUTES_. IN THE EVENT ANY PARTY TO THIS AGREEMENT
COMMENCES ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN CONNECTION WITH
OR RELATING TO THIS AGREEMENT OR ANY MATTERS DESCRIBED OR CONTEMPLATED HEREIN,
WITH RESPECT TO ANY OF THE MATTERS DESCRIBED OR CONTEMPLATED HEREIN, THE
PARTIES TO THIS AGREEMENT HEREBY (A) AGREE THAT ANY LITIGATION, PROCEEDING OR
OTHER LEGAL ACTION SHALL BE INSTITUTED IN A COURT OF COMPETENT JURISDICTION
LOCATED WITHIN THE CITY OF NEW YORK, NEW YORK, WHETHER A STATE OR FEDERAL
COURT; (B) AGREE THAT IN THE EVENT OF ANY SUCH LITIGATION, PROCEEDING OR
ACTION, SUCH PARTIES WILL CONSENT AND SUBMIT TO PERSONAL JURISDICTION IN ANY
SUCH COURT DESCRIBED IN CLAUSE (A) OF THIS _SECTION 10.12_ AND TO SERVICE OF
PROCESS UPON THEM IN ACCORDANCE WITH THE RULES AND STATUTES GOVERNING SERVICE
OF PROCESS (IT BEING UNDERSTOOD THAT NOTHING IN THIS _SECTION 10.12_ SHALL BE
DEEMED TO PREVENT ANY PARTY FROM SEEKING TO REMOVE ANY ACTION TO A FEDERAL
COURT IN NEW YORK, NEW YORK); (C) AGREE TO WAIVE TO THE FULL EXTENT PERMITTED
BY LAW ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY
SUCH LITIGATION, PROCEEDING OR ACTION IN ANY SUCH COURT OR THAT ANY SUCH
LITIGATION, PROCEEDING OR ACTION WAS BROUGHT IN AN INCONVENIENT FORUM; (D)
AGREE AS AN ALTERNATIVE METHOD OF SERVICE TO SERVICE OF PROCESS IN ANY LEGAL
PROCEEDING BY MAILING OF COPIES THEREOF TO SUCH PARTY AT ITS ADDRESS SET FORTH
IN _SECTION 10.12_ FOR COMMUNICATIONS TO SUCH PARTY; (E) AGREE THAT ANY
SERVICE MADE AS PROVIDED HEREIN SHALL BE EFFECTIVE AND BINDING SERVICE IN
EVERY RESPECT; AND (F) AGREE THAT NOTHING HEREIN SHALL AFFECT THE RIGHTS OF
ANY PARTY TO EFFECT SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW.

  


 

  


 

  

 

77  

  


 

  


 

  

10.13 _WAIVER OF JURY TRIAL_. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, EACH SUCH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT
OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER, (II) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (III) EACH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (IV) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS _SECTION 10.13_.

  


 

  

10.14 _Disclosure Letter_. Disclosure in any Section of the Disclosure Letter
shall apply to any Section of this Agreement to the extent that it is
reasonably apparent on the face of such disclosure that such disclosure is
relevant to such Section of this Agreement. The inclusion of information in
the Disclosure Letter shall not be construed as an admission that such
information is material to any of the Company or the Subsidiaries. In
addition, matters reflected in the Disclosure Letter are not necessarily
limited to matters required by this Agreement to be reflected in the
Disclosure Letter. Such additional matters are set forth for informational
purposes only and do not necessarily include other matters of a similar
nature. Neither the specifications of any dollar amount in any representation,
warranty or covenant contained in this Agreement nor the inclusion of any
specific item in the Disclosure Letter is intended to imply that such amount,
or higher or lower amounts, or the item so included or other items, are or are
not material, and shall not be construed as an admission of liability or
responsibility under any Law or in any dispute or controversy. Further,
neither the specification of any item or matter in any representation,
warranty or covenant contained in this Agreement nor the inclusion of any
specific item in the Disclosure Letter is intended to imply that such item or
matter, or other items or matters, are or are not in the ordinary course of
business (except where expressly stated in the relevant representation,
warranty or covenant), and shall not be construed as an admission of liability
or responsibility under any Law or in any dispute or controversy.

  


 

  

10.15 _Severability_. Any term or provision of this Agreement that is invalid
or unenforceable in any situation in any jurisdiction shall not affect the
validity or enforceability of the remaining terms and provisions hereof or the
validity or enforceability of the offending term or provision in any other
situation or in any other situation or in any other jurisdiction. If the final
judgment of a court of competent jurisdiction declares that any term or
provision hereof is invalid or unenforceable, all other conditions and
provisions of this Agreement shall nevertheless remain in full force and
effect. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the
parties as closely as possible to the fullest extent permitted by applicable
Law in an acceptable manner to the end that the transactions contemplated
hereby are fulfilled to the extent possible.

  


 

  


 

  

 

78  

  


 

  


 

  

10.16 _Construction_. The parties have participated jointly in the negotiation
and drafting of this Agreement. In the event an ambiguity or question of
intent or interpretation arises, the language shall be construed as mutually
chosen by the parties to express their mutual intent, and no rule of strict
construction shall be applied against any party. Any reference to any federal,
state, local or foreign statute or Law shall be deemed also to refer to all
rules and regulations promulgated thereunder, unless the context requires
otherwise.

  


 

  

10.17 _Provision Respecting Representation of Company_. Each of the parties to
this Agreement hereby agrees, on its own behalf and on behalf of its
directors, members, partners, officers, employees and Affiliates, that
Debevoise and Plimpton LLP may serve as counsel to each and any of the
Representative, Fully-Diluted Stockholders and their respective Affiliates
(individually and collectively, the " _Seller Group_ "), on the one hand, and
the Company and the Subsidiaries, on the other hand, in connection with the
negotiation, preparation, execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby, and that, following
consummation of the transactions contemplated hereby, Debevoise and Plimpton LLP
may serve as counsel to the Seller Group or any director, member, partner,
officer, employee or Affiliate of the Seller Group, in connection with any
litigation, claim or obligation arising out of or relating to this Agreement
or the transactions contemplated by this Agreement, notwithstanding such
representation or any continued representation of the Company and/or the
Subsidiaries, and each of the parties hereto hereby consents thereto and
waives any conflict of interest arising therefrom, and each of such parties
shall cause any Affiliate thereof to consent to and waive any conflict of
interest arising from such representation. In addition, all communications
involving attorney-client confidences between direct and indirect holders of
Common Stock, the Company and the Subsidiaries and their respective
Affiliates, on the one hand, and Debevoise and Plimpton LLP, on the other hand,
in the course of the negotiation, documentation and consummation of the
transactions contemplated hereby shall be deemed to be attorney-client
confidences that belong solely to the direct and indirect holders of Common
Stock and their respective Affiliates (but not the Company, the Surviving
Corporation or the Subsidiaries). Accordingly, the Surviving Corporation and
the Subsidiaries shall not have access to any such communications or to the
files of Debevoise and Plimpton LLP relating to such engagement from and after
the Effective Time. Without limiting the generality of the foregoing, from and
after the Effective Time, (a) the direct and indirect holders of Common Stock
and their respective Affiliates (but not the Surviving Corporation and the
Subsidiaries) shall be the sole holders of the attorney-client privilege with
respect to such engagement, and none of the Surviving Corporation or the
Subsidiaries shall be a holder thereof, (b) to the extent that files of
Debevoise and Plimpton LLP in respect of such engagement constitute property of
the client, only the direct and indirect holders of Common Stock and their
respective Affiliates (but not the Surviving Corporation and the Subsidiaries)
shall hold such property rights and (c) Debevoise and Plimpton LLP shall have no
duty whatsoever to reveal or disclose any such attorney-client communications
or files to the Surviving Corporation or any of the Subsidiaries by reason of
any attorney-client relationship between Debevoise and Plimpton LLP and the
Company or any of the Subsidiaries or otherwise. This _Section 10.17_ will be
irrevocable, and no term of this _Section 10.17_ may be amended, waived or
modified, without the prior written consent of Debevoise and Plimpton LLP.

  


 

  


 

  

 

79  

  


 

  


 

  

10.18 _Representative_.

  


 

  

(a) The parties have agreed that it is desirable to designate a representative
to act on behalf of the Fully-Diluted Stockholders for certain limited
purposes, as specified herein. The parties have designated Clayton, Dubilier and
Rice, LLC as the initial Representative, and the Stockholder Consent and the
executed Letters of Transmittal will expressly ratify and approve such
designation.

  


 

  

(b) The Company hereby agrees that Parent and the Escrow Agent shall be able
to rely conclusively on the instructions and decisions of the Representative
as to the settlement of any claims against the Purchase Price Adjustment
Escrow Amount pursuant to the Purchase Price Adjustment Escrow Agreement, to
the settlement of any claims against the Indemnification Escrow Amount
pursuant to the Indemnification Escrow Agreement or as to any actions required
or permitted to be taken by the Representative hereunder or under the Purchase
Price Adjustment Escrow Agreement or the Indemnification Escrow Agreement.

  


 

  

(c) All out-of-pocket fees and expenses (including legal, accounting and other
advisors' fees and expenses, if applicable) reasonably incurred by the
Representative in performing any actions under this Agreement, the Purchase
Price Adjustment Escrow Agreement or the Indemnification Escrow Agreement will
be paid out of the Representative Escrow Account from time to time, as and
when such fees and expenses are incurred and at the Representative's sole
discretion. In addition, the Representative shall have the right to recover
such fees and expenses from the Indemnification Escrow Account from any amount
that would otherwise be distributed to the Fully-Diluted Stockholders and,
prior to such distribution, shall deliver to the Escrow Agent a certificate
setting forth such fees and expenses actually incurred. The Representative
shall establish such terms and procedures for administering, investing and
disbursing any amounts from the Representative Escrow Amount as it may
determine in its reasonable judgment to be necessary, advisable or desirable
to give effect to the provisions of this Agreement. If any balance of the
Representative Escrow Amount remains undisbursed at such time as all disputes,
claims and other matters relating to the transactions contemplated by this
Agreement, the Purchase Price Adjustment Escrow Agreement and all other
instruments and agreements to be delivered pursuant hereto have been finally
resolved, then the Representative shall distribute to each Fully-Diluted
Stockholder, by wire transfer of immediately available funds to an account (or
by check to an address) designated by each Fully-Diluted Stockholder, such
Fully-Diluted Stockholder's Ownership Percentage of such remainder balance of
the Representative Escrow Account.

  


 

  

(d) Each of the Company, Merger Sub and Parent acknowledges and agrees that
the Representative is a party to this Agreement solely to perform certain
administrative functions in connection with the consummation of the
transactions contemplated hereby. Accordingly, each of the Company, Merger Sub
and Parent acknowledges and agrees that the Representative shall have no
liability to, and shall not be liable for any Losses of, any of the Company,
Merger Sub, Parent or the Surviving Corporation in connection with any
obligations of the Representative under this Agreement or otherwise in respect
of this Agreement or the transactions contemplated hereby, except to the
extent such Losses shall be proven to be the direct result of fraud by the
Representative in connection with the performance of its obligations
hereunder.

  


 

  


 

  

 

80  

  


 

  


 

  

(e) All of the indemnities, immunities and powers granted to the
Representative under this Agreement shall survive the Effective Time.

  


 

  

(f) The Representative hereby represents and warrants to Parent and Merger Sub
that:

  


 

  

(i) The Representative has been duly formed and is validly existing as a
limited liability company under the laws of the State of Delaware. The
Representative has all requisite power and authority to execute and deliver
this Agreement, the Indemnification Escrow Agreement and the Purchase Price
Adjustment Escrow Agreement.

  


 

  

(ii) The execution and delivery by the Representative of this Agreement, the
Indemnification Escrow Agreement and the Purchase Price Adjustment Escrow
Agreement and the performance by the Representative of its obligations
hereunder and thereunder do not and will not conflict with or violate any
provision of any applicable law, rule or regulation of any Governmental
Authority applicable to, or the organizational documents of, the
Representative.

  


 

  

(iii) Except (A) for filings under _Section 2.3_ , (B) for filings under the
HSR Act, and (C) as set forth in Section 3.3 of the Disclosure Letter, no
notice to, filing with, or authorization, registration, consent or approval of
any Governmental Authority is necessary for the Representative's execution of
this Agreement or the Purchase Price Adjustment Escrow Agreement, the
Indemnification Escrow Agreement or its consummation of any of the
transactions contemplated hereby and thereby.

  


 

  

10.19 _Release_. Effective as of the Closing Date, each of Parent and the
Surviving Corporation (each, a " _Parent Releasor_ "), on behalf of itself and
its heirs, legal representatives, successors and assigns and all of the other
Related Parties, hereby releases, acquits and forever discharges, to the
fullest extent permitted by Law, each of the Fully-Diluted Stockholders, the
Representative, and each of their respective past, present or future officers,
managers, directors, trustees, shareholders, partners, members, beneficiaries,
Affiliates, employees, counsel and agents, in each case, in their respective
capacities as such, or in connection with the direct or indirect investment in
the Company (each, a " _Seller Releasee_ ") of, from and against any and all
actions, causes of action, claims, demands, damages, judgments, debts, dues
and suits of every kind, nature and description whatsoever (collectively, "
_Claims_ ") which such Parent Releasor or its heirs, legal representatives,
successors or assigns ever had, now has or may have on or by reason of any
matter, cause or thing whatsoever prior to the Effective Time resulting or
arising from or relating to the Seller Releasee's status as such, or in
connection with the direct or indirect investment in the Company. Each Parent
Releasor agrees not to, and agrees to cause its respective Affiliates and
subsidiaries and all of the other Related Parties not to, assert any such
Claim against the Seller Releasees after the Effective Time. Notwithstanding
the foregoing, each Parent Releasor and its respective heirs, legal
representatives, successors and assigns and all of the other Related Parties
retain, and do not release, their rights and interests (x) under this
Agreement or the transactions contemplated hereby, (y) with respect to any
Claim or Liability solely to the extent resulting from a Seller Releasee's
fraud or criminal act or (z) with respect to any Claim or Liability to the
extent resulting from a Seller Releasee's status as an Employee.

  

  

  

 

81  

  


 

  

[Signature pages follow]

  

  

  


 

  

 

82  

  


 

  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed and delivered as of the date first above written.

  


 

  

  


 

  


 

  


 

  

     | PHARMEDIUM HEALTHCARE HOLDINGS, INC. |   
---|---|--- 
     |  |  |   
     |  |  |   
     |  |  |   
    

  |  

By:

  | /s/ William R. Spalding  |   
     |  | Name: William R. Spalding |   
     |  | Title: Chief Executive Officer |   
     |  |  |   
  

  

  

  

  

 

     | AMERISOURCEBERGEN CORPORATION |   
---|---|--- 
     |  |  |   
     |  |  |   
     |  |  |   
    

  |  

By:

  | /s/ Steven H. Collis  |   
     |  | Name: Steven H. Collis |   
     |  | Title: President and Chief Executive Officer |   
     |  |  |   
  

  

 

  

  

 

  

     | PARIS ACQUISITION CORP. |   
---|---|--- 
     |  |  |   
     |  |  |   
     |  |  |   
    

  |  

By:

  | /s/ Steven H. Collis  |   
     |  | Name: Steven H. Collis |   
     |  | Title: President |   
     |  |  |   
  

  

  

  

  

 

     | CLAYTON, DUBILIER and RICE, LLC, in its capacity as REPRESENTATIVE |
  
---|---|--- 
     |  |  |   
     |  |  |   
     |  |  |   
    

  |  

By:

  | /s/ Theresa A. Gore  |   
     |  | Name: Theresa A. Gore |   
     |  | Title: Vice President, Treasurer and Assistant Secretary  |
  
     |  |  |   
  

  

 

 

  

 

  

      '

